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Nowadays, there are many statistical methods available for genetic association analyses with 
data various designs. However, it is usually ignored in these analyses that an analytical 
method must be appropriate for an experimental design from which data is collected. In 
addition, association study is a population-based analysis and, thus its inference is highly 
vulnerable to many population-oriented confounding factors. This thesis starts with a 
comprehensive survey and comparison of those methods commonly used in the literature of 
genetic association study in order to obtain insights into the statistical aspects and problem of 
the methods. 
 
On the basis of these reviews, we managed to calculate the optimal trend set for the 
Armitage’s trend test for different penetrance models with a high level of genetic 
heterogeneity. We introduced two new strategies to adjust for the population stratification in 
association analyses. We proposed a maximum likelihood estimation method to adjust for 
biases in statistical inference of linkage disequilibrium (LD) between pairs of polymorphic 
loci by using non-random samples. In the process of the analysis, we derived a more 
sophisticated but robust likelihood-based statistical framework, accounting properly for the 
non-random nature of case and control samples. Finally, we developed a multi-point 
likelihood-based statistical approach for a genome-wide search for the genetic variants that 
contribute to phenotypic variation of complex quantitative traits. We tested these methods 
through intensive simulation studies and demonstrated their application in analyses with large 
case and control SNP datasets of the Parkinson’s disease. 
 
Despite that we have mainly focused on SNP data scored from microarray techniques, the 
theory and methodology presented here paved a useful stepping stone approach to the 
modeling and analysis of data depicting genome structure and function from the new 
generation sequencing techniques. 
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CHAPTER I  
GENERAL INTRODUCTION 
 
Since genes and chromosomes were found, most traits of human beings or any living things 
were believed to be controlled by one or more genes as well as a degree of environmental 
modifications (Kearsey and Pooni, 1996). These traits include not only height, weight, colour 
of eyes of humans, flowering time of plants and most of other biological characters people are 
familiar with, but also many genetic-oriented disorders such as Huntingdon’s disease (Walker, 
2007), Parkinson’s disease (Lesage and Brice, 2009), type II diabetes (McCarthy, 2010) and 
etc.. All those traits show various levels of genetic influence. Naturally, most traits are 
polygenic or complex and do not follow the Mendelian inheritance patterns, e.g. height of 
human, as opposed to the simple monogenic traits, e.g. Huntingdon’s disease. For complex 
traits, how many genes are responsible, where and what are they, and how do they act 
individually and jointly are hence the key initial questions to be answered by geneticists 
(Mackay, 2001). To answer such questions, a full picture of the genetic architecture between 
genes and traits has to be outlined, with the most comprehensive and ultimate goal  of 
depicting a completely resolved network among genome, transcriptome, proteome, 
metabolome and finally the phenotype of traits (Figure I-1). However, people’s 
understandings of such networks are still too limited to fully explain the determination from 
genes to complex traits, and hence either the direct analysis between gene and trait or certain 





Figure I-1. Network from genotype to phenotype. 
 
 
Although the pioneer work of mapping causal genes underlying polymorphic traits could be 
traced back to 1910s (Sturtevant, 1913), it has not yet been largely implemented for human 
traits until 1980s (Botstein et al., 1980) when restricted fragment length polymorphisms 
(RFLPs) could be readily verified in the genome (Petes and Botstein, 1977). With an 
established genetic map of sequence polymorphisms, Botstein and his colleagues (1980) 
suggested that, instead of mapping causal genes directly, people could map genetic 
polymorphic loci which are linked to the genes responsible for the trait phenotypes. Such 
genetic loci identified in mapping studies were later named as quantitative trait loci (QTLs). 
Literally, ‘quantitative’ might imply continuity, and hence quantitative traits are generally 
opposite to discrete traits. However, the meaning of quantitative trait is generally broadened 
to any polygenic traits even while they are not continuous, such as Parkinson’s disease and 
type II diabetes. Apart from the ultimate phenotypes at the organism level, e.g. the disease 
symptoms, Schork (1997) suggested mapping genes for intermediate phenotypes, e.g. the 
variation of gene expression levels or the hormone amounts. It is not only biological because 
such analysis could help to bridge the gap between genotypes and the ultimate phenotypes, 
but also statistical because the causal genes are expected to have larger impacts on 
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intermediate phenotypes than the ultimate one, allowing a higher chance to detect the 
genotype-intermediate phenotype relationship. Following Schork’s suggestion, the concept of 
‘genetical genomics’ was proposed by Jansen & Nap (2001) to map QTLs for mRNA 
abundances on the genome, namely the expression QTLs (e-QTLs). Later a genome-wide e-
QTL analysis conducted by Brem et al. (2002) in the budding yeast proved the gene-gene 
interaction or epistasis through identifying the trans-acting regulators, which influence the 
expression levels of one or more other genes. This landmark study illuminated a promising 
path to construct the gene regulatory network or pathway, and hence e-QTL mapping has 
become one of the hottest topics in the past decade (Ronald et al., 2005; Kendziorski et al., 
2006; Wray, 2007; Potokina et al., 2008; Holloway and Li, 2010; Druka et al., 2010). 
However, even with a fully constructed gene regulatory network, there is still a long way to 
go before bridging the gap between the transcriptome and the ultimate phenotype, i.e. the 
proteome and metabolome. To bridge the remaining gaps, following the same idea as the e-
QTL analysis, pioneer work in both the protein QTL (p-QTL) (Foss et al., 2007; Melzer et al., 
2008) and the metabolic QTL (m-QTL) (Wentzell et al., 2007; Ferrara et al., 2008) has 
already been launched, and it is possible that the fast developing technologies could enable 
the full scale of proteome and metabolome QTL analyses in the coming future and lead to a 
more comprehensive understanding of the gene-trait network. 
 
The research into the gene-trait network and the QTL analysis is not only for purely scientific 
purpose, but also for the intensive demands from many areas, such as agriculture, animal 
husbandry and human public health. For agriculture and animal husbandry, once the causal 
genes of interest traits are known, the efficiency of selections for plants and animals could be 
largely improved, especially for some rare traits. For public health, the detection of high risk 
genes not only helps to warn about a possible disease, but also assists in developing better 
disease treatment. For example a new concept of pharmacogenomics attempts to localize the 
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variations in genes that dictate individual specific response to particular drugs, i.e. the 
efficacy and toxicity, and finally to reach the goal of genetic aided personalized prescriptions 
(Limdi and Veenstra, 2010). Along with the traditional genetic applications above, genetic 
engineering such as gene cloning and modification could also benefit from mapping precise 
gene locations (Kearsey and Pooni, 1996). 
 
1.1 Genetic Markers 
Valid QTL mapping requires markers which could identify each individual as well as provide 
sufficient polymorphism, to detect linkages between the marker and the trait of interest. 
Before the first generation of genetic markers, i.e. RFLP, was introduced in the late 1970s 
(Petes and Botstein, 1977), morphological markers, e.g. certain phenotypic variants 
polymorphisms caused by mutations at a certain loci, were the primary choice since late 
1920s (Stadler, 1929). However, although such morphological markers had been proved to be 
effective for Mendelian traits in certain plants and animals, they are quite vulnerable to 
pleiotropy and multiple levels of heterogeneities. The polymorphic variation of morphological 
markers might also be reduced if dominance, deleterious effect and rare variants are present. 
These drawbacks hinder the application of morphological markers (Worland et al., 1987) and 
hence a new type of marker, i.e. the genetic marker, with both reliability and consistent high 
polymorphism, i.e. being consistently co-dominant, is highly desirable (Farooq and Azam, 
2002). 
 
A genetic marker is a stretch of polymorphic DNA sequence with a known location in the 
genome that could be used to identify genes as well as individuals. A genetic marker might be 
as long as a whole gene or as short as a single nucleotide. Due to its polymorphic nature, the 
genetic marker is often used interchangeably with the genetic polymorphism and the genetic 
variant if we are not emphasizing on its location in the genome. Since all heritable 
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information is believed to be carried by DNA, the genotypic variations at genetic markers are 
stable and hence represent the fundamental of any phenotypic variations at higher network or 
pathway levels. On the other hand, most genetic markers are co-dominant and hence are 
constantly highly polymorphic comparing to the morphological markers introduced above. 
Following RFLP, a series of succeeded genetic markers have been discovered, such as RAPD 
(random amplified polymorphism DNA) (Williams et al., 1990), AFLP (amplified fragment 
length polymorphism) (Vos et al., 1995), mini/microsatellite (Jeffreys et al., 1991), SFP 
(single feature polymorphism) (Winzeler et al., 1998) and SNP (single nucleotide 
polymorphism). Among all these genetic markers, SNPs are probably the most popular 
nowadays. The popularity of SNPs is not only because they are wide spread across the 
chromosomes (as many as 10 millions in the human genome that may account for 
approximately 90% of genetic variants in the genome), but also because of their binary 
property that is very suitable for statistically modelling.  
 
The belief of ‘common disease, common variant’ implies that the wide spread common SNPs, 
of which the minor allele frequency (MAF) is larger than 5%, could explain most of the 
common diseases, and such a belief becomes the driven idea of establishing the HapMap 
project to identify common SNPs in the human genome. Phases I+II of the HapMap project 
have identified approximately 3 million SNPs (Frazer et al., 2007), and the newly released 
Phase III released 1.6 million SNPs with a larger sample size and more divergent genetic 
background than the former two Phases (Altshuler et al., 2010). The growing availability of 
high density and genome-wide distributed SNP markers facilitates the genome scale fine 
mapping of QTLs, i.e. the so-called genome-wide association study (GWAS), in hope of 
identifying, at the molecular level, the causal genes or the quantitative trait nucleotides (QTNs)  
responsible for the variation of trait of interest. However, although hundreds of GWAS have 
reported thousands of candidate SNPs associated with complex traits in the past few years 
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(Donnelly, 2008; Ku et al., 2010), the collective effects of candidate common SNPs could 
only explain a very small proportion of the heritability for most of the analysed traits. The 
‘missing heritability’ failed to be accounted for by common SNPs implies remarkable 
contributions from less common (1% < MAF < 5%) or rare (MAF < 1%) SNPs, or other 
structural variants including insertion/deletion and inversion (Goldstein, 2009). 
 
Recently, Yang and his colleagues (2010) revealed that rare variants might be responsible for 
at least 40% variance of human height that was still missing after calculating the joint 
contribution of all SNPs with MAF > 1%, whereas the reported 50 candidate SNPs could only 
explain about 5% of the whole variance. This result further addresses the urgent demand of 
QTL analysis with rare variants. Although several pioneer studies of QTL mapping with rare 
variants, mainly rare SNPs, have been conducted (Bansal et al., 2010; Ku et al., 2010), they 
are mainly based on targeted candidate genes but are not at a genome-wide scale. It would be 
an intuitive idea to establish a comprehensive map of all genetic variants including rare 
variants to perform the genome-wide QTL analyses. However, the bottle-neck of the current 
genotyping methods impedes such attempts. The difficulty comes down to lacking affordable 
high throughput genotyping platforms or technologies that are feasible for detecting all type 
of variants (Scherer et al., 2007). In fact, because of technique limitations, almost all 
genotyping is partial and even contains errors. Take SNPs for example, the genotyping error 
rate is typical over 0.1% with the current array-based techniques (Hao et al., 2004; Saunders 
et al., 2007; Yeung et al., 2008), which is comparable to or even higher than the occurring rate 
of certain rare SNPs, rendering such genotyping strategies impractical for rare variants. 
Therefore, a reported singleton or low copy SNP in a sample may be very likely due to an 
error signal rather than a real hit. Ignoring such errors might cause serious biases for the QTL 
analyses. By acknowledging this fact, an advanced genotyping technique with reduced error 




Recent applications of the next-general sequencing (NGS) techniques are capable of 
producing millions of sequence reads in a single run, providing in-expensive genome-wide 
sequence solutions in a massively parallel manner with an unimaginable speed (Shendure and 
Ji, 2008; Metzker, 2010). For example, the 1000 Genome Project is utilizing NGS techniques 
to identify less common SNPs and structural variants as well as their haplotype contexts for 
HapMap populations (www.1000genomes.org). Compared to the ideal genotyping strategy, 
the current NGS techniques still have some limitations, e.g. the error rate of single read is 
relatively high, especially for certain variants (>1%) (Shendure and Ji, 2008). However, such 
a drawback could be compensated through increasing read coverage. It is believed that the 
capability for NGS to produce enormous sequencing data inexpensively is extremely 
attractive, and given the fast development of techniques, it is quite optimistic that above 
shortages will soon be overcome.  
 
1.2 Strategies for QTL Mappings 
1.2.1 Ideal Population and Random Sampling 
It would be necessary to clarify several basic concepts and assumptions before the 
introduction of QTL mapping strategies, as they represent the fundamental factors of 
establishing reliable statistical approaches for QTL analyses. 
 
Assumption of constant allele frequency 
In a natural population, it would be practical to assume that allele frequencies keep 
approximately constant throughout all generations unless the following disturbances cannot 
be ignored (Falconer, 1989): 
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Selection: Selection, either natural or artificial, alters the viability and/or fertility of 
individuals, and hence the individuals containing certain phenotypes that are favoured by 
selections could generate more offspring for the next generation than the individuals with less 
favoured phenotypes. In the presence of selective pressure, the proportion of favoured 
phenotypes will tend to increase in the population, and the allele frequencies of the genes 
underlying such phenotypes will hence be shifted. Note here, the selection here is mainly 
referred to as directional selection, where only one allele is favoured by selection and its 
frequency will tend to be consistently increased. Other types of selection might not 
significantly result in the shift of allele frequencies, e.g. disruptive selection and stabilizing 
selection. 
Recurrent Mutation: Unlike a random mutation, which is very likely to get lost during the 
evolution of a population, the recurrent mutation at the same genetic locus, however, will 
eventually survive.  
Migration: Either into or out of a population, the allele frequencies of the new population 
might hence change forever if the original population and the migrations have different allele 
frequencies at certain loci.  
Genetic Drift: In a small population, each allele will have its frequency drift randomly 
generation by generation and eventually get fixed or lost.  
 
It should be noted here that, excluding the genetic drift, the influence of allele frequencies 
from the other disturbing factors are directional and hence the impact could be exactly 
evaluated. More importantly, the influences from more than one such directional disturbing 
factor might finally reach equilibrium such that the allele frequencies will still stay constant 
henceforward, e.g. balance between mutation and selection. From such a consideration, it 
would be quite reasonable to assume the allele frequencies keep constant over generations for 




Random mating and Hardy-Weinberg equilibrium 
Following the assumption of constant allele frequency, if the genotype frequencies also keep 
constant over generations, such a population would be referred as following the Hardy-
Weinberg Equilibrium (HWE). Although it is not always necessary, random mating, which 
assumes each pair of gametes from the same gene pool would have the same chance to unite, 
is the sufficient condition for HWE jointly with the assumption of constant allele frequency, 
and hence is often implied with the assumption of HWE. For any given genetic marker locus 
with alleles M and m from a random mating diploid species, frequencies of marker genotypes 
MM, Mm and mm are expected to be 2
Mp , 2 M mp p and
2
mp  respectively, where Mp  is the 
frequency of allele M and mp  is the frequency of allele m. If the allele frequencies keep 
constant over generations, the genotype frequencies under random mating will also do so, and 
hence the HWE is acquired. However, consider another diploid population with the same 
marker alleles M and m but without any heterozygotes, the frequencies of genotype MM, Mm 
and mm are hence Mp , 0 and mp  respectively. If all individuals from such a population are 
strictly selfing with the same fertility, without any of the disturbances as introduced above, 
both the allele and genotype frequencies are also constant over generations and thus the HWE 
holds without random mating. Although such a strictly selfing species does not exist in nature 
because it lacks genetic diversity and hence it is vulnerable to natural selections, similar 
situations could be found in artificially inbred lines, e.g. barley and Arabidopsis. As a 
conclusion from above discussions, given the assumption of constant allele frequency, 
random mating is the necessary and sufficient condition of HWE in an outbred population, 
otherwise the HWE might not be valid. 
 
Along with the inbreeding mentioned above, non-random mating could also be naturally 
found with assortative mating, which could be either positive, where individuals would prefer 
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to mate with other similar individuals, or negative, where individuals would prefer to mate 
with dissimilar individuals. The positive assortative mating will generally result in the 
decrease of heterozygotes, similar to the effect of disruptive selection in the absence of over-
dominance, where the extreme phenotypes are favoured, and the negative assortative mating 
will result in the increase of heterozygotes, similar to the effect of stabilizing selections in 
absence of over-dominance. Although assortative mating will not change the allele 
frequencies (Falconer, 1989), it does affect the hold of HWE as the frequency of 
heterozygotes will shift. 
 
A population under HWE and free from all disturbances, e.g. selection, migration, mutation, 
could be named an ideal population. In many occasions, the population size of such an ideal 
population is assumed to be infinite, where the probability of inbreeding under random mating 
could be neglected. 
 
Random and Non-random Samples 
The phrase ‘Random Sample’ normally indicates a sample that is collected through simple 
random sampling without replacement from a given population, where each individual has the 
same chance to be selected. For convenience, the sampling population could be assumed ideal, 
which is quite practical for population based association study in humans. If the sample size is 
large enough, the random sample thus collected could be expected to hold all properties that 
an ideal population has, i.e. HWE, free from selection, migration, recurrent mutation and 
genetic drift. Any random sample discussed in this thesis will be referred to as being 
randomly collected from an ideal population henceforward unless otherwise specified. Note 
that, even in presence of population stratification, it is still reasonable to assume samples are 




1.2.2 Linkage Based QTL Analysis 
The genetic linkage describes the tendency of the haplotype of any two or more genetic loci to 
inherit together during the process of meiosis. Intuitively, such a tendency could be 
straightforward measured by the recombination fraction, denoted as r, i.e. the chance of two 
genetic loci to experience a recombination or segregation process during meiosis. It is easy to 
understand the range of r as [0, 0.5], where the lower bound is acquired if two genetic loci are 
completely linked to each other and hence are always inherited as a single locus, and the 
upper bound is acquired if two genetic loci are completely unlinked, either from different 
chromosomes or distant separated on the same chromosome to allow them to segregate freely. 
 
From the definition of genetic linkage given above, the more tightly linked to each other two 
genetic loci are, the smaller recombination fraction they will have, and we could hence 
establish statistical methods to map candidate QTLs of a specific trait through inferring the 
recombination fractions between a putative QTL and the genetic markers, i.e. statistically 
testing whether or not 0.5r = . In order to obtain an estimate of recombination fraction or its 
equivalences between any pair of genetic loci, family-based pedigree data are required, which 
is simply because the recombination event could only be observed during meiosis. Although 
the linkage analysis has been proved efficient for many Mendelian traits, especially 
Mendelian diseases caused by high-risk mutations in humans (Cui et al., 2010), the concern of 
the highly limited resolutions has been repeatedly mentioned and discussed (McMillan and 
Robertson, 1974; Lander and Botstein, 1989; Boehnke, 1994). It is easy to understand that 
since the recombination fraction is defined as the chance of segregation between two genetic 
loci during meiosis, while, without sufficient meiotic events, it would be impossible to 
accurately estimate r and hence to establish an informative statistical test (Silver, 1985). 
Hence, in order to improve the mapping resolutions, we may choose either or both of the 
following solutions to increase the number of recombination events: (1) increase the number 
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of individuals at each recombination generation, and (2) increase the number of segregating 
generations.  
 
Due to both the ethical and practical limits, the pedigree data of humans could not be acquired 
through planned breeding in labs as plants and animals, and hence the collection of pedigree 
data for humans is far more challenging (Feingold, 2001). Due to the difficulty in collecting 
large pedigree samples, more and more geneticists turn to the association study as introduced 
in the following section for better mapping resolutions. 
 
More details about the methods of performing linkage analysis please refer to Risch (1990a, b, 
c) and Feingold (2001). 
 
1.2.3 Linkage Disequilibrium Based QTL Analysis 
Assume that two alleles at a bi-allelic marker locus are denoted as M and m  with allele 
frequencies Mp  and mp  respectively, and similarly two alleles at a QTL denoted as A  and a  
with allele frequencies Ap  and ap  respectively (Table I-1). The difference between the 
observed and expected haplotype frequency under random paring of marker and QTL alleles 
is defined as the coefficient of linkage disequilibrium (LD) between these two loci, i.e. 
MA M AD f p p= − , where MAf  is the frequency of the haplotype MA. This simple algebraic 
equation shows that, if alleles M and A are randomly paired together in the population, it is 
easy to calculate MA M Af p p=  and hence D = 0, while on the contrary, if alleles at the marker 
locus and QTL are not randomly segregating but tend to link to each other through, for 






Table I-1. The Settings of Marker and Trait Loci. 
Locus Marker QTL 
Allele M m A A 
Frequencies Mp  mp  Ap  ap  
 
As stated above, the disequilibrium parameter D is defined statistically rather than 
biologically. Here I would like to clarify the relationship between D and recombination 
frequency r before presenting a statistical model of LD based QTL mapping. Consider a 
random mating population free of mutation, immigration or generation overlapping. We can 
safely assume that the frequencies of marker allele M  and QTL allele A  at the next 
generation, say Mp′  and Ap′  respectively, are equal to those at the current generation. Because 
the haplotype MA at the next generation is either inherited from haplotype MA of the current 
generation without recombination or randomly formed by M and A gametes if crossover 
happens, the frequency of haplotype MA at the next generation could be calculated as 
(1 )MA MA M Af r f r p p′ = − × + × × , where r is the recombination fraction between these two loci, 
from which the LD coefficient between the marker and trait loci at the next generation could 
be calculated as  
 (1 )( ) (1 )n MA M A MA M AD f p p r f p p r D′ ′ ′= − = − − × = − . (I-1.1) 
Formula (I-1.1) shows that the LD will decrease with a factor 1 r−  from one generation to the 
next, and if a population evolves for a certain number of generations, only those strongly 
linked loci, i.e. with very small r, could remain to be in significant linkage disequilibrium. 
Given such a feature, LD is hence eligible to detect the genetic linkage other than the 
recombination fraction, but with the potential of providing higher mapping resolutions. 
Ideally, the initial LD arises as a mutation was introduced into a population, but other events, 
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e.g. immigration, might also contribute to LD, the situation of which will be discussed in 
section I-1.2.4. 
 
Denoting the LD parameter between the marker and QTL loci at generation 0 by D0 and 
assuming allele frequencies keep constant across generations, the LD between the two loci at 
the T-th generation can be expressed as 
 0(1 )
T
TD r D= − . (I-1.2) 
Formula (I-1.2) shows that the LD will decay with a factor of 1 r−  from one generation to the 
next. It is also clear that after segregating for a number of generations, only those closely 
linked loci, i.e. those with very small r, will remain in significant LD. Therefore, estimates of 
LD in a random mating population can be used to detect the genetic linkage between 
polymorphic loci. Unlike a family based linkage study which relies on pedigree information, 
LD analysis can be applied to a wide range of populations, with the potential of providing 
much higher mapping resolution because it exploits accumulated historical recombination 
events. 
 
Besides the most prominent LD measure, D as defined above, there are several other 
measures of LD which are frequently used in the literatures. For example, Lewontin (1964) 




















where max min( , )M a m AD p p p p= and min max( , )M A m aD p p p p= − . D′  takes values in the 
domain [0, 1] irrespective of the allele frequencies. With such a property, it would be more 




Another commonly used alternative measurement of LD is defined as the correlation 
coefficient between alleles at two loci. If we assign alleles M and A with value 1, and alleles 
m and a with value 0, it could be easily shown that 
( ) ME M p= , 
2( ) ME M p=  
( ) AE A p= , 
2( ) AE A p= . 
As ( ) MAE MA f= , the correlation coefficient (r) between alleles M and A could be derived by 
 
MA MA M A
M A M m A a M m A a
f p p D
r




= = = , (I-1.4) 
 




Aσ  are the variance of 
alleles M and A respectively. 
 
1.2.4 Advantages and Challenges of Linkage Disequilibrium Based QTL 
Analysis 
Compared to the linkage based analysis, an association study does not require a known 
relationship between individuals and hence it could be applied to any population based data, 
which has the advantages of both easy access and abundant data to be collected (Williams-
Blangero and Blangero, 2006). Moreover, the feature of LD as shown in formula (I-1.1) could 
lead to a much higher mapping resolution than a linkage based analysis, which is because the 
LD automatically inherits the historical recombination information of the population 
evolvement, even if the data of those previous generations are actually not available, and the 
recombination fraction could only be evaluated from observed individuals. 
 







The first challenge comes from the population stratification or admixture (Chakraborty and 
Smouse, 1988). Population stratification means a population of interest is composed of 
multiple subpopulations which are systematically different in allele frequencies. This 
phenomenon could naturally be introduced through the migration of genetically isolated 
populations, and could also be due to the collection of data from different genetic orientations, 
e.g. different allele frequencies at certain genetic loci. If such a stratified population evolves 
with interbreeding among its subpopulations, the new population hence formed would be 
referred to be with population admixture. Note here, an admixed population may also 
naturally evolve from an ideal population under the pressure of disruptive selections or 
positive assortative mating, and if such processes are extremely strong or persist long enough, 
genetically isolated subpopulations may eventually be generated and thus the population 
stratification remains. For simplicity but without loss of generality, only the case of 
population with two isolated subpopulation, i.e. with population stratification, will be closely 
evaluated below to illustrate the impact of the population stratification on association studies. 
Suppose there are two marker loci with alleles A, a and B, b respectively, and both loci have 
their allele frequencies denoted as ( )XP A , ( )XP B  for a random mating population X and 
( )YP A , ( )YP B  for a random mating population Y. The coefficients of LDs in populations X 
and Y respectively could be simply given as ( ) ( ) ( )X X X XD f AB P A P B= −  and 
( ) ( ) ( )Y Y Y YD f AB P A P B= −  following the definition, where ( )Xf AB  and ( )Yf AB  are the 
frequencies of haplotype AB in population X and Y respectively. If the sizes of X and Y are of 
proportion :1m m− , the LD coefficient in the stratified population could be calculated as: 
 
( ) ( ) ( )
( ) (1 ) ( ) [ ( ) (1 ) ( )][ ( ) (1 ) ( )]
(1 ) (1 )[ ( ) ( )][ ( ) ( )]
X Y X Y X Y
X Y X Y X Y
D f AB P A P B
mf AB m f AB mP A m P A mP B m P B
mD m D m m P A P A P B P B
= −
= + − − + − + −





where D is the coefficient of LD in this stratified population and ( )f AB , ( )P A , ( )P B  are the 
corresponding frequencies of haplotype AB, allele A and allele B respectively. It could be 
noticed that the first two terms of formula (I-1.5), i.e. XmD  and (1 ) Ym D− , are due to the LDs 
in each subpopulation and the third term, i.e. (1 )[ ( ) ( )][ ( ) ( )]X Y X Ym m P A P A P B P B− − − , is due 
to the population substructure. It is thus clear from formula (I-1.5) that even if there is no real 
LD between loci A and B in each subpopulation, i.e. 0XD =  and 0YD = , a level of 
association between these two loci in the stratified population might still be observed unless 
either ( ) ( )X YP A P A=  or ( ) ( )X YP B P B= . Meanwhile, since the third term of formula (I-1.5) 
could either be positive or negative, such a structure effect might reduce the observed LD to 
almost null even with a real LD. It is hence very important to control the influence of 
population substructure in an accurate and reliable LD-based QTL analysis mapping. For 
convenience, the LD introduced through population stratification, i.e. the third term in 
formula (I-1.5), will be referred to as the structural LD henceforward. 
 
Consider an admixed population, if generation of structural LD is not recurrent, e.g. due to 
one event of immigration, after tens of generations, the structural LD could only survive 
between loci with strong linkage. In this situation, structural LDs may only cause the 
detection of spurious association if they are newly introduced. On the other hand, as the 
structural LDs hence introduced will increase the LD between two closely linked loci 
permanently, it is possible that benefits from analysing an admixed population could be 
acquired if it has evolved for a sufficient long period free from those confounding factors 
(Risch, 1992; Zheng and Elston, 1999). However, if the generation of structural LD is 
recurrent, e.g. multiple immigrations or assortative mating events, the structural LD will be 
kept among all loci that were influenced by those processes, even if they are on different 
chromosomes. Since the positively assortative mating is fairly common in humans and many 
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other species, it would be worthwhile to recognise that loci not under the pressure of such a 
process are free from the structural LD (Redden and Allison, 2006), which could be easily 
understood through noticing that the positive assortative mating does not change the allele 
frequencies of the whole population, and hence even a stratified population was eventually 
formed, the allele frequency of any a locus free from the assortative mating process should be 
identical among all subpopulations in the absence of genetic drift. However, Redden and 
Allison (2006) warned that if multiple traits are jointly or systematically under the positive 
assortative mating, e.g. the good looking people are more likely to be married to smart and 
rich people, all related loci under such selections will tend to be associated with each other, 
which might hence complicate the situation of association studies for certain traits. 
 
To adjust for the effect of population stratification in association studies, there are basically 
two different strategies. Firstly, assuming such effects are genome-wisely identical or similar, 
the global inflation factor λ  could be computed to justify the structure as the method named 
as Genomic Control (GC) suggested by Devlin & Kathryn (1999). Secondly, the structure 
effect for each marker locus respectively could be evaluated given a known population 
structure which, if unknown, could be acquired through principal component analysis, 
abbreviated as PCA (Price et al., 2006), or Pritchard’s STRUCTURE (Pritchard et al., 2000), 
and the second strategy is usually known as Structured Association (SA). Among all three 
methods, GC is the computationally easiest to implement. However, several studies have 
shown that GC may suffer certain loss of power if the inflation factor can not be assumed 
constant across the genome (Yu et al., 2006; Price et al., 2006; Rakovski and Stram, 2009), 
and hence it might be more practical to treat such effects locally. Of the other two, PCA is 
generally easier and much faster than Pritchard’s STRUCTURE, whereas Pritchard’s method 
enjoys the ability of inferring the probability of any individual being related to a particular 
subpopulation. However, as STRUCTURE assumes random mating in each of the 
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subpopulations, which might not be valid in inbreeding species, e.g. barley and rice, the 
application of STRUCTURE are hence limited to outbreeding species. Also, as the number of 
subpopulation may never be exactly indicated, the question of how to efficiently and properly 
integrate the information acquired from STRUCTURE is another issue under debate (Balding, 
2006). Comparatively, PCA does not have such limitations and could be generally 
implemented for many datasets.  
 
Genetic heterogeneity and cryptic relatedness 
The second challenge mainly comes from the nature of complex traits, the genetic 
heterogeneity, where multiple genes are responsible for a similar or identical trait. If it is 
controlled by multiple genes, an ideal statistical model for a complex trait would be expected 
to integrate all genetic factors together and identify all candidate genes at once. However, as 
there is still little knowledge about those responsible genes, e.g. number, location, function 
and interaction, such an ideal statistical model is still a vain hope. One of the simplest 
solutions is to identify candidate genes one by one and the contributions from the rest, i.e. the 
background gene effect, could be treated as residual effects to the gene under test. If all 
individuals are independent of each other and the normality assumption could be applied, 
these residual effects could be absorbed into the non-biological terms and the statistical model 
will be fairly simple. However, in the presence of genetically related individuals, where the 
independent assumption does not stand, a mixed linear model with multivariate normal 
distribution could be implemented, where the kinship of relatives are introduced through the 
covariance matrix (Lange, 1978), and this idea was later introduced into the association 
studies for pedigree data, such as the method Quantitative Transmission Disequilibrium Test 
(QTDT) (Abecasis et al., 2000; Abecasis et al., 2001). This adoption of multivariate normal 
distribution enables the association studies in either pedigree data or population based data. 
However, it should be noted here that the population based data may not be guaranteed free 
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from kinship between individuals, for example, in many inbreeding species, i.e. barley and 
rice, individuals are highly related. In such a situation, the proper estimates of the kinship 
between any pair of individuals are crucial to establish a reliable association study.  
 
The key issue to validate above methods is the assumption of the additive cumulation of 
effects from all responsible genes. Although this assumption seems quite reasonable if the 
phenotype is continuous and there is no prior information about the existence of epistasis, it 
might not stand initially if the phenotype is binary. For a complex trait with a binary 
phenotype, i.e. the situation of most diseases, the genetic effect from each responsible gene 
provides extra contribution to the prevalence of the phenotype of interest in the population 
(Risch, 1990a). It is pretty easy to understand that such contributions are not additive and the 
inclusion-exclusion principle has to be applied, for example, suppose the contributions of 
prevalence from two genes are denoted as α  and β  respectively, their joint contribution 
would be 1 (1 )(1 )α β αβ α β+ − = − − − . Generally, such interactions, e.g. the term αβ  may 
not be ignored if the multiple gene effects are explicitly included in the model. One of the 
possible solutions for binary trait is to use the generalised linear mixed models (GLMM), 
where the interaction terms could be eliminated through certain transformations, and the 
kinship information between relatives could be hence implemented. However, as no analytic 
form of interpreting certain integrations regarding random effects could be acquired for 
GLMM, certain approximations or numerical integration techniques have to be involved 
(Breslow and Clayton, 1993). Due to both its mathematical complexity and computational 
demands, the GLMM has not been widely implemented into association study regarding the 
kinship of relatives.  
 
Although the GC model actually considered both population stratification and cryptic 
relatedness between individuals, as has been discussed above, the general control of all 
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marker loci with the same inflation factor is so restricted that the statistical power might be 
largely reduced. One of the most comprehensive strategies to overcome both above two 
obstacles, i.e. the population stratification and the genetic heterogeneity with relatedness, was 
introduced by Yu, J. and his colleagues in 2006. In their model, the effect of population 
stratification was considered as a fixed effect and was corrected through the introduction of 
dummy variables; the background gene effects are treated as random effects, as suggested by 
Lange (1978) and Abecasis (2000), where each individual is assumed to have its own 
background gene effect randomly chosen from the same normal distribution, and hence the 
covariance matrix of this random effects could be written as 22 σK , where K is the kinship 
matrix among individuals and 2σ  is the variance of random effects. In case the information 
about the population stratification and the relatedness among individuals are unknown, the 
first several principal component vectors could be introduced to replace the dummy variables 
in order to correct for population stratifications (Price et al., 2006) and the pairwise identity 
by descent (IBD) among individuals could be estimated from various strategies (Schork, 1993; 
Pong-Wong et al., 2001). However, although Yu’s strategy is generally valid for continuous 
traits, as has been mentioned above, in the case of binary phenotypes, the additive model of 
background gene effects will be violated. As the phenotypes of many traits of interest are 
binary, e.g. most diseases, more reliable and accurate strategies that could properly account 
for the relatedness among individuals for binary phenotypes are still highly demanded. 
 
Compared to the association study, both above obstacles have no or limited impact on the 
linkage analysis. For the population stratification, because the recombination fraction does not 
depend on allele frequencies, whereas LD does, it is normally believed that the linkage 
analysis is free from the influence of population stratification. However, Wang & Elston 
(2005) pointed out that population stratification should also have impacts on certain linkage 
analysis designs if part of the founders’ genotypes are missing. For example, if the parental 
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genotypes of affected sib-pairs are missing, the allele frequencies will be deeply involved in 
estimating the IBD between sib-pairs, and hence the bias of allele frequencies introduced by 
population stratification will result in the bias of inferred linkage between markers and the 
putative QTL. Nevertheless, if all information of founders is available, the linkage analysis 
will be free of the population stratifications. One such design, transmission disequilibrium test 
(TDT), integrates both the benefit from linkage analysis and association studies that it is free 
from the population stratification as the linkage analysis and it confers the high mapping 
resolution of the association study (Spielman and Ewens, 1993; Ewens and Spielman, 1995). 
However, as it significantly increases the burden of sampling (Cardon and Palmer, 2003), it 
will not be so efficient to adopt the TDT unless the population stratification is clearly of 
concern. On the other hand, since the occurrence of disease in one family is very likely due to 
only one casualty gene, the influence of  genetic heterogeneities in the linkage analysis is 
similar to that of population stratifications, and hence generally will not cause spuriously 
detected QTL. However, it has been pointed out that the genetic heterogeneity might result in 
the loss of power to detect a real QTL in the linkage analysis (Dizier et al., 2000). As the 
relationship among individuals is usually clear, the modelling of genetic heterogeneity with 
relatedness could be easily accomplished as suggested by Lange (1978) and Abecasis (2000). 
As a conclusion, the comparison between linkage analysis and association study is listed in 
Table I-2. Although the LD-based QTL analysis has above two main obstacles, both its 
mapping resolution and sampling advantages proclaim its superiority to the linkage-based 
QTL analysis, and hence the association study becomes more and more a dominant approach 







Table I-2. The Comparison of Linkage Analysis and Association Study. 
 Linkage Analysis Association Study 
Type of Data Pedigree Data Population and Pedigree Data 
Sample Size Small or Median Large 
Mapping Resolution Low High 





1.3 Structure of the Thesis 
This thesis could be divided into two parts, both of which share the same purpose of 
improving the performance of statistical methods in association studies while dealing with 
two major confounding factors, i.e. population stratification and non-random sampling. 
 
In Chapter II-1, commonly used statistical methods for various study designs in association 
analyses are introduced. This is followed by Chapter II-2 which investigates and compares 
those existing methods in their performance and equivalence. Then a thorough investigation 
of the choice of trend coefficients in the Armitage’s trend test is introduced in Chapter II-3 to 
optimize its statistical performance, where it will be shown that the genetic heterogeneity 
could largely influence the ‘optimal’ choices. Two strategies for controlling population 
stratification in Armitage’s trend test are also introduced to enable joint analysis of data from 
multiple cohorts. Intensive simulation study and re-analysis of recently published Parkinson’s 
disease case and control data demonstrate that the newly developed method confers 
significantly improved statistical power for detecting the associations compared to the original 




Chapter III presents two different likelihood based statistical strategies for association 
analyses. Chapter III-1 introduces a new strategy of inferring LD between two genetic loci 
from non-random samples. Such a strategy is later extended into the association analysis 
between the genetic marker and the QTL for case and control data in Chapter III-2. It will be 
shown that the above mentioned method for association study confers improved power and 
flexibility enabling different confounding factors of the disease trait to be tested. Chapter III-3 
introduces a likelihood based association analysis which integrates the information from both 
LD and recombination fraction in order to predict QTLs within marker intervals. 
 
1.4 Preliminaries 
1.4.1 Statistical hypothesis test 
When referring to a statistical test, people are mainly talking about a statistical hypothesis test, 
which is designed to distinguish probability distributions from one of which a series of 
questioned random variables are generated. In order to perform such a test, a paradigm 
developed by Neyman and Pearson (Rice, 1994) is the most commonly used approach. The 
probability distributions are divided into two groups, say null hypothesis denoted by 0H  and 
alternative hypothesis denoted by AH , and a statistic T(X) of the question sample values X is 
obtained to determine whether or not to reject 0H  by comparing T(X) to pre-set acceptance 
and rejection regions. While applying the Neyman-Pearson paradigm, four kinds of outputs 
might be yielded as shown in Table I-3. It is common to denote the probability of type I and II 
errors as α  and β  respectively. The probability that the null hypothesis ( 0H ) is rejected 
when the alternative hypothesis ( AH ) is true is referred to as the power of the test, which 
clearly equals to 1 β−  from Table I-3. A ‘good’ test would have both α  and β  very small, 
however, given a fixed sample size, these two probabilities are traded off with each other;  as 
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α  decreases, β  must increase, and vice versa. In practice, α  is fixed to a preset value and a 
statistic T(X) is then constructed to minimize β , and hence performances of different tests are 
compared for their power under this scheme. 
 








Null Hypothesis ( 0H ) is True 
Correct Decision 
P=1-α  
Type I Error 
(False Positive) 
P=α  
Alternative Hypothesis ( AH ) is True 
Type II Error 
( False Negative) 
P= β  
Correct Decision 
P=1- β  
 
Along with the paradigm, the Neyman-Pearson Lemma was introduced to construct an 
optimal statistic T(X) to minimize β , and this Lemma states ‘among all tests with a given 
probability of a type I error, the likelihood ratio test minimizes the probability of a type II 
error’ (Rice, J.A. 1995), where the definition of likelihood ratio test will be given later. This 
Lemma provides a clear strategy to construct an optimal statistic, and jointly with the 
Neyman-Pearson paradigm any statistical hypothesis test could be constructed if only the 
likelihood functions under both null and alternative hypotheses are available. It could be 
noted here that likelihood ratio test is an approach or strategy to establish a statistical test 
rather than a simple statistical test as its name indicated, where there are several other 
strategies available, such as the Bayesian approach. However, due to the advantages of the 
likelihood ratio test, where it is ‘almost always applicable and is also optimal in some cases’ 
(Casella and Berger, 2002), the likelihood ratio test is probably the most commonly used 
approach.  
 














and a corresponding test is constructed to examine whether µ  is significantly different from 
0µ . With such a concept, the statistical hypothesis test is also named ‘test of significance’ by 
Fisher (1925a), and the rate of type I error, α , is hence called the ‘significance level’ of the 
test. Note here, since the null hypothesis and alternative hypothesis are mutually exclusive to 
each other, for convenience only the null hypothesis will be mentioned afterward unless 
otherwise necessary. 
 
With the above hypothesis, suppose there are random variables 1X , …, nX  following 
2( , )N µ σ  independently, where µ  is unknown, estimated as sample mean X , and 2σ  is 
known, a significant level α  means 0 0:H µ µ=  would be rejected if 0 0X xµ− > , where 0x  
is determined by equation ( )0 0P X xµ α− > = . If 0 0:H µ µ=  is true, the equation could be 
solved as 
0 / 2X
x zασ= , where Xσ  is the standard deviation of X , i.e. X n
σσ = , and 
/ 2
zα  is 
the upper / 2α  point of the standard normal distribution Z. 
0
H  is thus accepted if 
0 / 2X
X zαµ σ− ≤ , and hence the 100(1 )%α−  confidence interval for 0µ  is 







= , which follows  the 
standard normal distribution if X µ−  and 2
X
σ  are distributed independently, is clearly a 
statistic test of the given hypotheses with the acceptance region 
/ 2 / 2
[ , ]z zα α− , and is hence 




If 2σ  is unknown in the above example, an unbiased estimate of the population variance 
















, and by keeping all the other procedures the same, in the 
new example,  the 100(1 )%α−  confidence interval for 0µ  is 1, / 2 1, / 2[ , ]n nX XX s t X s tα α− −− + , 
where 
X




=  and 
1, / 2nt α−  is the upper / 2α  point of 






=  follows the Student’s t distribution with 1n−  degrees of freedom, and is hence 
named the T-statistic test of the hypotheses with the acceptance region 







= , given a sufficiently large sample size n, the T-statistic and the Z-
statistic are asymptotically equivalent. 
 
In the above statistical hypotheses tests, the null hypothesis 
0 0
:H µ µ=  will be rejected while 
µ  is either sufficiently large or small, and such a statistical test could be referred as a two-
tailed test. Alternatively, if the null hypothesis changes to 
0 0
:H µ µ≤  or 
0 0
:H µ µ≥ , the 
corresponding statistical test would be one-tailed, which could be easily derived following a 
similar procedure. It could also be noted here that the Z statistic could be alternatively derived 




1.4.2 Maximum Likelihood Estimator (MLE
1
) and Likelihood Ratio Test 
(LRT) 
Suppose there are random variables 
1
X , …, 
n
X  with a joint density or frequency function 
1 2 1 2
( , ,..., | , ,..., )
n k
f X X X θ θ θ , where k, n Z +∈ , i.e. positive integers, and θ  denote unknown 
parameters, and the corresponding likelihood function is defined as: 
1 2 1 2
1 2 1 2
( | ) ( , ,..., | , ,..., )
             ( , ,..., | , ,..., )
k n
n k
L L X X X









X  are assumed to be i.i.d. (independent identically distributed) the likelihood function 
could be rewritten as:                                    
 1 2
1




L f X θ θ θ
=
= ∏Xθ . (I-1.6) 
Because the likelihood function is established as the joint density or frequency function of 
random variables, it represents the probability of observing such data given a set of unknown 
parameters. The idea of a maximum likelihood procedure is to inverse the logical dependence 
between data and parameters by evaluating the most possible or likely values of unknown 
parameters given the observed data. Note here, the likelihood function (I-1.6) is often referred 
as the complete likelihood function, where the joint probability of all observations, X, is 
adopted. On the other hand, other forms, i.e. prospective and retrospective, of likelihood 
functions are also available, where a part of the whole observations X, says 
1
X , could be 
assumed to be conditioned on the rest observations, says 
2
X , either prospectively or 
retrospectively, and the conditional density or frequency function, i.e. ( | )f
1 2
X X , is adopted 
instead of the joint one, i.e. ( )f X . Despite the equivalence between prospective and 
retrospective likelihood functions under certain restrictions that have been intensively 
discussed (Prentice and Pyke, 1979; Weinberg and Wacholder, 1993; Roeder et al., 1996; 
Murphy and Van der Vaart, 2000), it has been pointed out that if the sufficient statistics of 
                                                 
1
 Without causing any misunderstanding, MLE, as well as later mentioned abbreviations, will be used as the 




X  could be directly given irrespective of parameters θ , and such statistics are thus ancillary 
to θ , the conditional likelihood function is statistically equivalent to the complete one 
(Kalbfleisch and Sprott, 1970; Sprott, 1975; Smyth and Verbyla, 1996). 
 
In the absence of boundaries, if the likelihood function is differentiable on its domain, the 












, 1,...,i k= . (I-1.7)  
Note that equations (I-1.7) are not the sufficient condition to maximize ( | )L Xθ , not even to 
ensure local maxima/minima (extrema), and hence in order to search the global maximum, the 
second (partial) derivative equations could be applied in presence of the second-order (partial) 
derivatives of ( | )L Xθ  that if 







 exists for any 0 ,i j k< < , ,i j Z +∈ , the Hessian 
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. (I-1.8)  
If all the eigenvalues of ( ( | ))cLH Xθ  are positive, i.e. ( ( | ))cLH Xθ  is positively definitive, it 
could be concluded that cθ  is the global maximum of ( | )L Xθ  in the absence of boundary. 
However, if some eigenvalues of ( ( | ))cLH Xθ  equal 0 while the rest are positive, 
( ( | ))cLH Xθ  is a singular matrix and is inconclusive, so further effort is required to infer 
whether cθ  is the MLE or not in this circumstance. In case of boundaries applied, both 
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boundaries and local maxima of ( | )L Xθ  have to be checked to determine the true global 
maximum. In practice, people would prefer to deal with the natural logarithm of ( | )L Xθ , 
( | )l Xθ , rather than ( | )L Xθ  itself, where this transformation introduce several advantages. 
Firstly, ( | )l Xθ  shares any coincident extrema with ( | )L Xθ  given that the logarithm 
function is monotonically increasing on its domain (0, )+∞ ; Secondly, ( | )l Xθ  has superb 
mathematical advantages over ( | )L Xθ  given that the likelihood function takes the form of 
function (I-1.6) in most of the time; Thirdly, this transformation enables the use of several 
important statistical methods, such as Fisher’s information matrix (Fisher, 1925b) and Rao’s 
score test (Rao, 1948). 
  
However, equations (I-1.7) may not be directly solved analytically due to the complexity of 
the likelihood function, and hence either numerical or indirect estimates are required. In such 
a case, the Expectation-Maximization algorithm (EM algorithm) could be applied to find the 
MLE iteratively (Dempster et al., 1977). Although EM algorithm was initially designed to 
find the MLE from incomplete data, e.g. the missing marker genotypes, it could equivalently 
deal with unobserved data, such as the QTL genotypes. In early 1990s, Meng, X. & Rubin, D. 
B. (1993) introduced a class of generalised EM algorithm called Expectation Conditional 
Maximization algorithm (ECM algorithm) that uses a sequence of sub-Conditional 
Maximization (CM) steps instead of a single M-step, which may be still rather complicated, 
and hence it could simplify the computation of MLE further. The procedure of performing 
ECM algorithm to deal with unobserved data could be briefly introduced as follow:  
 
Given observed data X and unobserved data Y, the full data log-likelihood function of 
parameters θ  could be given as ( | , ) log Pr( , | )l =X Y X Yθ θ . The t+1-st E step of ECM 
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algorithm calculates the expectation of the full data log-likelihood conditioned on unobserved 
data Y with parameters tθ  from the t-th CM step, and hence it could be given as: 
( | ) log[Pr( , | )] ( | , )t tcl f d= ∫X, X Y Y X Yθ θ θ θ  if Y is continuous 
 Or (I-1.9) 
( | ) log[Pr( , | )]Pr( | , )t tcl =∑
Y
X, X Y Y Xθ θ θ θ  if Y is discrete,  
where ( | , )tf Y X θ  and Pr( | , )tY X θ  are the corresponding density or frequency functions of 
unobserved data Y conditional on observed data X and parameters tθ . The t+1-st CM step 
then updates each parameter one by one through maximizing ( | )tcl X,θ θ  following the 
sequence 
1
1 2( , ,..., | ) ( | )
t t t t t t
c k cl lθ θ θ+ ≥X, X,θ θ θ  
1 1 1
1 2 3 1 2( , , ..., | ) ( , ,..., | )
t t t t t t t t t
c k c kl lθ θ θ θ θ θ θ+ + +≥X, X,θ θ  
… 
1 1
1 1( | ) ( ,..., , | )
t+1 t t t t t
c c k kl l θ θ θ+ +−≥X, X,θ θ θ . 
Given a proper initial point 0θ , the iterative product, tθ , of t-th ECM-step is promising to 
converge to the MLE of θ , and hence for a given convergence criterion δ  achieved at 0 -tht  
iteration, i.e. 1( | ) ( | )t tl lδ +≥ −X Xθ θ , for any 0t t> , the algorithm will yield the approximate 
MLE of θ  such that 0t
c≈θ θ . 
 
Obviously, the ECM procedure does not require the Hessian Matrix but only the second-order 
partial derivative of each sub-CM-step is required to maximize each sub-step, and hence not 
only the computational requirement is reduced but the issue of singular Hessian Matrix could 
also be avoided, because it could be much easier to calculate higher-order partial derivatives 
with respect to a particular parameter and conclude its exact characteristic at a certain point 
than to evaluate the characteristics of several parameters simultaneously. It could be noticed 
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that following the procedure of functions (I-1.9) to construct the CM-step at each iteration, the 
partial derivatives of ( | )tcl X,θ θ  will keep the same form but with updated ( | , )tf Y X θ  (or 
Pr( | , )tY X θ ) and tθ , and hence in the following chapters only ( | , )tf Y X θ  or Pr( | , )tY X θ  
will be updated in E-steps instead of evaluating an updated ( | )tcl X,θ θ . 
 
As mentioned in section 1.4.1, the likelihood ratio approach is a powerful method in statistical 




sup ( | )
( )











,    (I-1.10) 
with a rejection region [0, c], where 0Θ  and Θ  denote the null and full parameter spaces, and 
c, with the definition domain 0 1c≤ ≤ , could be specified given the exact form of ( )λ X  with 
a certain significant level. Suppose 0θˆ  and θˆ  are the MLEs of θ  in parameter space 0Θ  and 











,  (I-1.11) 
which hence reveals the relationship between MLE and LRT. 
 
With formula (I-1.11) and certain assumptions, the distribution of ( )λ X  might be derived 
analytically and hence a direct statistical hypothesis test could be performed, e.g. Z-statistic 
given the assumption of normality. However, it is really difficult or even impossible to do so 
if the likelihood function is very complicated. In such a situation, a widely used asymptotic 
LRT could be performed by acknowledging that 
 
22log ( ) dfλ χ− X ∼ , (I-1.12) 
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where df is determined by the difference of dimensions between 0Θ  and Θ  (Rice, 1994). 
Alternative to the LRT, another likelihood-based Rao’s score test (Rao, 1948) could be 
established under the null hypothesis. Assigning  
1











θ θθ , 
it could be derived 
1 2
0 0 0
ˆ ˆ ˆ( ) ( ) ( )T dfχ−U I U ∼θ θ θ , 
where the df is defined the same way as in formula (I-1.12) of the LRT, U is often referred as 
the score matrix, and 0 0
ˆ ˆ( | ) ( | )TE E= − =I H UUθ θ  is the Fisher’s Information Matrix. 
 
Note here, since 2χ  distribution with 1 degree of freedom is defined as 2Z , where 
(0,1)Z N∼ , 2χ  test with 1 degree of freedom is hence identical with Z test. For consistence 
purpose, the 2χ  test with 1 degree of freedom will be mainly used rather than the Z test 
throughout this thesis. 
 
1.4.3 Linear Regression Analysis 
Linear regression model is the most widely used strategy to perform an association-based 
QTL mapping given its flexibility, manipulability and widely accepted validity. Generally, a 
linear regression model would have the following form 
 = +y Xb ε  with ( )E =y Xb  or ( ) 0E =ε , (I-1.13) 
where 
1 2( , ,..., )
T
ny y y=y  is the 1n×  column vector of dependent variables, b is the 1m×  
column vector of regression coefficients, X is the n m×  matrix of independent variables, and 
ε is a 1n×  column vector of the deviates defined as ( )E−y y , often referred to as the residual 
term. The variance-covariance matrix, V, of ε  defines the statistical property of function (I-
1.13). If 2σ=V I , where I is the identity matrix, function (I-1.13) gives the fixed effect model, 
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where especially, while 2m = , function (I-1.13) gives the simple linear regression model. 







= +∑V Ω I , where 
each Ω  is a n n×  symmetric matrix with its elements 1ijΩ ≤  and 1iiΩ =  for any 
, 1, 2,...,i j n= , function (I-1.13) gives the mixed model. Another form of function (I-1.13), i.e. 







= +∑V Ω I  and Xb  is a constant. Since 
both fixed and random effect models are special cases of the mixed model, it is convenient to 
start with introduction of the mixed model. 
 
Alternative to function (I-1.13), the mixed model could be written into the form:  
 = + +y Xb Zu e , (I-1.14) 
with assumptions:  
E
   
=   




   
=   




where Z  could be partitioned into k sub-matrices that ( )1 k=Z Z Z… , of which iZ  is a 
kn m×  design or incidence matrix of a full column rank with its element equalling 1 or 0; u is 





























, where 2 2/i e iγ σ σ= , and Ti i i=G u u  is a matrix 
need to be specified before use. By noticing that T
i i i i=Ω Z G Z , it could be shown that 
k
T T
i i i i
i
∑Z u u Z  2
k
T
i i i i
i
σ= ∑Z G Z  2
k
T
e i i i i
i
σ γ= ∑ Z G Z  and 2 ( )
k
T
e i i i i
i
σ γ= +∑V I Z G Z . It is clear 
that the variance component set 2 2:{ , | 1, }e i i kσ σΘ =  is functionally identical to 2:{ , }eσ′Θ γ  to 
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define the exact form of V, where γ  is defined as a 1k ×  column vector with its ith element 
iγ , and hence for convenience, both Θ  and ′Θ  will be regarded as the variance components 
in following discussions. 
 
Before we carry on deep discussion of estimating variance components in mixed model, 
several simpler cases will be discussed here where the variance components are easy to be 
handled. 
 
The best linear unbiased estimator (BLUE) of regression coefficients b of function (I-1.14) is 
given by: 
 T 1 1 T 1ˆ ( )− − −=b X V X X V y  (I-1.15) 
and the variance of this estimate is 
 T 1 1ˆ( ) ( )Var − −=b X V X , (I-1.16) 
where V must not be singular and X  must be of full column rank, or certain kinds of 
generalised inverse matrices have to be adopted. Searle (1971) emphasized that the estimates 
acquired by the use of generalised inverse matrix, in case either V or T 1−X V X  is singular, 
cannot be named as estimator given that the corresponding solution from a generalised inverse 
matrix relies on the exact form of the chosen generalised inverse matrix and hence in later 
chapters certain modifications will be presented in order to avoid the singularity and retain an 
unique estimator. 
 
Considering a special case where 2
eσ=V I , function (I-1.14) is the mixed model and reduced 
to the form 
 = +y Xb e  (I-1.17) 
  
36 
with assumptions ( ) 0E =e  and 2( ) eVar σ=e I . The corresponding BLUE of regression 
coefficients b  now is  
 T 1 Tˆ ( )−=b X X X y  (I-1.18) 
with its variance 
 T 1 2ˆ ˆ( ) ( ) eVar σ
−
=b X X , (I-1.19) 
and an unbiased estimator of 2
eσ  could be directly given as 
 
2 1 ˆ ˆˆ ( ) ( )Te
n m
σ = − −
−
y Xb y Xb . (I-1.20) 
With the assumptions that the estimator of b, bˆ , is of normal distribution, i.e. 
T 1 2ˆ ( , ( ) )eN σ
−b b X X∼ , and statistics bˆ  and 2ˆ
eσ  are independent with each other, a series of t-
tests or 2χ  tests against the null hypothesis 0H : 0ib =  could hence be performed for each 
element of bˆ .  
 
In a special case where 2m = , function (I-1.17) could be reduced further to the simple linear 












y 1 e  (I-1.21) 
with assumption ( ) 0E =e  and 2( ) eVar σ=e I . Formulae (I-1.18), (I-1.19) and (I-1.20) could 
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=     
   





ˆ ˆ ( ) ( )
ˆ ˆ( 1) ( ) 1
e
x





   −
=   
























=  is the estimator of 
correlation between x and y. Given the assumption that 
2
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∼ , with a sufficient 









β χβ =∼ . Note here, since the test is performed under the null hypothesis, where the 
null hypothesis 0β =  implies that y and X are uncorrelated, it could hence be derived that 











, and with a large sample size n, the test statistic could be 









β ρ χβ =≈ ∼ . It should be also noted here that in 
certain circumstances, the null hypothesis may be 0H : β η= , where 0η ≠ , as will be 








β η χβ =
−

∼ , where we use the estimation of η, i.e. η , rather than its estimator, i.e. ηˆ , to 
indicate that we treat η as a known parameter and its variance will not be included in the 
denominator of the 2χ  test. 
 
By now, none of above derivations needs the normality assumption that 2( , )eN σe 0 I∼  and 
2( , )eN σu 0 G∼ , under which following results could be obtained straightforward by given 
definition (I-1.14) (Searle, 1971):  
a. 2( , ( ))
k
T
e i i i i
i
N σ γ+∑y Xb I Z G Z∼  
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b. 1 1ˆ ( , ( ) )TN − −b b X V X∼ , 2 ( )
k
T
e i i i i
i
σ γ= +∑V I Z G Z  and 
c. bˆ  are distributed independently with 2ˆ
eσ . 
It could be noticed here that results b and c are coincident with the assumptions being given to 
validate a 2χ  test against the null hypothesis 0H : 0ib = . Moreover, an F-statistic test is also 
available to test for significance of the null hypothesis 0H : 0=b , e.g. different genotypes are 
assumed to have different genetic effects. 
 
The normality assumption also enables the use of MLE and LRT for the mixed model, and 
equation (I-1.14) could be alternatively expressed in the likelihood function under the 
multivariate normal distribution: 







= − − − 
 
b γ y X y Xb V y Xb
V
. (I-1.25) 
The MLE of b from function (I-1.25) could be given by solving: 
T 1
T 1










y Xb V y Xb
b b
y Xb V X , 
which yields 
T 1 1 T 1ˆ ( )− − −=b X V X X V y . 
This result is identical with the BLUE as given by formula (I-1.15). 
 
Unlike the fixed effect model, where 2
eσ=V I , the bˆ  given as BLUE from formula (I-1.14) or 
MLE from formula (I-1.25) depends on the exact form of covariance matrix V , and hence γ , 
of which the ith element iγ  is defined at function (I-1.14), has to be estimated before or 
simultaneously with an estimate of b  being properly derived. However, to estimate variance 
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components in a mixed model may be rather difficult especially while the data is unbalanced, 
where no close form of estimators is available. The balanced data is defined with an equal 
sub-class sample size while the unbalanced data is otherwise. Although, there are many 
different strategies to estimate the variance components, for convenience, two most famous 
methods will be focused here, i.e. MLE and restricted maximum likelihood (REML) estimator, 
and some of the other methods will also be mentioned. 
 
Following the maximum likelihood paradigm (I-1.7) and (I-1.8), the MLE of likelihood 
function given by function (I-1.25) should meet the following requirement: 
























= + − − =
∂






( ) ( ) ( ) 0
2 2
T T T







= − + − − =
∂
Z H Z y Xb H Z Z H y Xb , (I-1.28) 
where logl L= , 2/ ( )
k
T
e i i i i
i
σ γ= = +∑H V I Z G Z  and ( )1 k=Z Z Z… . Equations (I-1.26) 
and (I-1.27) could be solved explicitly to be  
 1 1 1ˆ ( )T T− − −=b X H X X H y  (I-1.29) 
   
 ( )2 1 1 1 1 11ˆ ( ) ( )T T T Te
n
σ − − − − −= −y H y y H X X H X X H y .   (I-1.30) 
However, the explicit forms of equations (I-1.28) are available only under certain 
circumstances even with a balanced design of data (Miller, 1977) and the corresponding exact 
analytic solutions of variance components have been given by Szatrowski & Miller (1980), 
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also see Corbeil & Searle (1976a). For unbalanced data, where no analytic MLE of variance 
components is available, an iterative procedure introduced by Hartley & Rao (1967) could be 
implemented to calculate the variance components numerically. Later, Hemmerle & Hartley 
(1973) introduced a computing algorithm, i.e. the W-transformation, which could reduce the 
dimension of matrices from the sample space into the parameter space and hence largely 
reduce the tremendous computing load of inverting the covariance matrix V, where they also 
noted that their algorithm would not yield negative estimates of variance components. 
However, the MLEs of variance components for unbalanced data have been proved to be 
biased in many occasions (Corbeil and Searle, 1976a; Wu et al., 2001). Although the iterative 
procedure introduced by Hemmerle & Hartley (1973) will not yield negative estimates of 
variance components, the MLE might eliminate the interaction terms during the iterative 
process and hence yield a zero estimate for those terms under certain circumstances even 
while such effect does exist (Corbeil and Searle, 1976a). Note that these interaction terms are 
not included in the mixed model as introduced at function (I-1.14). 
 
In order to deal with the bias introduced by MLE, the restricted maximum likelihood (REML) 
estimators of variance components was introduced by Corbeil & Searle (1976b), which are 
believed to retain less bias than the MLEs (Wu et al., 2001). The idea of REML was adopted 
from Patterson, H. D. and Thompson, R. (1971) to partition the likelihood function (I-1.25) 
into two parts, one of which is free from the fixed effect and hence the variance components 
could be estimated straight without the interference from the fixed effect. Initially, Patterson 








, where 1( )−′ ′= −S I X X X X  is 
symmetric and idempotent. It is easy to show that SX  is null and hence 2(0, )N σSy SHS∼ , 
which is free from the fixed effect. Similarly it could be shown that 
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1 1 1 2( , )T T eN σ
− − −
H Xy X H Xb X H X∼  and 1( , )Cov − =Sy H Xy 0 . It could hence be claimed that 




















,   (I-1.31) 
i.e. X is defined as a design or incidence matrix similarly as Z , where 
in
1  is a 1in ×  column 
vector with all elements equalling 1, Corbeil & Searle (1976b) pointed out that 1−SH S  might 
be singular, i.e. one or more of  in  equal 1 that S is of one or more null columns and thus 
singular, and hence they suggested use of T instead, where T is produced by deleting 1n th , 
1 2( )n n th+ , …, and 1 2( )mn n n th+ + +  rows from S , and hence no null column would be 
present in T . It is easy to show that given X of form (I-1.31), T retains the same property as S, 
i.e. 0=TX , and hence  
 T T− −
   
= =   




















   
   




X H Xb X H X
∼ . (I-1.33) 
Since the two partitions of z are uncorrelated with each other as shown in (I-1.33), we could 
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.   (I-1.35) 
Likelihood function (I-1.34) is clearly free of b and the REML estimators of variance 
components 2
eσ  and γ  could be calculated from maximizing function (I-1.34). Equalizing the 
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y T THT Ty  
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THT TZ G Z T
y T THT TZ G Z T THT Ty ,                    
1,2, ,i k= … , 
where the later equation is derived by noting the facts that log (log( ))tr=M M , 
( ( )) ( ( ))d tr tr d=M M  and 1 1 1d d− − −= −M M MM , where M  is any non-singular square matrix 
and d is the differential operator. 
 
Again, there is no general analytic solution for these equations although in balanced data the 
analytic REML estimators of variance components are available (Corbeil and Searle, 1976a; 
Harville, 1977), which are identical to the analysis of variance (ANOVA) estimators of 
balanced data (Searle, 1971) and hence are unbiased but have the minimum variances among 
all possible unbiased estimators. For unbalanced data, either a general iterative procedure or a 
W-transformation procedure could be applied to give the REML estimators of variance 
components (Corbeil and Searle, 1976a). Note here, the REML estimator of b, derived from 





Alongside ML and REML, other methods are also available to work out the estimators of 
variance components, such as the generalised estimating equations (GEE) (Liang and Zeger, 
1986),  the minimum  norm  quadratic  unbiased  estimation (MINQUE) (Rao, 1971a, b) and 
ANOVA based Henderson’s methods for unbalanced data (Searle, 1971).  
 
It could be noted here, if no interaction term is present and the sample size is large enough, 
MLE and REML estimators would be very close to each other and hence in many occasions it 
is free to choose either of the methods to derive the estimates of variance components. A 
comprehensive comparison between MINQUE, Henderson’s method, ML and REML was 
made by Harville, D. A. (1977), and a further work was launched by Wu et al. (2001), which 
shows that ML, REML, GEE and MINIQUE could similarly be partitioned into mean and 
covariance functions. These could intuitively reveal the relationship among those methods. 
From the notation given by both Harville and Wu, since MINQUE does not require the 
normality assumption and as each iterative process of REML could be recognized as an 
iterative MINQUE process, both MLE and REML estimators derived under normality 
assumption might still be valid even if the distributions of the random effects and the residual 
term are undefined. Note here, as the estimates of variance components from MINIQUE 
heavily depend on initial values, MINIQUE itself is hence not recommended in practical data 
analysis for variance estimation. 
 
The statistical preliminaries introduced in this section will be repeatedly referred to in the 
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CHAPTER II  
THE COMPARISON OF LINEAR 
MODELS IN ASSOCIATION 
STUDY AND THE OPTIMAL 
TREND COEFFICIENTS IN 




CHAPTER II-1  
INTRODUCTION OF GENETIC 
MODELS AND STATISTIC METHODS 
OF ASSOCIATION ANALYSIS IN 
RANDOMLY MATED POPULATION 
1.1 Overview 
As has been introduced in General Introduction, the LD-based analysis has two important 
advantages over the linkage-based analysis in QTL mapping, i.e. the higher mapping 
resolution and more abundant resources, and hence nowadays, most QTL mappings are based 
on the inference of LD. In Chapter II-1, I will start with introduction of genetic models that 
link genetic effects of genes to a quantitative trait, followed by a brief introduction of the 
commonly used statistical methods in association analysis. Although the association analysis 
can be implemented for analysing both family and population based samples (Abecasis et al., 
2000), as the population based association analysis generally retains higher statistical power 
as well as the broader genetic background, the population based association analysis is of 
most interest nowadays (Balding, 2006) and this introduction will focus on population based 
association analyses only. 
 
1.2 Models of Quantitative Genetic Effects 
1.2.1 Explicit Model 
An explicit model assumes the observed phenotypes can directly reflect the effects of 
genotypes (the genotypic values) and environmental factors. Statistically, they are of linear 
relationship, say 
ij i ijy V ε= +  or ( )ij iE y V= , where ijy  denotes the phenotype of jth 
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individuals with ith genotype, iV  is the corresponding genotypic value of the causal genes and 
ijε  denotes the deviation of phenotype ijy  from iV  with ( ) 0ijE ε = . The explicit model is 
introduced ideally to deal with continuous phenotypes, but it can also be applied to binary 
phenotypes, where the genotypic value represents the probability, or equivalent factors, of 
taking one of the binary phenotypes given a particular genotype in the present sample.  
 
1.2.2 Implicit Model 
Implicit model considers that the genotypic values of genotypes can only determine the 
phenotype through certain threshold(s), and hence in the case of binary phenotype, the 
observed phenotype can only reflect the genotypic values through the model 
 
1                    if 













 and  φ ∈ R , (II-1.1) 
where 
ij i ijz V ε= + , iV  and ijε  have the same definition as that in explicit model, and R is the 
field of real numbers. More precisely, the implicit model belongs to the generalised linear 
model, which will be closely discussed in section II-1.4.4. 
 
1.3 Association Analysis in Random Samples 
Taking the same setting of the bi-allelic marker locus and QTL as given in Table I-1, the joint 
distributions of marker and QTL genotypes can be computed as shown in Table II-1 under the 
assumption of random mating, where Mp p= , Aq p=  and AM A M AMD f p p f pq= − = − . The 
genotypic values of QTL genotypes are denoted as AAV , AaV  and aaV , or equivalently 1V , 2V  
and 3V . If we define ( ) / 2AA aaV Vµ = + ,  AAa V µ= −  and Aad V µ= − , the genotypic values 
can be alternatively expressed as AAV aµ= + , AaV dµ= +  and aaV aµ= − , where a and d are 
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commonly denoted as the coefficients of additive and dominance effects. Without loss of 
generality, one can assume 0a > , and in the absence of over-dominance, d a≤ .  
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Table II-1. Joint Distribution of Marker and QTL Genotypes in a Random Mating Population. 
D is the coefficient of LD between marker locus and QTL; p and q are marker allele (M) and QTL (A) frequencies respectively; a and d are the additive and dominance effects of QTL. 
 QTL genotypes 
Marker genotype 
AA Aa aa 
MM 2( )D pq+  2( )[ (1 ) ]D pq p q D+ − −  2[ (1 )]D p q− −  
Mm 2( )[(1 ) ]D pq p q D+ − −  22 2 (1 2 )(1 2 ) 2 (1 )(1 )D p q D pq p q + − − + − −   2[ (1 )(1 )][ (1 ) ]D p q p q D+ − − − −  
mm 2[ (1 ) ]D p q− −  2[(1 ) ][ (1 )(1 )]p q D D p q− − + − −  2[ (1 )(1 )]D p q+ − −  
Genotypic value  










1.3.1 Simple Linear Regression (SLR) 
As suggested by Lande & Thompson (1990), assigning the phenotype to y and the number of 
marker allele M of ith individual to ix , function (I-1.21) now takes the form 
 
ij i ijy x eα β= + ⋅ + , 
or 
α β= ⋅ + ⋅ +y 1 x e  
(II-1.2) 
where y is a column vector with its element 
ijy  being the phenotype of jth individual with ith 
genotype; 1 is a column with all its element equals 1; x is the column vector with its element 
ix  as defined above, and e is the column vector with its element ije  being the residual term 
with ( ) 0ijE e = , 
2( )ijVar e σ=  and ( , ) 0ij lkCov e e =  unless i = l and j = k.  
 
Suppose the expectation of phenotype 
ijy  is ideally equal to the genotypic value of its 





β =  from formula (I-1.22). By noticing 





A AA A a Aa a aa
A a A a
E y f V f f V f V
f f a f f dµ
= + +




( ) 2( ) ( )
2 ( )
2 ( ) ( )
AAMM AA AaMM Aa aaMM aa AAMm AA AaMm Aa aaMm aa
AM A AA AM a aM A Aa aM a aa
M AM A aM a AM a aM A
E xy f V f V f V f V f V f V
f f V f f f f V f f V
f f f f f a f f f f dµ
= + + + + +
= + + +
= + − + +
, 
2 2( ) 4 2M M mE x f f f= + , 
and 
MA M A Ma M a mA m A ma m aD f f f f f f f f f f f f= − = − + = − + = − , 
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It is clear from equation (II-1.3) that the test of null hypothesis: 0β =  is equivalent to test 
against 0D = , and hence the statistical method such proposed is a LD-based method. Note 
here, the relationship between β  and D  as presented above is generally valid for any 
adequate choice of 
i
x  and will be shown in Chapter II-2. 
 
Under the null hypothesis, where 0β = , it is clear that 2. (0, / )i iy N nα σ− ∼  asymptotically 
through the central limit theorem irrespective the exact distribution of 
ije , where in  denotes 
the number of individuals with ith genotype. Because βˆ  is a linear function of .iy α− , one 
can hence conclude that βˆ  follows a normal distribution asymptotically under the null 
hypothesis irrespective of the exact distribution of 
ije  and the exact values of ix . Given a 










β ρ χβ =≈ ∼ , where 
ˆ
xyρ  is the estimator of the correlation coefficient between x and y.  
 
Although it has been mentioned above that any choice of 
i
x  would not violate the normality 
of βˆ  under null hypothesis, it does affect the statistical power and thus the type II error rate. 
It would be shown that the suggestion given by Lande & Thompson (1990) is the proper 
choice only under the additive model, e.g. 0d =  in explicit model, and a comprehensive 




1.3.2 Fixed Effect Model (ANOVA) 
To avoid the uncertain choice of 
i
x  as mentioned in section II-1.3.1, an alternative strategy 
can be implemented to perform the association analysis through treating the genotypic value 
of three genotypes independently. The linear regression hence established takes the form of 
equation (I-1.17) (Knapp and Bridges, 1990)  
 
= +y Xb e  
or 
ij i ijy eβ= + , 
(II-1.4) 
where 1,2,3i =  denotes the ith marker genotype with its ‘genetic effect’ iβ  on the trait; ijy  
and 
ije  denote the phenotype and the residual term of the jth individual with ith marker 
genotype; X is the incidence matrix with elements equalling to 1 or 0; y, b, e are corresponding 
vectors of 
ijy , iβ  and ije  that 2( )Var σ=e I . Note the constant term, i.e. α  in equation (II-1.2), 
is eliminated here. Such a transformation is to avoid the singularity of X  in the presence of 
α , and this process will not affect the statistical test hence derived. 
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where .iy  denotes the sample mean of ith marker genotype with the sample size in , and n is 
the full sample size, where clearly 
i
i
n n=∑ . 
 
Ideally, the expectation of phenotype 
ijy  is supposed to equal the genotypic value of its QTL 
genotype, and hence one can calculate 
2 2( ) 2
( ) 2
A AA A a Aa a aa
A a A a
E y f V f f V f V
f f a f f dµ
= + +
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Clearly, a statistical test for significance of null hypothesis ( ) ( )iE y E y i= ∀  is equivalent to a 




Following the normality assumption, where 2( , )N σy Xb I∼ , 2 1ˆ ( , ( ) )TN σ −b b X X∼  and by 



































 are the unbiased estimators of ( )iE y  and ( )E y  respectively. One 
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∑ ∼  and 1 2( , )F t t  denotes the F-statistic 
with degrees of freedom 1t  in the numerator and degrees of freedom 2t  in the denominator. 







1 df tQ χ =∼  and 2
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does not rely on the exact distribution of 
ijy , if 






















































































− ∀∼  stands under null hypothesis, which is generally true given that 
2ˆ ( , / )i i iN nβ β σ∼  asymptotically through the central limit theorem and ( ) iE y iβ= ∀  under 
the null hypothesis. 
 
It can be noted that above derivations are identical to the analysis of variance (ANOVA) 
procedure under the one-way fixed effect model with normality assumption. More generally, 
linear regressions with incidence matrices X are all equivalent to corresponding ANOVA 
based methods given the normality assumption (Searle, 1971). Also note here such genetic 
effects in ANOVA models may be alternatively regarded as random effects (Hill, 1975). 
However, due to the unbalanced nature of the randomly sampled data, the estimates of such 
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random effects can be severely biased (Luo, 1993, Knott, 1994), and hence only the fixed 
model is introduced as above.  
 
1.3.3 Likelihood Based Approach 
Taking the joint distribution of marker and QTL genotypes given in Table II-1, the complete 
likelihood function of a randomly collected sample under the assumption of random mating 
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ijy  indicates the observed phenotype of the jth individual with the ith marker genotype, 
and we suppose this parameter only provides information of phenotype but not its genotype; 
M i= , G k=  denote the ith marker genotype and the kth QTL genotype respectively; Ω  is 
the set of parameters, of which the parameters will be defined for a particular model; 
Pr( , | )G k M i= = Ω  presents the ( , )i k th entry of Table II-1 and will be denoted as ikh  in the 
following discussion; Pr( | , )ijy G k= Ω  is defined by the exact model of quantitative genetic 
effects, which can be either explicit or implicit. 
 
However, directly maximizing function (II-1.10) would be really difficult in most situations, 
since it seems impossible to maximize all parameters at the same time. Alternatively, as 
introduced at functions (I-1.9), if treating the unknown distribution of QTL genotype as 
missing data (Luo et al., 2000, Luo and Wu, 2001), equivalently to function (II-1.10), the 








( | , ) Pr( | , , ) logPr( , , | )











l y M G k y M i y M i G k
w h y G k
= = =
= = =
 Ω = = = Ω = = Ω 




Function (II-1.11) is calculated given the following results 
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where the superscript t denotes terms and parameters acquired at the t-th iterative process.  
 
Formula (II-1.12) hence gives the E-step of the t-th iterative algorithm as introduced in 
section I-1.3.2, and the t-th CM-step can be given by partially maximizing function (II-1.11) 
conditioned on each parameter. The t+1-st 
l
θ  can hence be given by solving equation 
 
1 11 3 3
1, 1 1,1, 1 1,
1 1 1
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θ  denotes the lth parameter, 1, 2,..,l m= ; 
1 2,
t
l lΩ  denotes the set of the 1l th to the 2l th 
parameters at the t-th iterative process, which is null if 
1 2
l l< .  
 
Note here, as discussed in section I-1.4.2, generally, equations (II-1.13) are only the necessary 
conditions of maximizing each sub-CM-step, and further efforts of deriving second-order 
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partial derivatives are required to clarify whether the solutions hence acquired maximize each 
sub-CM-step. However, in practice, one may ignore the step of checking the sufficient 
condition of each sub-CM-step if each iterative process does increase the likelihood function 
(II-1.11) as there might be only one possible root for each sub-CM-step. 
 
As also discussed in section I-1.4.2, given a proper initial point, 
0
Ω , the convergence of 
iteration would be claimed once a certain criteria δ  is met at 
0
t -th iterative process such that 
1( | , ) ( | , )t tl y M l y Mδ +≥ Ω − Ω  for any 
0
t t> , as well as the approximate MLEs 1t+Ω . A 
corresponding LRT can hence be performed using 
2
02[ ( | , ) ( | , )]c D c dfl y M l y M χ=− Ω − Ω ∼ , 
where df is usually 1, i.e. D is fixed to 0, but if the null hypothesis 0D =  eliminates other 
parameters simultaneously, i.e. a parameter is either defined to be a constant value or 
absolutely excluded from the likelihood function, calculation of df should count in all such 
parameters along with D . For convenience, in the following discussion, the establishment of 
LRT might be neglected unless necessary. 
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where Pr( | , , )ijk ijw G k y M i= = = Ω . The similarity between formulae (II-1.14) and (II-1.13) 
shows that ECM algorithm can be viewed as an iterative strategy of maximizing the 
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likelihood function (II-1.10) and might be generally adopted without the establishment of the 
expectation log-likelihood function (II-1.11). 
 
Following the above procedure, the MLEs and LRT can not be evaluated unless the exact 
form of  Pr( | , )ijy G k= Ω  has been defined. For continuous data, as suggested by Luo et al. 
(1998), assuming the hold of normality assumption, one may write 
 
2
[ ( ) / 2 ]1















k a dµ µ − −= + − +  denotes the genotypic value of kth QTL genotype as 
given in Table I-1, and v  is the variance. Clearly, function (II-1.15) is an explicit model and 
can be equivalently written into 
ij k ijy µ ε= + , where (0, )ij N vε ∼ . For binary data, the 
intuitional choice of Pr( | , )ijy G k= Ω  would be  
 
1
Pr( | , ) (1 )ij ij
y y
ij k ky G k f f
−
= Ω = − , (II-1.16) 
which is equivalent to 
Pr( 1| , )ij ky G k f= = Ω = , 
where given the kth QTL genotype, 
ijy  is of value 1 or 0 to denote the retaining of a particular 
phenotype or not with the probabilities 
k
f  and 1
k
f−  respectively. In an ideal population, 
k
f  
is often referred to as the penetrance coefficient of kth QTL genotype, and hence the genetic 
model given as function (II-1.16) can be named as the penetrance model. It can be also 
noticed that formula (II-1.16) is an explicit model as ( )ij kE y f=  in accordance with the 
definition from section II-1.2.1. 
 
On the other hand, the implicit models for binary data can be given following function (II-1.1) 
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1                    if 















ij k ijz µ ε= + . 
Under the assumption (0,1)ij Nε ∼ , one may write 
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k a dµ µ µ − −= − = − + . Function (II-1.17) is often referred to as the probit 
or liability model as firstly introduced by Wright (1934). 
 
1.3.4 Under the Scheme of Likelihood  
As has been given by the log-likelihood function (II-1.10), the complete likelihood function 
takes the form 
,
( | , ) Pr( , | )ij
i j
L y M y M iΩ = = Ω∏ . 
Under the HWE, the distribution of marker genotypes, i.e. Pr( )M i= , 1,2,3i = , can only be 
determined through one parameter p, the frequency of marker allele M, in the form 
2Pr( 1)M p= = , Pr( 2) 2 (1 )M p p= = −  and 2Pr( 3) (1 )M p= = − . It is easy to show that in , 
1,2,3i = , are the sufficient statistics of p , where in  denotes the observed number of 
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individuals with marker genotype M i= . Since such sufficient statistics can be directly 
calculated irrespective of the exact value of the other parameters, the MLE of p  given from 
function (II-1.10) should be identical with the estimate calculated from the sufficient statistics 
i













 . Incorporating p  into the 
above likelihood function results in  
( | , ) logPr( | , ) logPr( )ij
ij
l y M y M i M i Ω = = Ω + = ∑ . 
As the last term, i.e. Pr( )M i= , takes a definite value subjected on i, it will have no impact on 
further derivations, i.e. MLE and LRT, and hence it can be concluded that the complete 
likelihood function is equivalent to the conditional likelihood function 
,
( , | ) Pr( | , )ij
i j
L M y y M iΩ = = Ω∏ . 
 
Although the above discussion explains the equivalence of complete and conditional 
likelihood function in an ideal population, the difference between the linear models and the 
likelihood based model arise about the modelling of phenotypic values. The linear models 
directly model Pr( | , )ijy M i= Ω , the relationship between phenotype and marker genotype, 
whereas the likelihood based model models Pr( | , )ijy G k= Ω , the relationship between 
phenotype and QTL genotype. Theoretically, it seems more informative to model 
Pr( | , )ijy G k= Ω  rather than Pr( | , )ijy M i= Ω , because the putative QTL is the candidate gene 
rather than an associated factor. However, several researches have shown that likelihood 
based model doesn’t guarantee a higher statistical power over linear models. For example, 
with continuous phenotype, simulation analysis of Luo et al. (2000) showed that SLR always 
presented the highest statistical power even while the optimality of ix  is severely violated, 
although as indicated by Luo & Wu (2001) likelihood based method has shown an overall 
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higher statistical power than the SLR while binary phenotype was presented. On the other 
hand, ANOVA is generally of the least statistical power among all methods (Kendall and 
Stuart, 1961, Luo et al., 2000). 
 
It should be noted here that the likelihood scheme doesn’t guarantee that MLEs of linear 
models are identical to their BLUEs, although it is always true if the normality assumption of 
the residual term is held. For binary data, the MLE of ANOVA model, i.e. formula (II-1.4), is 
identical with its BLUE, but it is not true between the MLE and BLUE of SLR, where, 
however, it will be shown in section II-2.4.1 that their statistical tests are still asymptotically 
equivalent. 
 
1.4 Case Control Study 
In the previous section, i.e. II-1.3, common statistical methods for association analyses of 
random samples have been introduced. However, for certain binary traits, e.g. many common 
genetic diseases, which are of intensive interest but with a low prevalence in the population, it 
would be highly impractical and useless to perform a simple random sampling as most of the 
data so collected contain no information of such a trait, and hence alternative sampling 
strategies are required. In such a situation, Case-Control design is widely adopted in many 
scientific researches for binary outcomes. Generally, patients with a specific disease or 
syndrome are collected as case samples and individuals without such outcomes are collected 
as control samples, where both sampling procedures for case and control can still be assumed 
random, and further analyses are conducted to measure whether or not the pattern of an 
exposure, e.g. environment or genetic factors, is associated with the pattern of the Case-
Control samples. Statistically, the Case-Control design can significantly increase the 
statistical power while dealing with rare genetic variants compared to the random sampling 
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design and hence in allelic association analysis of disease traits, Case-Control is probably the 
most commonly adopted study design.  
 
Table II-2. Distribution of Genotypes in Case-Control Study. 
Where n and Ni represent the number of individuals of each marker genotype in case and the whole data respectively, t and T  represent the 
sample size of case and the whole data respectively, and xi represents the trend coefficient for each marker genotype. 
 
MM  Mm  mm  Total 
Case 1n  2n  3n  t  
Control 1 1N n−  2 2N n−  3 3N n−  T t−  
Total 1N  2N  3N  T  
 
Suppose the observations of Case-Control samples are presented in a contingency table as 
Table II-2 with random sampling in both case and control, the distributions of marker 
genotypes conditioned on case and control individuals should be identical in expectation 
under the null hypothesis, where there is no LD between the testing marker locus and the 
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Note here, since ( )iE k k i= ∀  under null hypothesis, it is easy to show that the variances of 
numbers of different genotypes are also identical in expectation, thus 2 2 2ˆ ˆ( ) ( )iE E iσ σ σ= = ∀ , 
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where 2ˆ 2 (1 )i i ik kσ = −  and 
2ˆ 2 (1 )k kσ = −  if the binary phenotypes are assigned to be 1 and 0. 
We may hence notice formula (II-1.9) in section II-1.3.2 is also valid here and is in proportion 




, thus asymptotically equivalent to each other. 
 
1.4.2 Allelic Analysis 
From the distribution of genotypes shown in Table II-2, the observations of alleles can be 
calculated as Table II-3. 
 
Table II-3. Distribution of Allele Frequencies in Case-Control Study 
The parameters take the same definition as Table  I-2. 
 
M  m  Total 
Case 1 22n n+  3 22n n+  2 t  
Control 1 1 2 22( )N n N n− + −  3 3 2 22( )N n N n− + −  2(T t− ) 
Total 1 22N N+  3 22N N+  2T  
 
Again, a Pearson’s 2χ  test can be launched by calculating 
 
[ ]21 2 1 22 2
12
1 2 1 2
2 (2 ) (2 )
( ) 2 (2 ) (2 )
A df
T T n n t N N





 − + − + 
∼ . (II-1.19) 




















 to represent the frequencies 
of allele M in Case and Control respectively. When T is sufficiently large, where both 
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M Cp  can be assumed to follow a normal distribution asymptotically, a Z-statistic can then 
be used to evaluate the difference between 
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=  and the variance term is calculated under the null hypothesis, where 
| |
ˆ ˆ( ) ( )M D M CE p E p p= = . As it is easy for us to examine that the statistical test (II-1.20) is 
identical to the one (II-1.19) given the fact 
2 2
1dfZ χ == , only the 2Aχ  test will be mentioned as 
the allelic analysis henceforward. 
 
Note that similar to formula (II-1.18), formula (II-1.19) from the Pearson’s 2χ  test is 
asymptotically equivalent to the 2χ  test from ANOVA or SLR, where these two are 
equivalent due to the binary property of β  in this situation. The proof is easy to acquire 
following the same route of formula (I-1.9) and is not repeated here. 
 
1.4.3 The Armitage’s Trend Test 
As introduced in section II-1.3.1, the 2χ  test based on SLR can be applied irrespective of the 
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∼ . (II-1.21) 
Assign 3ix i i= − ∀ , formula (II-1.21) gives the most widely used form of Armitage’s trend 
test 
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 − + − + 
∼ . (II-1.22) 
The idea of analysing a n m×  contingency table using SLR was initially launched by Yates 
(1948), who also firstly suggested the use of equally spaced trend coefficients, ix , if no priori 
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knowledge about such trend is available. Cochran (1954) and Armitage (1955) independently 
applied Yates’ method into 2n×  contingency table and hence formula (II-1.22) is also 
referred to as the Cochran-Armitage trend test. 
 
Taking the same notation in allelic analysis, a Z-statistic equivalent to formula (II-1.22) 















∼ ,   
(II-1.23) 
where 2ˆ ˆ





=  denotes the observed frequency of genotype MM. 
 
1.4.4 Liability (Probit) and Logistic Model 
As implicit models, both liability (probit) and logistic models can relate binary dependent 
variables to complex independent variables through introducing a cumulative distribution 
function with a specific cutting point or threshold in the form of 
1Pr( 1| ) ( )i i iy F
−
= =X X b , 
where iX  denotes the ith column in a matrix of independent variables and b  denotes the 
vector of regression coefficients. Since ( | ) Pr( 1| )i i i iE y y= =X X  for binary data, the above 
formula indicates a link function 
 ( )( | )i i iF E y =X X b , (II-1.24) 
and hence both liability (probit) and logistic models are members of the generalised linear 
regression (GLR) model family, which will reduce to the linear regression while 




For the liability or probit model, the link function is given as  
 ( ) ( )1( | ) ( | )i i i iF E y E y−= ΦX X , (II-1.25) 
where 1( )−Φ ⋅  is the reverse of cumulative standard normal distribution function, and the 









Φ = − 
 
∫ . (II-1.26) 
For a logistic model, the link function is given as 
 ( ) ( | )( | ) ln
































 and hence a logistic model is often referred as a logit model as well. 
 
The same as the linear model discussed above, both the liability (probit) and logistic models 
analyse the regression of phenotypes on marker genotypes directly without explicitly 
modelling the relationship between genotypes at marker loci and QTL. Following the 
introduction in section II-1.2.2, both the liability (probit) and logistic models assume that 
genetic effects of different marker genotypes follow an identical distribution and a specified 
threshold for each marker genotype is then assigned to separate binary phenotypes from this 
point, where the liability (probit) model assumes a normal distribution and the logistic model 
assumes a sech-square distribution. Unlike the likelihood based model, where the genotypic 
values of a putative QTL are more likely to follow a normal distribution, the genetic effects of 
the testing marker genotypes are related to genotypic values of the putative QTL through 
complicated functions, and hence the normality assumption may not stand. However, as it will 
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be shown later, i.e. in section II-2.4.1, in the scheme of score test, any general linear 
regression models under certain regular conditions are identical to the Armitage’s trend test. 
 
Here, we give a proof for the equivalence between a logistic model and the Armitage’s trend 
test. Taking the same setting in Table II-2, let i ixα β= +X b , the logistic model (II-1.27) 

















where ( | )i i if E y= X . Since the observations in Table II-2 follow a multinomial distribution, 
ignoring the constant terms, the log-likelihood function can be given as 
 ( , | , ) log ( ) log(1 )i i i i i
i
l x y n f N n fα β ∝ + − −∑ . (II-1.29) 
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Ι H . 
The corresponding score test given at section I-1.4.2 can hence be calculated as 
2
1 2
0 0 0 1
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1.5 Rationale of this Study 
In above, I have summarized the most basic statistical models for allelic association analyses. 
From the above introduction, it can be noticed that some of the statistical methods applied to 
random and non-random samples are highly related. Take the fixed effect (ANOVA) model 
and the Pearson’s chi-square test for example, a fixed effect model initially assumes the 
normal distribution of the residual term to establish a valid F-statistic, however, such an 
assumption can be relaxed to any distribution if the observed sample size under each marker 
genotype is sufficiently large, and the Pearson’s chi-square test is hence appropriate. Similar 
situation is also true between the SLR and the Armitage’s trend test. However, the likelihood 
method based on the complete likelihood function is not available for the non-random 
samples, i.e. case control samples, because the marker allele frequency can not be directly 
estimated from the data. An alternative strategy to perform the likelihood based association 
study for case control samples will be introduced in Chapter III-2, but will not be mentioned 
in the following discussions. Apart from the general validity of both the SLR and the fixed 
effect (ANOVA) model, the comparison of their performance, e.g. the statistical power, is 
also of intensive interest. However, as the performance of SLR mainly depends on the choice 
of ix  as mentioned in section II-1.3.1, it would be necessary to evaluate the best or the 
optimal choice of ix  which can lead to maximize the statistical power of a SLR and control 
the rate of false positive. Meanwhile, as has been shown in section II-1.4.4, in the case of 
binary traits, the explicit and implicit models might result in asymptotically equivalent 
statistical test, which implies that if the sample size is sufficiently large it might not be 
necessary to adopt a generalised linear model instead of the ordinary linear models. In the 
following chapter, more general situation will be considered to acquire detailed statistical 




CHAPTER II-2  
COMPARISON OF STATISTICAL 
METHODS AND GENETIC MODELS 
2.1 Overview 
Although the power functions of both the SLR and the fixed effect model can be found 
elsewhere (Luo et al., 2000), in Chapter II-2, we will compare their statistical power in a more 
direct way. However, before a reasonable comparison is launched, the proper choice of ix  for 
the SLR has to be evaluated through understanding the biological meaning behind the ‘genetic 
effect’ of each marker genotype. Following such a comparison, we will discuss the 
relationship between the Armitage’s trend test and the allelic analysis for case control studies 
as we have noticed that one of the most influential papers (Sasieni, 1997) has certain flaws 
and insufficiency in its discussion of this topic. We will then show that implementation of the 
implicit model and the explicit model as introduced in section II-1.2 will generally result in 
asymptotically identical test statistics, and hence these two models are statistically equivalent. 
These general equivalences question the attempt to use the generalised linear models, and we 
might ask that to what extends a generalised linear model can provide more than an ordinary 
one? All of the three sub-topics we will discuss in Chapter II-2 will reasonably lead us to put 
more attention to the SLR based methods, and hence the re-analysis of the trend coefficients 








2.2 Performance of Ordinary Linear Models 
2.2.1 The Optimal Choice of xi in the SLR for Random Samples 
Unlike ANOVA, where the matrix X  in formula (I-1.17) is naturally defined, the ix  of the 
SLR is chosen arbitrarily, e.g. function (II-1.2) as suggested by Lande, R. & Thompson, R. 
(1990). In order to understand how the choice of ix  will affect the statistical inference, the 
relationship between ix  and the phenotypic values of QTL genotypes has to be explicitly 
characterized. 
 
Suppose the testing marker is associated with a putative QTL, then the distribution of marker 
genotypes should have impacts on the phenotypes through the LD between the testing marker 
and the putative QTL. Such impacts are believed to be represented by ‘genetic effects’ for 
each marker genotypes as MMV , MmV  and mmV , i.e. ( )MM MME y Vα= +  etc., where ( )MME y  
denotes the expectation of phenotype given marker genotype MM and α  is a constant across 
different marker genotypes. If the ‘genetic effects’ are known, the regression of phenotypes 
on marker genotypes can be performed by assigning 1 MMx V= , 2 Mmx V=  and 3 mmx V= . For a 






























,   (II-2.1) 
which can be simply written as ψ , 1, 0 and will produce an identical test statistic to the 
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where i ix ax b′= + , ,a b R∈  and 0a ≠ .  
 
Similar to formula (II-1.3), we can now calculate 
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(II-2.3) 
It can be noticed that ˆ( )E β  as given in formula (II-2.3) is always proportional to D 
irrespective of the value of ψ , e.g. ˆ( ) 0E β =  under the null hypothesis, and hence from the 









β ρ χβ =≈ ∼  will always be 
valid irrespective of the choice of ψ . However, if different ψ  are chosen, the test statistics do 
vary, and hence the loss of statistical power would be expected once the inappropriate ψ  is 




On the above formulation, how do we choose the best or ‘optimal’ ψ  to be fitted in the SLR? 
With the ‘optimal’ ψ , the corresponding statistical test should have its statistical power 
maximized and its false positive rate minimized in expectation. Since the complete solution to 
this question would be really cumbersome, we closely discuss here only the case where d = 0, 
i.e. co-dominance model. A general result will be given later without the details of derivation. 
 
Firstly, since ˆ( ) 0E β =  under the null hypothesis from formula (II-2.3), the corresponding 




β  clearly equals 0 and thus the minimum. The second 
requirement for the optimality is automatically fulfilled. 
 
Secondly, since both n  and ( )Var y  are independent of ψ , it is equivalent to maximize the 
test statistic 
2ˆ
xynρ  or to maximize 
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It is easy to show that the maximum of 








 is acquired at 2ψ =  and so as the 




From above derivations, the suggestion proposed by Lande & Thompson turns out to be the 









 given 2ψ =  and 0d = , where λ  is the correlation coefficient 
between marker allele M and A as defined by formula (I-1.4). This result can be explained by 
realizing that when 0d = , the genotypic values of QTL genotypes AAV aµ= + , AaV µ=  and 
aaV aµ= −  are equivalent to 2AAV = , 1AaV =  and 0aaV =  from formula (II-2.2), and hence 
the correlation between genotypic values of QTL genotypes and the ‘genetic effects’ of 
marker genotypes under the co-dominance model turns out to be the correlation between the 
QTL marker allele M and the QTL allele A. 
 
For a general case, where 0d ≠ , it should be noticed from formula (II-2.3) D  is complexly 
involved and hence can not be eliminated while maximizing 
2ˆ
xyρ  . Neglecting the tedious 
calculations, the optimal ψ  can be computed through equalling the first derivative of 








(1 ) 2 (1 )(1 2 )
Dd
ap p dp D p q
ψ = −
− + + − −
. (II-2.4) 
It is easy to show that the optimal ψ  given as formula (II-2.4) is coincidence to assign ix  
with the ‘genetic effects’ as defined above, i.e. 1 ( )MM MMx V E yα= + = , 
2 ( )Mm Mmx V E yα= + =  and 3 ( )mm mmx V E yα= + = , and hence taking the ‘genetic effects’ as 
ix  can automatically maximize the statistical power in expectation. Since the calculation of 
( )MME y  and etc. is always applicable irrespective of whether the data is random or not, the 
‘genetic effects’ can hence be adopted as a general strategy of establishing the optimal choice 
of ψ  as indicated by formulae (II-2.1). However, even knowing this, the optimal ψ  can not 
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be specified without knowledge of D and q, although the information of a, d is given prior to 
the test and p can be directly estimated from the sample. This limitation definitely obstructs 
any attempt to derive the optimal ψ ; however, as will be shown in Chapter II-3, such 
influence from unknown D and q might be largely reduced in a Case-Control study.  
 
It has to be addressed here that the validation of formula (II-2.4) requires d a≠ − , i.e. the 
recessive model, because otherwise the transformation (II-2.1) is not defined. To overcome 
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It is easy to prove that 
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( ) ( )
0 lim 1
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< <  and 
1 3
3
( ) ( )
lim 0
E y E y
x
→
=  in the absence 
of over-dominance, and hence transformation (II-2.5) will always have a definition.  
 
Although the exact form of the ‘genetic effects’ can not be specified as indicated above, it is 
possible to write such ‘genetic effects’ in terms of genotypic values of QTL genotypes as 
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f f f f
a V a d
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ma mA Ma MA
M Mm M
m M M m
f f f f D
d V d d
f f f f
µ − −= − = × − = . Formulae (II-2.6) hence present the 
relationship between the ‘genetic effects’ of marker genotypes and the genotypic values of 
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QTL. Without loss of generality, formulae (II-2.6) can be denoted as the definition of the 
‘genetic effects’ of marker genotypes. Although those formulae have been written into similar 
forms, the ‘genetic effects’ defined as formulae (II-2.6) and the genotypic values of QTL 
given at Table II-1 have different statistical genetic properties. For example, in the dominance 







− =  which 
equals 0 if and only if 0Maf = , which is not generally true unless the marker allele M and the 
QTL allele A are completely linked as well as p q< . 
 
As an alternative to maximizing the expected value of 2χ , we may be interested in a 
regression formulation which yields minimum unexplained variance, or equivalently 
maximum explained variance. Notice from formula (I-1.24), i.e. 2 2 2
1





σ σ ρ−= −
−
,  it is 
equivalent to minimize 2ˆ
eσ  and to maximize 
2ˆ
xyρ , and hence the ‘genetic effects’ of marker 
genotypes not only maximize the test statistic in expectation but also minimize the 
expectation of unexplained genetic variance at the QTL.  
 
2.2.2 Comparison of Statistical Power of SLR and ANOVA 
In association studies, we are more interested in the ability of a model to conclude a current or 
pervious state from the observed data than to predict a further state, and hence it might be of 
more concern about the probability of false statistical inference than the goodness of fit, i.e. 
we will be more interested in improving the statistical power rather to acquire a sound 
goodness of fit statistic, e.g. the coefficient of determination (Steel and Torrie, 1960). As a 
matter of fact, for most complex traits, a single SNP could only explain very little variance, 
and the corresponding goodness of fit for such a model will not be impressive at all. With 
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such a concept, we will focus on the comparison of the statistical powers between the SLR 
and the ANOVA irrespective their goodness of fit. 
 





























where .iy  is the sample mean of phenotype given the ith marker genotype, and y  is the 
sample mean of the full sample. We may notice that the 
2
1dfχ =  test statistic for SLR can be 
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.( , )i ix yρ  is the correlation between ix  and .iy  calculated by assigning .iy  to each 
corresponding individual. Clearly, formula (II-2.7) is asymptotically proportional to 
2
.( , )i ix yρ  by the second expression of formulae (II-1.9) as given before. 
 
At a significant level α , when the alternative hypothesis is true, i.e. the testing marker locus 
is associated with a QTL, the statistical test bearing a higher chance of claiming positive has a 





2dfχ =  test statistic, e.g. formulae (II-1.9), is higher than that of a 2 1dfχ =  test statistic, e.g. 
formula (II-1.19), the comparison between the ratio of such confidence thresholds and 
2
.( , )i ix yρ  is hence crucial to determine the performance between SLR and ANOVA, i.e. the 
statistical power. Ideally, if the optimal ix  is known, say ix

,  since .lim ( )i i i
n
y E y Vα
→∞
= = + , 
where ( )iE y  and iV  are the population mean of phenotype and the ‘genetic effect’ given the 
ith marker genotype, we can have 
2






. In such a circumstance, the statistical 
power of a SLR will always be higher than that of an ANOVA, because the ratio of 
confidence thresholds between a 
2
1dfχ =  test statistic and a 2 2dfχ =  test statistic under the same 
significant level is always less than 1. If no prior information is available, it would be 
preferred to choose equally spaced ‘genetic effects’, e.g. 3ix i i= − ∀ , which is the optimal 
choice given 0d =  or co-dominance model as shown above. However, even while 
3ix i i= − ∀  is far from the optimal choice, a SLR might still have a higher statistical power 
than an ANOVA. For example, suppose 1. 2. 3.y y y= ≠ , taking 3ix i i= − ∀ , we can calculate 
2
.( , ) 1i ix y pρ = − , and similarly, 2 .( , )i ix y pρ =  while 1. 2. 3.y y y≠ = , where the HWE is 
assumed. Since the ratio of commonly used confidence thresholds between a 
2
1dfχ =  test 
statistic and a 
2
2dfχ =  test statistic are .95 0.64r = , .99 0.72r =  and .995 0.74r = , where Pr  denotes 
the ratio of P% confidence thresholds between a 
2
1dfχ =  test statistic and a 2 2dfχ =  test statistic, 
we can notice that a SLR might still have a higher statistical power than an ANOVA for a 
certain value of p, i.e. the frequency of marker allele M, even while the optimality of chosen 
ix  is seriously violated. 
 
From the discussions above, we can conclude that it would be recommended to perform a 
SLR rather than an ANOVA in order to acquire a higher statistical power, especially while the 




2.3 The HWE in Case-Control Study 
Denoting the test statistic (II-1.19) of the allelic analysis as 2
Aχ  and the test statistic (II-1.22) 
of the Armitage’s trend test as 2
Gχ , Sasieni, P. D. (1997) compared the 2χ  tests of allelic 
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Formula (II-2.8) is definitely a very useful formula and has revealed the relationship between 
the allelic analysis and the Armitage’s trend test, e.g. the test statistics would be identical 
between these two methods if and only if the HWE holds in the joint samples. In his paper, 
Sasieni argued that the Armitage’s trend test is better than the allelic analysis, and we will 
later show that this statement is reasonable. However, Sasieni’s conclusion is based on several 
claims that are highly in doubt. Firstly, he claimed that the HWE in both cases and controls 
does not guarantee the HWE of the joint sample. Since such deviation from the HWE can be 
properly adjusted by the Armitage’s trend test, it is preferable to the allelic analysis; Secondly, 
he claimed that the observation 1 22n n+  from Table II-3 can only follow a binomial 
distribution under the HWE and hence the allelic analysis can only be valid if both cases and 
control are in HWE. Unfortunately, both the claims are inadequate or even mis-claimed, and 
such questionable claims have already been adopted by many other researchers, for example, 
Balding (2006) also mentioned the requirement of HWE for the allelic analysis after the 
citation of Sasieni’s paper. We would like to explain why these claims are questionable as 
follows. Firstly, a joint population of two HWE subpopulations, say cases and controls, will 
not follow HWE only if these two subpopulations have different genotype patterns, i.e. 
different allele frequencies. However, as the validation of a test statistic is generally 
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=  should equal each 
other in expectation; in such a circumstance, the genotype distribution should be identical in 
both the ‘cases’ and the ‘controls’. The first claim is hence inadequate. Secondly, the 
observation that number 1 22n n+   follows a binomial distribution only requires the simple 
random sampling for both cases and controls from the same population, i.e. with the same 
allele frequency, irrespective of whether or not the HWE holds. Since such a requirement is 
always true under the null hypothesis, the allelic analysis is generally valid. The second claim 
given by Sasieni is hence misleading. The true reason to choose the Armitage’s trend test over 
the allelic analysis lies in the fact that the process of counting allele number in the allelic 
analysis does not use the information of the genotype distributions. The information includes 
not only the HWE but also the trend coefficients, and hence although the allelic analysis is 
generally valid, it is less informative than the Armitage’s trend test. However, if there are too 
few observations for a certain marker genotype, e.g. due to the low maker allele frequency, 
the Armitage’s trend test might be highly vulnerable to the genotyping errors and its test 
statistic might be seriously biased from the 
2
1dfχ =  (Yates, 1934). In such a circumstance, the 
allelic analysis is more reliable than the Armitage’s trend test.  
 
Note here, the deviation of HWE will only affect the variance parts, or denominator, of 
formulae (II-1.19) and (II-1.22), and such deviations may be largely attributed to two major 
sources, the random sampling, i.e. random drift of genotype distribution from its theoretical 
distribution, and the non-random sampling, e.g. population stratification as introduced in 
section I-1.2.4. If a deviation is introduced by a random sampling, the Armitage’s trend test 
can correctly adjust for such a bias of HWE as pointed out by Weir (1990) and hence give a 
more reliable result, although such an improvement is normally fairly small unless extreme 
situation happens. Otherwise, if such a deviation is introduced by a population stratification, 
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as will be shown in section II-3.3, both methods, i.e. the allelic analysis and the Armitage’s 
trend test, will tend to overestimate the variance of the regression coefficients and hence result 
in a loss of statistical power. Note here, population stratification may also introduce spurious 
LDs, which may either increase or decrease the numerator of formulae (II-1.19) and (II-1.22), 
and cause serious false inferences. However, as will be shown in Chapter II-3, the influence 
from population stratification on the numerators and the denominators of formulae (II-1.19) 
and (II-1.22) might not be always present together, and we must treat such a situation 
carefully. A more comprehensive discussion of the influence from population stratification in 
Case-Control studies will be given in Chapter II-3. 
  
2.4 The Equivalence between Models of Quantitative 
Genetic Effects 
As has been mentioned in section II-1.4.4, the score tests of both logistic and liability (probit) 
models are asymptotically identical to the Armitage’s trend test if a generalised SLR model 
( ( ))i iF E y xα β= +  is adopted. Since identical test statistics will yield identical statistical 
inferences, these models are asymptotically equivalent in statistical analysis. Notice that the 
Armitage’s trend test is an explicit model and the other two are implicit models, their 
asymptotical equivalence stimulates the idea that there might be a more general equivalence 
between explicit and implicit models, and that is what we will show in this section. 
 
2.4.1 Under the Generalised SLR 
As the equivalence between the logistic model and the Armitage’s trend test under the 
generalised SLR has been demonstrated in section II-1.4.4, in the following we will show that 




Consider the log-likelihood function introduced as function (II-1.29) 
( , | , ) log ( ) log(1 )i i i i i
i
l x y n f N n fα β + − −∑∼ . 
Suppose a link function takes the form of 1( )i ig f z
−
= , where i iz xα β= +  and ( )g ⋅  denotes 
any monotonic, continuous and smooth function defined on R, from the discussion before and 
under the null hypothesis, i.e. 0D = , we can have 0 0 0iz z iα= = ∀ , 0 0β =  and it f i
T
= ∀ , 
where 0α  and 0β  are the MLEs of α  and β  for function (II-1.29) under the null hypothesis. 
To establish the score test, we can firstly calculate the first and second-order derivatives of 
function (II-1.29) as  
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where either of ξ  or ψ  represents one of α  and β . From the discussion before, under the 
null hypothesis, i.e. 0D = , we have 0 0 0iz z iα= = ∀ , 0 0β =  and it f i
T
= ∀ , where 0α  and 0β  
are the MLEs of α  and β  from function (II-1.29) under the null hypothesis. Incorporating 
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where g ′  and g′′  are the first and second-order partial derivative functions of g  respectively, 
and ( )i iE Tn N t−  is null by noticing that ( )i i tE n N
T





= ∀ . The corresponding score test can hence be established as 
( )2 2




nT N t xT
g z







0 0 0 2









t T t N x N x
 
 









0 0 0 1
2 2( ) ( )
i i i i
i iT
df
i i i i
i i
T T n x t N x












U I U ∼ , 
where 0H  is the Hessian matrix under the null hypothesis, i.e. the matrix of second-order 
partial derivatives given 0D = , introduced as formula (I-1.8). It can be easily noticed that the 
corresponding score test is identical to formula (II-1.21) irrespective of the exact form of 















 exists, e.g.  g is monotonic, continuous and smooth. 




Note here, if we take ( )i ig z z= , i.e. an identity function, the above result will still hold, as the 
identity function is clearly monotonic, continuous and smooth. However, it can be noticed 
that given the same link function ( )i i iE y f xα β= = + , the MLEs of function (II-1.29) for α  
and β  are different from their corresponding BLUEs despite the asymptotically equivalent 
test statistics.  
 
2.4.2 Under the Generalised Fixed Effect Model 
Take the same log-likelihood function (II-1.29) as section II-2.4.1, but consider a generalised 
fixed effect model as ( ) ( )1 1( | )i i ig E y g f β− −= =X  instead of the generalised SLR, we can 
calculate the first and second derivatives of function (II-1.29) under the scheme of generalised 
fixed effect model as 
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= × , we can hence have 
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= , we can establish the score test for the generalised fixed 
effect model as 
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which is clearly identical to the Pearson’s chi-square test (II-1.19) and hence is asymptotically 
equivalent to formulae (II-1.9), i.e. the F-test statistic of the fixed effect model. 
 
2.4.3 Under the Scheme of a Likelihood-based Approach 
For the likelihood based method of a random sample as introduced in section II-1.3.3, the 
score test is impractical due to a complicated information matrix hence derived, and we will 




Under the penetrance model as introduced at formula (II-1.16), i.e. the explicit model of a 
binary trait for a random sample, the ECM algorithm of binary data at t-th iterative step can 
be given as: 
 
E-step: 
Formula (II-1.12) now takes the form of  
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It is clear that penetrance coefficients are independent of each other if 
t
ijkw  are treated as 

























where the other parameters, i.e. D, p and q, can be updated independently of kf  (Luo and Wu, 
2001). 
 
For implicit models, taking ( )k kf g µ= , where  ( )g ⋅  denotes any monotonic, smooth and 





k k a dµ µ
− −
= + − + , we can update new 





















ij ijtc k k
ijk
i j k k k
n
ij kt k k
ijk




i j k k
k k k k


















− ∂ Ω ∂ ∂
= − ∂ ∂ − ∂ 
− ∂ ∂
=  
− ∂ ∂ 
 
− ∂ ∂ 
=  





























, we can notice 
that equating formulae (II-2.14) to 0 is equivalent to the following equations 
 
1 2 3 0
t t tP P P+ + = , 
1 3 0
t tP P− =  
and 
2 0
tP = , 
(II-2.15) 
of which the only solution is 
1 2 3 0








w y f k
= =
− = ∀∑∑ , which is identical to formulae (II-2.13) from the explicit model, 
and hence the sub-CM-steps of updating parameters are related to the penetrance coefficients 
for explicit and implicit models, i.e. formulae (II-2.13) and (II-2.15) respectively, are 
mutually deductive. Since such a mutual derivation will always hold during each CM step, we 
can conclude that the MLEs of explicit and implicit models hence derived are mutually 
deductive. Notice such a mutual derivation does not rely on any hypothesis, i.e. null or 
alternative, the test statistics of LRTs derived through formulae (II-2.13) and (II-2.15) are 
hence identical, and the explicit and implicit models are statistically equivalent for a random 





Above derivations show that explicit and implicit models are statistically equivalent to each 
other under a quite general situation, and due to the simplicity of manipulating an explicit 
model, it seems rather rational for us to implement an explicit model rather than an implicit 
one unless we can prove that the introduction of an implicit model does significantly improve 
the statistical inferences, e.g. the sample size is fairly small and the asymptotical equivalence 
does not stand. It can also be noted here that even in the presence of covariates, e.g. the 
dummy variables that are introduced to correct the population stratification, such statistical 
equivalence can also be proved following a similar procedure as introduced in section II-2.4.1 
and II-2.4.2. 
 
2.5 Modified Armitage’s Trend Test 
From the above discussions, the general statistical equivalence between explicit and implicit 
models results in the preference to the explicit model due to its mathematical simplicity, and 
we have also shown that an SLR generally has a higher statistical power than that of a mixed 
effect model especially if proper ix , i.e. the genetic effects, are chosen. As both above results 
generally stand irrespective of the exact distribution of the phenotype, we would prefer to deal 
with the Case-Control samples under an SLR, i.e. the Armitage’s trend test or the allelic 
analysis. Meanwhile, we also argued that the Armitage’s trend test integrates more 
information than the allelic analysis as both the trend and HWE information have been 
removed during the procedure of performing the later test. With such an understanding, we 
will then focus on the modification of Armitage’s trend test in the next chapter, as it is 





CHAPTER II-3  
A MODIFIED ARMITAGE’S TREND 
TEST FOR DIFFERENT PENETRANCE 
MODELS AND POPULATION 
STRATIFICATION 
3.1 Overview 
As has been introduced in section II-2.2.1, if an SLR is implemented to perform the 
association study of a quantitative trait in a random sample, the optimal choice of ix  can both 
maximize the statistical power and explain the largest proportion of variance for SLR, where, 
however, such an optimal choice may not be available due to the unknown parameter D and q. 
For a Case-Control study, the optimal ix  can be similarly defined, however, unlike the 
situation of a quantitative trait, another factor, i.e. background genes, will also influence the 
optimal choice of ix  as mentioned in section I-1.2.4. In this chapter, following Armitage’s 
denotation, ix  will be referred as the coefficient of trend or trend coefficient when we are 
dealing with Case-Control studies. 
 
In a paper Sasieni published in 1997, he suggested the use of trend sets {1, 1, 0} and {1, 0, 0} 
for dominance and recessive models respectively. However, as has been shown in section II-
2.2.1, even for a random sample, Sasieni’s suggestion might not be the optimal choice unless 
certain restraints are met, which are hardly true in most situations. By knowing this, we will 
surely ask how far away Sasieni’s suggestion is from the optimal choices. To answer this 
question, we will firstly theoretically calculate the appropriate choices of the trend 
coefficients for different penetrance models, e.g. the co-dominant model, and we will 
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introduce two different strategies to correct the population stratification while applying the 
Armitage’s trend test. At last, the hence modified Armitage’s trend tests will be implemented 
for analyzing both simulation data and a real dataset. 
 
3.2 The Optimal Trend Set 
3.2.1 Common Variants or Rare Variants 
Before computing the optimal trend set, two points have to be clarified in advance. Firstly, for 
many diseases, even a homozygote of disease causal alleles will not ensure a 100% chance of 
expressing disease phenotype and such an incidence risk might increase as the increase of age. 
If only one of alleles at the putative QTL is responsible for the disease of interest, which is 
generally true for SNP markers, a disease causal allele with its penetrance coefficient of the 
homozygote less than 1 is practically equivalent to a virtual allele completely linked with the 
causal one but with a lower allele frequency and the penetrance coefficient of its homozygote 
equalling 1. For example, a disease causal allele γ  with its allele frequency P  and penetrance 
coefficients 10 1f< < , 2 10 f f< <  and 3 0f =  are practically equivalent to a virtual allele 
*γ  
with its allele frequency * 1P P f=  and penetrance coefficient 
*
1 1f = , 
*
2 2 2 1 1( ) ( )f f Pf f Pf= − −  and 
*
3 0f = , because it is easy to examine that they will cause the 
same disease incidence rate, i.e. 2
1 22 (1 )P f P P f+ − , in a random population. It is hence 
reasonable to assume 1 1f = , 2f f=  and 3 0f =  without loss of generality, and f is the only 
questioned variable left. Secondly, ‘common disease, common variant’, as a widely adopted 
hypothesis, is the proposition behind the HapMap project. However, this concept has been 
challenged as only a small proportion of phenotypic variance can be explained by claimed 
QTLs for most common diseases (Moore et al., 2010, Cantor et al., 2010). For example, only 
less than 10% of Parkinson’s disease is due to the known candidate genes (Lesage and Brice, 
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2009). Behind such a low discovery rate, it can be either common variants with small genetic 
risk, e.g. small penetrance coefficients, or rare variants with high genetic risk, both of which 
are hard to detect through a statistical test because of their small contribution to case 
individuals. As from the first part of this discussion, both above situations would be 
statistically attributed to rare variants with an extremely high incidence risk, i.e. the 
penetrance coefficient of homozygote always equals 1. With a similar consideration, Yang et 
al. (2010) found that the contribution from rare variants can explain most of the remaining 
heritability that is missing from the current GWASs for human height. Meanwhile, the small 
contribution from a single candidate gene implies that there might be a considerable level of 
genetic heterogeneity, and such an effect will be included in our following derivations.  
 
Note here, complex traits controlled by multiple genes might be grouped into two categories 
based on whether all multiple genes affect each individual or not. Firstly, several genes of 
each individual might contribute to the phenotype of interest aggregately, and further 
complexities may be introduced if these genes are interactive, i.e. epistasis, or/and individuals 
are highly related (Abecasis et al., 2000, Yu et al., 2006); Alternatively, a single or a few 
genes might solely be responsible for the phenotype of interest for a group of individuals, and 
other groups of people may have different causal genes, i.e. the genetic heterogeneity. As 
suggested by Yang et al. (2010), we may reasonably believe that large parts of missing 
variance or heritability are due to the rare variants, which further implies that most of these 
rare variants might be functional individually rather than aggregately in a particular individual 
due to their low frequencies in the population. Nevertheless, although we can not completely 
rule out the possibility that epistasis might play an important role in the unexplained variance 
in case multiple genes are functional aggregately, because it is extremely impractical to detect 
every pairwise gene interaction simply using phenotype-genotype data (Cantor et al., 2010). 
Also such analyses of epistasis are mainly performed after candidate QTLs having been 
  
98 
detected. So, we will only consider the situation of genetic heterogeneity in our following 
analysis but excluding epistasis. 
  
3.2.2 Calculation of the Optimal Trend Set 
In section II-2.2.1, we have shown that the optimal choice of ix  for a random sample is 
1 1( )x E y= , 2 2 ( )x E y=  and 3 3 ( )x E y= , and it will be now demonstrated that it is also true for 
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and hence the Armitage’s trend test statistic, i.e. 
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Since ( )Var k  and ( )Var y  can be calculated directly and independently, one of the optimal 
choices of ix , the trend coefficients, is clearly ( )i ix E k= . By noticing that .i ik y=  and 
therefore ( ) ( )i iE k E y= , we have proved the claim at the beginning of this section. For 
practical and convenience to make comparison, we will take the equivalent transformation (II-
2.5) as  




( ) ( )
( ) ( )
E k E k
x




 and 3 0x = , 
  
99 
and hence 2x  is of the key interest in the following discussion. 
 
To derive the exact form of 2x , a genetic model for Case-Control samples has to be 
characterized. Assign if  to denote the penetrance coefficient of the ith QTL genotype and ijg  
to denote the joint distribution of the ith marker genotype and the jth QTL genotype in a 
random mating population from which case and control samples were collected. We can 
hence have the joint distribution of marker and QTL genotypes as shown in Table II-4 and the 
value of 
ijg  as given in Table II-5. This is an alternative expression of Table II-1, with the 
transformations /Q p D q= +  and /(1 )R p D q= − − , where p, q are the frequencies of alleles 
M and A respectively, and D is the coefficient of LD with the disease causal allele A 
positively associated with M, i.e. 0D > .  
 
Table II-4. Joint Distribution (Unnormalised) of Marker and QTL Genotypes for Case Control Samples. 
i
f  denotes the penetrance coefficient of ith QTL genotypes; 
ij
g  denotes the joint probability of the ith marker genotype and the jth QTL 
genotype in a random population. 
 Cases Controls 
MM Mm Mm MM Mm mm 
AA 
1 11f g×  1 21f g×  1 31f g×  1 11(1 )f g− ×  1 21(1 )f g− ×  1 31(1 )f g− ×  
Aa 
2 12f g×  2 22f g×  2 32f g×  2 12(1 )f g− ×  2 22(1 )f g− ×  2 32(1 )f g− ×  
aa 
3 13f g×  3 23f g×  3 33f g×  3 13(1 )f g− ×  3 23(1 )f g− ×  3 33(1 )f g− ×  
 
Table II-5. Joint Distribution of Marker and QTL Genotypes in a random Population where Case and 
Control Samples Were Collected. 
/Q p D q= +  and /(1 )R p D q= − − , where p, q denotes the allele frequencies of maker allele M and QTL allele M respectively and D is 
the coefficient of linkage disequilibrium between the marker locus and the QTL. 
 MM Mm mm 
AA 2 2q Q  ( )22 1q Q Q−  2 2(1 )q Q−  
Aa 2 (1 )q q QR−  2 (1 )( 2 )q q Q R QR− + −  2 (1 )(1 )(1 )q q Q R− − −  




In the presence of genetic heterogeneity, where there are multiple independent genes at 
different loci to cause a similar phenotype or symptom, the case sample can be divided into 
two parts, of size 1N  and 2N , where the former is contributed from the putative QTL, while 
the later one, due to the heterogeneity, has the same distribution of marker genotypes as that 
of the control sample with a sample size 3N . From the discussion in section II-3.2.1, it is 
reasonable to assume q, the frequency of disease causal allele, to be very small, and we can 
have 1 1f = , 2f f=  and 3 0f = . Following Table II-4 and Table II-5, we can calculate 
2
11 21 31AAf g g g q= + + =  
12 22 32 2 (1 )Aaf g g g q q= + + = −  
2
13 23 33 (1 )aaf g g g q= + + = −  
11 12( ) /( )
case
MM AA Aaf g f g f f f= + × + × , 
21 22( ) /( )
case
Mm AA Aaf g f g f f f= + × + × , 
31 32( ) /( )
case
mm AA Aaf g f g f f f= + × + × , 
13 12[ (1 ) ] /[ (1 ) ]
control
MM aa Aaf g f g f f f= + − × + − × , 
23 22[ (1 ) ] /[ (1 ) ]
control
Mm aa Aaf g f g f f f= + − × + − × , 
33 32[ (1 ) ] /[ (1 ) ]
control
mm aa Aaf g f g f f f= + − × + − × , 
1 1 2 1 2 3( ) /[ ( ) ]
case control case control
MM MM MM MMk N f N f N f N N f= + + + , 
2 1 2 1 2 3( ) /[ ( ) ]
case control case control
Mm Mm Mm Mmk N f N f N f N N f= + + + , 
3 1 2 1 2 3( ) /[ ( ) ]
case control case control
mm mm mm mmk N f N f N f N N f= + + + , 
where Gf , 
case
Gf  and 
control
Gf  denote the frequencies of genotype G in the population, case and 
control samples, respectively, and ik  is the expected case proportion given the ith marker 
genotype. One may hence derive  
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 if 0f ≠  and 0q → , 1 2 32 2
1 2 3
(1 )[ ( ) ]
( 2 ) ( )(2 2 )
R N Q N N R
x
N Q R QR N N R R
− + +
=
+ − + + −
 (II-3.1) 
and 
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. (II-3.2) 
We can immediately notice that the theoretical value of 2x  is free from the penetrance 
coefficient f , unless in the recessive model where 0f = . This result shows that in the 
Armitage’s trend test, only two models need to be considered, says 0f =  and 0f ≠ , and 
let’s call them the ‘Recessive Model’ and the ‘Non-Recessive Model’ respectively. Notice 
that both formulae (II-3.1) and (II-3.2) automatically regroup the case individuals that are 
contributed from alternative genes or genetic heterogeneity, i.e. 2N , to the control individuals, 
we may hence name the proportion 1
1 2 3
N
N N N+ +  as the effective case proportion denoted 
as r. 
 
Compared to the original Armitage trend test, which does not assume the HWE as we have 
discussed in section II-2.3, we calculated formulae (II-3.1) and (II-3.2), i.e. the optimal trend 
coefficient 2x , based on a population in HWE. However, an assumption of HWE does not 
limit the application of our optimal trend coefficient 2x , because in the absence of 
confounding factors, e.g. population stratification etc., it would be quite reasonable to assume 
HWE in an out-bred species. Moreover, even in the presence of population stratification, each 
subpopulation could still be assumed as following HWE. We will deal with population 




3.2.3 The Non-Recessive Model 
Prior to any further calculations, it would be very useful to evaluate the range of 2x  in these 
two models and then interpret the genetic significance behind it to outline some basic pictures. 
Here, we would like to start with a briefly discussion of the non-recessive model first.  
 







 is the standardised coefficient of LD as defined by formula (I-1.3), the 
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where the use of D′  rather than D is mainly because D′  still has a definition even while 
0q →  and r is the effective case proportion as defined above. It is easy to understand that 
formula (II-3.3) is a monotonic increasing function of D′  since both p and r fall within their 
domain (0, 1), and the boundary of 2x  can hence be computed as 
1 (1 )
[ , ]





, where the 
lower and upper bounds can be achieved by setting D′  equal to 0 and 1 respectively. It can be 
noticed that the lower bound implies the default trend set {1, 0.5, 0} is the optimal choice 
under the null hypothesis where 0D′ = . However, this result is due to the transformation (II-
2.5), and theoretically any trend sets should have asymptotically the same false inference rate 
when 0D′ = . On the other hand, the upper bound is still a function of the effective case 
proportion r  and the marker allele frequency p , both of which have their domains (0, 1). We 
may notice that the optimal 2x  can only approach 1 while 0p→  or 1r → , where, however, 
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both situations are far from the reality in practice: Firstly, r has to be smaller than 1, as there 
are always control samples, i.e. 3N  cannot be null, and a considerable proportion of case 
individuals may come from the genetic heterogeneity, say 2N  might not be ignored; Secondly, 
a genetic variant would rarely be chosen as a common marker to perform GWAS if its minor 
allele frequency (MAF) is lower than 0.05 (Tabangin et al., 2009), which is mainly because of 
both the belief of ‘common disease, common variant’ and the fear of spurious association due 
to both genotyping and sampling errors. It hence turns out that the upper bound of 2x  will not 
be too much different from 0.5 as shown in Figure II-1, which illustrates the relationship 
between the upper bound of the optimal 2x  (vertical axis) and the allele frequency p 
(horizontal axis) from formula (II-3.3) with the effective case proportion r equalling to 0.05 
(blue), 0.1 (green) and 0.2 (pink) and the equal sample sizes in case and control.  
 
 
Figure II-1. Figure II-1 presents the relationship between the upper bound of optimal x2 (vertical axis) and marker allele frequency p 
(horizontal axis) under a non-recessive model, where the blue, green and pink curves are drawn with r  equalling to 0.2, 0.1 and 0.05 




Since the correlation 2 ( , )Cor x k  as indicated above is the key factor that affects the statistical 
power as mentioned above, the less it will deviate from 1, the better the corresponding trend 
set will be. The theoretical performance of default trend set {1, 0.5, 0} under the non-
recessive model are hence illustrated in Figure II-2 through calculating 2 ( , )Cor x k  as the 
increase of D′ , where k are assigned with the value of an optimal trend set as such an 
assignment is equivalent to assign ( )i ik E y= ; the case and control sample sizes are assumed 
to be equal and r is assumed to be 0.05, both of which together indicate that the putative QTL 
of interest explains 10% of the whole case sample;  p  is assigned to be 0.05 (blue), 0.1 
(green), 0.2 (pink), 0.5 (yellow). It can be noticed from Figure II-2 that even with the largest 
loss of statistical power, i.e. 0.05p = , 1D′ =  and the corresponding optimal 2x  should be 
around 0.65 as indicated in Figure II-1, the value of 2 ( , )Cor x k  only reduces by less than 1% 
of its maximum value 1. For a higher marker allele frequencies, says 0.5p = , such deviation 
is even smaller than 0.001. Since the optimal trend set is identical among any non-recessive 
models, we may hence conclude that the default trend set {1, 0.5, 0} can be generally adopted 
for non-recessive models. Such a statement will be further evaluated through a simulation 




Figure II-2. In a non-recessive model, the relationship between adjusted LD D′  and correlation between x and k with default trend set {1, 
0.5, 0}, given marker allele frequency p and the exact case proportion r. 
 
Consider a Case-Control sample with equal sample size in case and control, i.e. 1 2 3N N N+ = , 
is selected from an infinite population with penetrance coefficients 1 1f = , 2f f=  and 3 0f = , 
where 1N  is the sample size of case individuals contributed from the putative QTL, 2N  is the 
sample size of case individuals due to heterogeneities, e.g. background gene effects and 






= + + , that matters as indicated at formula (II-3.3), only the value of 
r will be updated in the following simulations with constant 1000 cases and 1000 controls. In 
our simulation studies, 1N  case individuals are generated following the joint distribution for 
case individuals as indicated in Table II-4, where the sample size of individuals with ith 
marker genotype is counted as 1in ; 2N  case individuals and 3N  control individuals are 
generated following the joint distribution for control individuals as indicated in Table II-4 as 
well, where the sample sizes of individuals with ith marker genotype from such case and 
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control samples are counted as 2in  and 3in  respectively. Finally, we denote 1 2i i Din n n+ =  and 
Cin  to be the observed sample size of individuals with ith marker genotypes in case and 
control respectively. The parameters and the results of such simulations are both listed in 
Table II-6, where each test is replicated 1000 times and the number of tests which pass the 
0.1% level of significance after the Bonferroni’s correction is reported as the result. As both 
the optimal and default trend sets have been defined before, we only note here the dominant 
trend set takes the form {1, 1, 0} as suggested by Sasieni (1997). Also note here, we 
implement the Bonferroni’s correction for two reasons: Firstly, in order to compare the 
statistical powers, instead of comparing the average test-statistics or p-values, we can set up a 
restrictive threshold and measure the hits of each test that pass it. Secondly, as the 
Bonferroni’s correction is widely used to establish a threshold that identifies a genome-wide 
significance, we would like to adopt it for the sake of practicality. 
 
It can be noticed from the upper part of Table II-6, where the penetrance coefficient 0.5f = , 
i.e. the co-dominance model, although the simulation results do show certain improvement of 
the statistic power by using the optimal trend set, shown as column Optimal,  than the default 
one, shown as column Default, such an improvement is quite small, and hence can be 
neglected. As a similar conclusion can also be acquired from the simulation results of the 
dominance model, where 1.0f =  as shown at the lower part of Table II-6, and hence we can 
conclude that the optimal trend set and the default trend set have very similar statistical 
powers while dealing with case-control samples under a non-recessive model. Such a result is 
coincident with our previous analyses illustrated at Figure II-2, where we have suggested the 






Table II-6. Simulation Results of Three Trend Sets for Dominant and Additive Model 
For each simulation, 1000 cases and 1000 controls were generated, and the remaining parameters are listed in the first 5 columns, where f 
denotes the penetrance coefficient of heterozygote at the disease locus, i.e. f=0.5 denotes co-dominant and f=1.0 denotes dominant; r denotes 
the effective case proportion; p and q are the frequencies of marker and disease allele which are positively associated with the adjusted 
linkage disequilibrium D’. Each simulation was repeated by 1000 times, and the corresponding empirical statistical powers given the 0.1% 
significant level after Bonferroni’s correction were listed in the last three columns with trend sets ‘Optimal’, i.e. calculated from formula II-
3.1, ‘Default’, i.e. {1, 0.5, 0}, and ‘Dominant’, i.e. {1, 1, 0}, respectively.  
f  r  p  q  D′  
Proportion of 1000 replicates surpassed 
0.1% Significant Level after 
Bonferroni’s Correction 
Optimal Default Dominant 
0.5 0.10 0.01 0.001 0.2 35.8 35.8 NA 
0.5 0.10 0.01 0.001 0.5 100 100 NA 
0.5 0.10 0.05 0.001 0.2 0.8 0.7 NA 
0.5 0.10 0.05 0.001 0.5 82.9 81.8 NA 
0.5 0.10 0.05 0.001 0.8 100 100 NA 
0.5 0.10 0.10 0.001 0.2 0.1 0.1 NA 
0.5 0.10 0.10 0.001 0.5 30 29.8 NA 
0.5 0.10 0.10 0.001 0.8 97.1 96.8 NA 
0.5 0.10 0.20 0.001 0.2 0 0 NA 
0.5 0.10 0.20 0.001 0.5 3 3.1 NA 
0.5 0.10 0.20 0.001 0.8 47.8 48.1 NA 
0.5 0.10 0.20 0.001 1.0 87.1 86.6 NA 
1.0 0.10 0.01 0.001 0.2 36.7 36.6 36.6 
1.0 0.10 0.01 0.001 0.5 100 100 100 
1.0 0.10 0.05 0.001 0.2 0.7 0.8 0.4 
1.0 0.10 0.05 0.001 0.5 83.1 82.4 82.4 
1.0 0.10 0.05 0.001 0.8 100 100 100 
1.0 0.10 0.10 0.001 0.2 0.1 0.1 0.1 
1.0 0.10 0.10 0.001 0.5 30.6 30.1 28.5 
1.0 0.10 0.10 0.001 0.8 97.1 97.2 96 
1.0 0.10 0.20 0.001 0.2 0 0 0 
1.0 0.10 0.20 0.001 0.5 3.1 3.1 2.8 
1.0 0.10 0.20 0.001 0.8 48.4 47.8 39.5 
1.0 0.10 0.20 0.001 1.0 87.4 86.8 83.3 
 
Meanwhile, we can also notice that the dominance trend set {1, 1, 0}, shown in the most right 
column ‘Dominant’ in Table II-6, has a generally lower statistical power than the other two. It 
can hence be concluded that the trend set {1, 1, 0} is not recommended even under the 
dominance model, and the suggestion from Sasieni is inadequate. It can be noticed that such a 
difference will become more significant as p  deviates away from 0, which is mainly because 
while p is small, i.e. 0.01p = , the observed individuals with marker genotype MM in both 
Case and Control are extremely rare or even missing due to the limited sample size, and in 
such a situation, there is fundamentally no difference among these three trend sets. More 
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precisely, if one of the observed genotypes is missing from either or both case and control 
samples, the Armitage’s trend test is not recommended due to two reasons: Firstly, the case 
proportion of such a marker genotype is either 0 or undefined, and hence the trend coefficient 
for such a genotype is non-informative; Secondly, the missing genotype also hinders the 
information about the HWE, which is not necessarily true of the joint samples to valid an 
Armitage’s trend test though. A good example of such an influence can be examined by 
denoting 1 0N =  in formula (II-2.8), i.e. a genotype is missing from both case and control 
samples, and the ratio hence derived is always less than 1 as the second term in formula (II-
2.8) is negative. Such a result means the Armitage’s trend test hence derived will always 
underestimate a test statistic than the allelic analysis, and because of the very general 
validation of the allelic analysis, the Armitage’s trend test is not favoured under such a 
situation.  
 
Finally, it can be concluded that under a non-recessive model, although the default trend set 
{1, 0.5, 0} is actually the optimal choice under the null hypothesis as mentioned above, it is 
still a very powerful trend set if not the most. Thus, under a non-recessive model, we can feel 
free to use the default trend set {1, 0.5, 0} without the risk of losing the statistical power. Plus, 
another advantage of using the default trend set {1, 0.5, 0} lies in the fact that there is no need 
to determine which marker allele is positively associated with the disease causal allele prior to 
launch an Armitage’s trend test as the corresponding test statistic is symmetric.  
 
3.2.4 The Recessive Model 
In the previous section, we have shown that the default trend set {1, 0.5, 0} can be generally 
adopted to conduct an Armitage’s trend test under a non-recessive model without the risk of 
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losing statistical powers. However, as will be shown in this section, the choice of an adequate 
trend set under a recessive model is not as straightforward as that under a non-recessive model. 
 
To understand the optimal 2x  under the recessive model as given by formula (II-3.2), we can 
take the same transformation 1 2 3{ , , , , } { , , }Q R N N N q r D′→  as launched in the previous 
section. However, the formula of the optimal 2x  turns out to be much more complicated than 






(1 ) [ (1 ) 2 ](1 )
[ (1 ) 2 ] [1 (1 ) 2 ]
D p D D p p p r
x
D p p p D D p p r
′ ′ ′
− + − + −
=
′ ′ ′− + + − − −
  . (II-3.4) 
Unlike function (II-3.3), function (II-3.4) is not generally monotonic, and hence the range of 
the optimal 2x  is highly subject to the parameters. In order to understand how these 
parameters can affect the value of the optimal 2x , we illustrate the relationship between the 
value of the optimal 2x  and the adjusted LD coefficient, i.e. D′ , subject to various r and p as 

















Figure II-3. The relationship between the value of the optimal 
2
x and the adjusted LD coefficient D′ from formula II-3.2, given the 
effective case proportion r= 0.2 (a), r=0.1 (b) and r=0.05 (c). For each figure, four curves are presented based on different marker allele 




From Figure II-3 (a)-(c), we can notice that the optimal 2x  is not always monotonic any more, 
especially while p is small, e.g. 0.01p = . Meanwhile, unlike under the non-recessive model, 
where the optimal 2x  will not be too much different from 0.5 even while 1D′ =  unless p is 
sufficiently small (Figure II-1), we can notice that under the recessive model the optimal 2x  
will eventually reach 0 as 1D′ →  irrespective of the other parameters. Such a non-monotonic 
property and a wide range of possible values simply hinder any attempt to find a general valid 
trend set for the recessive model. However, we can notice that in the condition of a high level 
of heterogeneity, e.g. 0.1r ≤ , and not too small a marker allele frequency, e.g. 0.05q ≥ , the 
optimal 2x  is merely monotonic within the interval [0, 0.5], and by noticing that the 
corresponding curve of the optimal 2x  is rather flat around 2 0.25x =  for [0.2,0.8]D′∈ , we 
can propose the trend set {1, 0.25, 0} for the recessive model if no information about D′  and 
r is available. This approximation is reasonable by noticing that one single gene normally 
contributes only a very small fraction of the whole case sample and the normally implemented 
genetic markers have an MAF over 0.01 or 0.05.  
 
Note here, it is true that the information of D′  and r might be acquired from the genotype 
data directly. To investigate a possible D′ , we can calculate the average D′  among genetic 
markers within the interval between two recombination hotspots, as it is reasonable to believe 
the putative QTL should have a much stronger association with a marker within the same 
recombination hotspot interval than with one outside. It is also possible to estimate the level 
of genetic heterogeneity if the causal gene is recessive. However, due to the concern of its 
accuracy, the estimate of r might not be practical for a complex disease where a single gene 
may only contribute a fairly small fraction of the whole case sample. Nevertheless, if we can 
assume the level of heterogeneity is high, the inference of D′  solely is sufficient to give an 




. However, there are several concerns about 
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estimating D′  between genetic markers: Firstly, a Case-Control sample is not a random 
sample, and hence the marker allele frequency estimated from such a sample might be biased. 
Such a bias will surely cause a more severe bias to the estimate of D′  as will be shown in 
Chapter III-1. In that chapter, we will introduce a new strategy to estimate the LD coefficient 
in non-random samples and hence we can still estimate a reliable D′  with the new strategy. 
Secondly, as such an estimate will be repeated at the level of 2n , where n is the number of 
markers in the same recombination hotspot interval, even if such intervals are known, the 
computational burden would be quite considerable. Although both concerns can be solved as 
discussed above, we will show later at the end of this section that a higher D′  does not 
guarantee a higher statistical power, so we will not implement such a strategy to calculate the 
optimal 2x . On the other hand, we will also show that the trend set {1, 0.25, 0} as proposed 
above performs reasonably well.  
 
Similar to Figure II-2, we can evaluate the performance of different trend sets in comparison 
to the optimal one under the recessive model by calculating their corresponding 2 ( , )Cor x k  as 
the increase of D′ , because 2 ( , )Cor x k  of the optimal trend set will always equal 1. The 
results of such analyses are illustrated in Figure II-4 to Figure II-6, where the corresponding 
trend sets are {1, 0.5, 0}, {1, 0.25, 0} and {1, 0, 0}, respectively, and in each comparison, we 
always assume 0.05r =  and p takes value of 0.05 (Blue Square), 0.1 (Green Dot), 0.2 (Pink 
Upward Triangle) and 0.5 (Brown Downward Triangle). It can hence be noticed that both 
trend sets {1, 0.5, 0} and {1, 0, 0} have poor performance at certain regions, for instance, {1, 
0.5, 0} may suffer from a serious loss of statistical power if D′  is large than 0.2 and {1, 0, 0} 
may suffer from an even more serious loss if D′  is smaller than 0.8. Such a gap, i.e. between 
0.2 and 0.8, can be efficiently filled up by the trend set {1, 0.25, 0} as illustrated at Figure II-5. 
We can notice that the trend set {1, 0.25, 0} will suffer a certain loss of statistical power at 
two extremes as this trend set is initially designed to represent the optimal trend set within 
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0.2 0.8D′< <  as indicated in the discussion for Figure II-3. Because the statistical power only 
matters in the presence of a true LD, i.e. D′  is sufficiently large, the default trend set {1, 0.5, 
0} is not suitable for the recessive model, and the remaining two can be jointly applied instead 





Figure II-4. Under a recessive model, the relationship between D′  and 
2
( , )Cor x k  with trend set {1, 0.5, 0}, i.e. the default trend set, in 






Figure II-5. Under a recessive model, the relationship between D′  and 
2
( , )Cor x k  with trend set {1, 0.25, 0}, i.e. the recessive trend set, 
in terms of marker allele frequency p  and the effective case proportion r . 
 
 
Figure II-6. Under a recessive model, the relationship between D′  and 
2
( , )Cor x k  with trend set {1, 0, 0}, in terms of marker allele 
frequency p  and the effective case proportion r . 
 
 
In order to evaluate our suggestion above, simulation studies are carried out following the 
almost identical procedure as introduced in the previous section II-3.2.3, except the recessive 
model is implemented, i.e. 0f = . The remaining parameters and the simulation results are all 
listed in Table II-7 and Table II-8 subject to different r, i.e. the effective case proportion, as r 
  
115 
is important to determine the optimal trend set under the recessive model as indicated by 
Figure II-3. Because the performance of trend set {1, 0, 0} is too poor to be mentioned unless 
D′  is fairly close to 1, in the simulations we only include the optimal trend set, the default 
trend set {1, 0.5, 0} and the recessive trend set {1, 0.25, 0}, the results of which are 
represented in columns Optimal, Default and Recessive respectively. In Table II-7, r equals 
0.05, which means the putative QTL is responsible for 10% of the whole case individuals 
given the equal case and control sample size. Despite the best performance of the optimal 
trend set throughout, we can notice that unless D′  is small, e.g. D′ < 0.2, the recessive trend 
set has shown much stronger statistical power than the default one, and the advantage of the 
recessive trend set is amplified with increase of D′ , which is exactly what we have predicted 
from Figure II-4 and Figure II-5. A similar result can be observed in Table II-8, where 0.1r = , 
i.e. the putative QTL is responsible for 20% case individuals, but because the overall 
statistical power increases tremendously due to the increase of r, the advantage of the 
recessive trend set over the default one is not so obvious. Compared to the optimal trend set, 
the recessive one can provide similar statistical powers especially for 0.5D′ =  and 0.8D′ = . 
However, it does suffer a certain loss of statistical power especially while 1D′ =  as shown in 
Table II-7, but such a loss of statistical power has been alleviated with the increase of r as can 
be observed in Table II-8, where both the optimal and recessive trend set share similar 
statistical power except for 0.2D′ = , because almost all replicates for both trend sets are 
significant while 1D′ = . The loss of statistical power for the recessive trend set while D′  
approaches its extremes is exactly what we have predicted in Figure II-5, and hence we would 
again suggest the use of trend set {1, 0, 0} as a complementary to the recessive trend set {1, 
0.25, 0} in cases when D′  are extremely high. However, as the performance of trend set {1, 0, 
0} is heavily dependent on the genotype assigned with trend coefficient 1, if this particular 
genotype is extremely rare or even missing in case or/and control samples, this trend set 




Table II-7. Simulation Results of Three Trend Sets for Recessive Model with r Equalling 0.05 
For each simulation, 1000 cases and 1000 controls were generated, and the remaining parameters are listed in the first 4 columns with the 
penetrance coefficient f of heterozygote at the disease locus equalling 0 constantly, i.e. recessive, where r denotes the effective case 
proportion; p and q are the frequencies of marker and disease allele which are positively associated with the adjusted linkage disequilibrium 
D’. Each simulation was repeated by 1000 times, and the corresponding empirical statistical powers given the 0.1% significant level after 
Bonferroni’s correction were listed in the last three columns with trend sets ‘Optimal’, i.e. calculated from formula II-3.2, ‘Default’, i.e. {1, 
0.5, 0}, and ‘Recessive’, i.e. {1, 0.25, 0}, respectively.  
r  p  q  D′  
Proportion of 1000 replicates surpassed 0.1% 
Significant Level after Bonferroni’s Correction 
Optimal Default Recessive 
0.05 0.01 0.001 0.2 45.5 45.4 36.1 
0.05 0.01 0.001 0.5 100 100 100 
0.05 0.01 0.001 0.8 100 100 100 
0.05 0.05 0.001 0.2 1.8 1.4 1.5 
0.05 0.05 0.001 0.5 95.3 85.4 95.2 
0.05 0.05 0.001 0.8 100 99.8 100 
0.05 0.10 0.001 0.2 0.3 0.3 0.3 
0.05 0.10 0.001 0.5 64.3 42.9 63.4 
0.05 0.10 0.001 0.8 100 95.3 99.9 
0.05 0.20 0.001 0.2 0 0 0 
0.05 0.20 0.001 0.5 13.8 7.6 13.6 
0.05 0.20 0.001 0.8 91.2 56.9 87.4 
0.05 0.20 0.001 1.0 100 86.2 99.5 
0.05 0.35 0.001 0.2 0 0 0 
0.05 0.35 0.001 0.5 1.8 1.2 1.8 
0.05 0.35 0.001 0.8 29.8 13.6 28.3 
0.05 0.35 0.001 1.0 80.2 35 71.2 
0.05 0.50 0.001 0.2 0 0 0 
0.05 0.50 0.001 0.5 0.4 0.4 0.5 
0.05 0.50 0.001 0.8 5.2 3.2 4.5 















Table II-8. Simulation Results of Three Trend Sets for Recessive Model with r Equalling 0.10 
For each simulation, 1000 cases and 1000 controls were generated, and the remaining parameters are listed in the first 4 columns with the 
penetrance coefficient f of heterozygote at the disease locus equalling 0 constantly, i.e. recessive, where r denotes the effective case 
proportion; p and q are the frequencies of marker and disease allele which are positively associated with the adjusted linkage disequilibrium 
D’. Each simulation was repeated by 1000 times, and the corresponding empirical statistical powers given the 0.1% significant level after 
Bonferroni’s correction were listed in the last three columns with trend sets ‘Optimal’, i.e. calculated from formula II-3.2, ‘Default’, i.e. {1, 
0.5, 0}, and ‘Recessive’, i.e. {1, 0.25, 0}, respectively.  
r  p  q  D′  
Proportion of 1000 replicates surpassed 0.1% 
Significant Level after Bonferroni’s Correction 
Optimal Default Recessive 
0.10 0.01 0.001 0.2 100 100 100 
0.10 0.05 0.001 0.2 62.1 59.5 59.9 
0.10 0.05 0.001 0.5 100 100 100 
0.10 0.10 0.001 0.2 18.2 16.6 16.7 
0.10 0.10 0.001 0.5 100 100 100 
0.10 0.20 0.001 0.2 2.6 1.7 2.4 
0.10 0.20 0.001 0.5 96.9 91.5 96.9 
0.10 0.20 0.001 0.8 100 100 100 
0.10 0.50 0.001 0.2 0 0.1 0 
0.10 0.50 0.001 0.5 13.1 10.8 13 
0.10 0.50 0.001 0.8 83.7 68.6 82.5 
0.10 0.50 0.001 1.0 99.7 95 99.5 
 
Note here, it seems quite reasonable to assume that 1D′ ≈  if the density of markers is 
sufficiently high, and in such a circumstance only the trend set {1, 0, 0} is required for the 
recessive model because normally we believe that only a marker closely linked to the putative 
QTL matters. However, although a closely linked marker can preserve a higher LD than a 
marker less closely linked does if no confounding effect involved, e.g. the immigration, as 
indicated in Table II-6, Table II-7 and Table II-8, the marker allele frequency also plays an 
important role in determining the test statistical power and hence we can not simply assume a 
marker with lower LD is less important. Take the first and last rows in Table II-7 for example, 
it is clear that the statistical power of a sample with 0.01p =  and 0.2D′ =  is twice as that of 
a sample with 0.50p =  and 1.0D′ =  if either an optimal trend set or a recessive trend set is 
implemented. With this understanding, we should always implement the recessive trend set, 
i.e. {1, 0.25, 0}, because the linkage disequilibrium is not the only factor that influences the 




As a brief conclusion here, the recessive trend set {1, 0.25, 0} should be mainly used if a 
recessive model is under test, but the trend set {1, 0, 0} can be implemented as a 
complementary analysis in case D′  between the testing marker and the QTL is extremely 
high providing the genotype assigned with trend coefficient 1 is not too rare. 
 
3.2.5 Regarding the False Positive 
Above, we have analysed the statistical power of the Armitage’s trend test with different trend 
sets as shown in Table II-6, Table II-7 and Table II-8. However, another issue remains; do the 
alternative trend sets other than the default one increase the chance of claiming a false 
positive? We would like to assess this question empirically. As we have mentioned before, 
any trend sets should have asymptotically identical false inference rates under the null 
hypothesis, i.e. D = 0, where the false negative rate is always null and hence is obviously 
identical among different trend sets. To evaluate the false positive rates among different trend 
sets, the default trend set {1, 0.5, 0} and the recessive trend set {1, 0.25, 0} are compared 
through a simulation study under the null hypothesis, where p, the frequency of marker allele 
M, increase from 0.01 to 0.90 with step 0.01 and the simulation for each p was replicated 
1000 times under the null hypothesis with 1000 case individuals and 1000 control individuals. 
The corresponding simulation results are given in Table II-9, and we can notice that the 
difference between these two trend sets is not significant (P-value = 0.204). 
 
Table II-9. False Positive Rates of Default and Recessive Trend Sets 
The false positive rates of default {1, 0.5, 0} and recessive {1, 0, 0} trend sets are analysed through simulations under the null hypothesis. 
1000 cases and 1000 controls are simulated for each of 1000 replicates given a particular marker allele frequency p, which increase from 0.01 
to 0.90 with step 0.01. The number of claimed positive from 1000 replicates at the 0.01 significance level for each step was recorded., of 
which the means and standard deviations of these two trend sets are listed as below. A t-test was carried out between these two trend sets 
with 178 degrees of freedom.   
 
Trend Set  t-Test 
(df) Default Recessive 
False positive rate 
per 1000 replicates at 
99% confidential 
interval 
Mean 10.438 9.854 
1.275 




Although above empirical analyses show that the alternative trend sets are unlikely to cause a 
higher false positive rate, we should again note here that in practice, the genotyping errors 
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might largely influence the test statistics from an alternative trend sets, especially the one {1, 
0, 0}. This is mainly because such an alternative trend set heavily relies on one of the two 
homozygotes, and if one of the homozygote genotypes is comparatively rare, even a single 
individual being wrongly genotyped would dramatically shift the test statistics. Comparatively, 
the default trend set is more robust under such a situation. Of course, as we have suggested 
above, if some of the genotypes are missing for either case or control sample due to too low 
an allele frequency, the allelic analysis is recommended. 
 
3.2.6 Conclusion 
In above discussions, we have shown that only two situations need to be considered in a Case-
Control study, i.e. the non-recessive model where 0f ≠  and the recessive model where 
0f = . Because of their different features, the performance of adopting the optimal trend set 
for these two models are quite different. In a non-recessive model, because the optimal 2x  
will not significantly differ from 0.5 due to the high heterogeneity level in practice, the 
improved statistical power from the use of optimal trend set is very limited, and hence the 
default trend set {1, 0.5, 0} can be a both conventional and appropriate choice instead of the 
optimal one. However, in a recessive model, because the optimal 2x  highly depends on the 
parameters, i.e. r and D′ , the performance of the default trend can be much worse than an 
alternative one, e.g. the optimal trend set and the recessive trend set. As the optimal trend set 
under such a situation might not be available, it is hence recommended to adopt the recessive 
trend set {1, 0.25, 0} instead and the trend set {1, 0, 0} can be implemented as a 
complementary as the simple recessive trend set might suffer a certain loss of statistical power 




As the choice of an optimal trend set has become clear, in the next stage, the information of 
population stratification will be combined into the Armitage’s trend test in order to analyse 
jointly datasets from different resources.  
 
3.3 Correction for Population Stratification in the 
Armitage’s Trend Test 
As has been discussed in section I-1.1 and II-3.2.1, the low discovery rate of causal genes 
urges the need to increase the statistical power of GWAS. Other than the improvement of 
statistical methods, the increase of sample size would be a more direct and convenient way 
given the explosion of available GWAS data in the past few years (Ku et al., 2010). To 
integrate results from different GWAS, meta-analysis is probably the most common way to 
analyse and integrate information from those previous results. However, as an ‘analysis of 
analyses’, meta-analysis will surely lose some information because much of the genetic 
information is not included in a result output. If the original genotype-phenotype information 
of all integrated data is available, the implementation of an association study on these 
integrated data would be an optimal choice, which would definitely lead to the increase of the 
corresponding statistical powers if genuine genetic association does exist in many of those 
resources. However, to integrate data from different resources will almost surely encounter 
the issue of population stratification, because many of these data are collected from different 
genetic cohorts. Although most of these cohorts are European oriented in the major reference 
dataset, we can not exclude the possibility that minor differences might exist for certain 
regions in the genome, and as we will show later, the influence from even a minor difference 
in marker allele frequency can be dramatically amplified by the differences between case-
control ratios from different sources. In order to cope with the issue of population 
stratification raised by the combination of data from multiple cohorts, two approaches, i.e. 
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Method I (Dummy Variables) and Method II (Non-central χ2 test), are introduced in the 
following sections and evaluated by both simulation studies and real data analyses. 
 
3.3.1 Method I: Dummy Variables 
To correct the effect of population stratification in a linear model, our intuitional idea would 
be the introduction of an extra parameter vector λ , a dummy variable, to adjust this 
substructure effect. Suppose there are n individuals sampled from m subpopulations, we can 
write a linear model in the form β= +y X Zλ , where y is a 1n×  column vector of phenotypes 
with the ith phenotype being denoted as iy ; X is a 1n×  column vector of trend coefficients 
with its ith element denoted as ix ; Z is a n m×  matrix with its element ijz  equalling 1 only if 
the corresponding ith individual belongs to the jth subpopulation or otherwise 0; β  is the 
regression coefficient for the trend coefficients and λ  is an 1m×  column vector with its jth 
element representing the substructure effect of the jth subpopulation with i n≤ , j m≤  and 
,i j Z +∈ .  
 
The formula β= +y X Zλ  can be alternatively expressed as  














   
      
   
X X X Z X
y
Z X Z Z Z
 from formula 






X X X Z
Z X Z Z
 can be understood by noticing that the 
columns of X and Z are linearly independent with each other, which is generally true as the 
columns of Z are obviously linearly independent and X can not be represented by any a linear 
combination of such columns unless rare occasions happens, e.g. one of the marker genotypes 
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are missing from one subpopulation and the other two genotypes share the identical trend 
coefficients, and hence matrices ( )X Z  and ( )
T T T
T T T
   
=      
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X X X X Z
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Z Z X Z Z
 are all of full-




1 1 1 1 1 1
( )




T T T T T T T
−
− − −







X X X Z
Z X Z Z
A A X Z Z Z
Z Z Z XA Z Z Z Z Z XA X Z Z Z
, 










= − =∑A X X X Z Z Z Z X  is a real number. The estimator of β  can 
hence be calculated as: 
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X y X Z Z Z Z y
X X X Z Z Z Z X
, (II-3.6) 
where ( , )jCov x y  denotes the covariance between trend coefficients and phenotypes of the jth 
subpopulation and ( )jVar x  denotes the variance of trend coefficients of the jth subpopulation. 
It is easy to examine that under the null hypothesis, where ( , ) 0jCov y x =  for any j m≤  and 
j Z +∈ , estimator (II-3.6) gives 0
ˆ 0β =  and hence 0 0ˆ( ) 0Eβ β= = , where 0βˆ  is the estimator 
of β  under the null hypothesis. In order to establish a statistical test for βˆ , we now proceed 

















X X X Z
Z X Z Z
 as introduced at formula (I-1.19), where 2σˆ  is the unbiased estimator of 
variance of residual term which can be given following (Searle, 1971) 
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. (II-3.7) 
By noticing that 
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=MM M  and T =M M , formula (II-3.7) can hence be alternatively written as  
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Given the expression of 2σˆ  above, under the null hypothesis, where ( , ) 0jCov x y j= ∀ , the 




































X X X Z Z Z Z X
, (II-3.8) 
where 2
0σˆ  is an unbiased estimator of the residual variance under the null hypothesis. 
 
After deriving βˆ  and 0ˆ( )Var β , we can perform a chi-square test against the null hypothesis 
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with 1 degree of freedom. The normality of βˆ  can be understood through a similar discussion 
given in section II-1.3.1.  
 
Note here, normally, while performing a linear regression with dummy variables, it would be 
recommended to perform a test of whether the coefficients of dummy variables, i.e. λ , are 
significantly different from each other. However, in our situation, under the null hypothesis, 
λ  represent the ratios of case individuals in each subpopulation, and inequalities among case 
ratios can be observed prior to a test, so we may feel comfortable to adopt formula (II-3.5). 
What’s more, as will be shown in the next section II-3.3.2, even when the ratios of case 
individuals in each subpopulation are identical, it is still reasonable to keep the dummy 
variables in order to correct the overestimate of 0





3.3.2 Method II: Non-Central 2χ  Test 
Other than correcting population stratification with dummy variables, i.e. Method I, we can 
treat the influence from population stratification as an impact on the 0β , i.e. the expected 
regression coefficient β  of the SLR under the null hypothesis, which will deviate from 0 due 
to the effect. Our aim in this section is to evaluate and remove such a deviation. At the same 
time, we will discuss how to properly estimate the variance of β  in the presence of 
population stratification. 
 
In order to evaluate the deviation of β  from 0 under the null hypothesis, suppose there are m 
subpopulations with in  individuals each, where in each subpopulation the proportion of case 
individuals are denoted as iθ , and the testing marker allele frequency of each subpopulation is 
denoted by ip . Notice that under the null hypothesis, the case and control samples from the 
same subpopulation should share the same distribution, and if the HWE is assumed we can 
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where 1N ′ , 2N ′  and 3N ′  represent the number of individuals of three genotypes in the 
combined population respectively, and 1k′ , 2k′  and 3k′  represent the corresponding case 




Let the trend set take the form 1 1x = , 2x t=  and 3 0x = , and we may hence calculate the 
variance of ix  under the null hypothesis as: 
2 2
22
1 2 1 2
2 2
1 2 1 2
2
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n n
n N N t N N t
n
′ = −
′ ′ ′ ′+ + 
= −  
 
′ ′ ′ ′+ − +
=
.  
Note that, as it is easy to see that ( )i iE N N ′=  under the null hypothesis and HWE, where iN  
denotes the observed number of individuals with the ith genotypes, we can approximately 
have ( ) ( )Var x Var x′ ≈ . On the other hand, it is clear that ( ) ( )Var y Var y′ =  as ( )Var y  is only 








where ( )Var x′  can be approximately given as above, what matters now is the numerator 
( , )Cov x y′ . As has been proved at section II-3.2.2 that ( , ) ( , )Cov x y Cov x k′ ′= , the covariance 
between x and y under the null hypothesis can be theoretically calculated as 
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(II-3.10) 
where ˆ ip  and ip  denote the estimator and estimate of the testing marker allele frequency of 
samples selected from the ith subpopulation under the null hypothesis, the later of which can 







ijN  denotes the observed number of individuals with 
the jth marker genotype from the ith subpopulation. It is clear that 0β  calculated as equation 
(II-3.10) is not generally equal to 0. 
 
If 0 0β ≠ , we can have 0 0( )j jE y xα β= +  under the null hypothesis, where ( )jE y  denotes the 
expectation of a phenotype with the jth marker genotype, and we may hence claim that 
0 0j jy xα β− −  asymptotically follows a normal distribution with mean 0, where jy  denotes 
the sample mean of phenotypes with the jth marker genotype. From such a result, we can 
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As the first term of the above formula asymptotically follows a normal distribution with mean 
0, we may claim that βˆ  asymptotically follows a normal distribution as well, with mean 0β  


















β β χβ =
−

∼  when the samples size is 
sufficiently large that the central limit theorem could be applied.  
 
With above derivations, our next aim is to properly estimate the variance of βˆ . Actually, such 
a topic has already been considered by Devlin & Roeder in their famous paper ‘Genomic 
Control for Association Studies’ published in 1999, and we will follow a similar procedure to 
their derivation. However, we will also show that Devlin & Roeder’s suggestion to use an 
inflation factor to reduce the false positive rate in the presence of population stratification 
may not be valid becuase such an inflation of variance will only reduce the test statistic of the 
corresponding Chi-square test rather than increase it.  
 
Following Devlin & Roeder’s idea, we adopt Wright’s coefficient of inbreeding F, to 
generally represent any influence that results in the reduction of heterozygotes. Because 
population stratification would decrease the proportion of heterozygotes in the combined 
population, and we can hence consider equations 
21Pr( ) (1 )
N
MM Fp F p
T
= = + − , 
2Pr( ) 2(1 ) (1 )
N
Mm F p p
T
= = − −  
and 
23Pr( ) (1 ) (1 )(1 )
N
mm F p F p
T
= = − + − − . 
Denoting the solutions of F for above equations are 1F , 2F  and 3F , respectively, and by 










 . Note here, such an estimate would also minimize the sum of mean 
square errors for above three equations, i.e. the estimate of linear least squares.  
 
In the following, we will evaluate the influence of F on the variance of βˆ . For convenience, 
only the non-dominance situation will be considered, where equally spaced trend sets are 
implemented. For instance, let G denote the number of allele M for a single individual, we can 
calculate ( ) 2E G p=  and ( ) 2(1 ) (1 )Var G F p p= + − . For reference, we would like to cite the 
Armitage’s trend test here as given at formula (II-1.22)   
[ ]21 2 1 22 2
12
1 2 1 2
(2 ) (2 )
( ) (4 ) (2 )
G df
T T r r R N N





 − + − + 
∼ , 
where ir  and is  represent the sample size of ith genotype in case and control respectively; R 
and S are the sample size of case and control respectively; t is the trend coefficient from trend 
set {1, t, 0}. Recall that a 
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T
−
 = + − +   is the variance of 
K calculated from formula (II-1.22); iG  and jH  denote the number of marker M of the ith 
case individual and the jth control individual respectively. Note here, although such a chi-
square test given by formula (II-1.22) is general non-central as ( ) 0E K ≠  under the null 
hypothesis in the presence of population stratification as indicated by (II-3.10), the derivation 
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In their paper, Devlin & Roeder argued that ( , )i lCov G G , ( , )j lCov H H  and ( , )i jCov G H  
equal 4 (1 )Fp p−  if they are from the same subpopulation. However, recalling that F is 
defined in the combined population, we cannot simply assume F is identical throughout all 
subpopulations. More precisely, under the null hypothesis, where case and control samples of 
any a subpopulation are generated with an identical distribution for marker genotypes, the 
population stratification is the only source of such a generalised F if each subpopulation is 
ideal, e.g. without inbreeding and under HWE, and hence it is not only unnecessary but also a 
mistake to calculate the variance as suggested by Devlin & Roeder. The correct way to 
calculate formula (II-3.11) is to accept ( , )i lCov G G =  
( , ) ( , ) 4 (1 )j l i jCov H H Cov G H Fp p= = −  in the full sample, and hence we can have  
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= − −
. (II-3.12) 
The above variance of K is the proper estimate which counts in the influence of F introduced 
by population stratification. Recall the alternative variance of K, i.e. ( )V K , calculated by 
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Comparing formulae (II-3.12) and (II-3.13), we can notice that the inflation of variance 









 when a default trend set is 
implemented, and hence such an inflation factor will always reduce the test statistic of an 
Armitage’s trend test, which will also be shown in the simulation studies.  
 
By noticing that under the null hypothesis and theoretically 
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where in , iR  and iS  are the full, case and control sample size collected from the ith 
subpopulation, respectively; 
ijN  is the corresponding sample size for the jth marker genotype 
in the ith subpopulation; ip  is the allele frequency of marker M in the ith subpopulation and 































= . Formula 
(II-3.14) is hence the modified Armitage’s trend test for the non-recessive model in the 
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presence of population stratification. However, as above derivations are not always valid for a 








generally valid for any trend set, and hence we can write the general test statistic of our 
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= . Clearly, a sufficient condition for 0η =  is i jθ θ=  or i jp p=  for all 
i j≠ . Thus either different Case-Control ratios or different marker allele frequencies in 
different subpopulations might contribute to spurious associations. However, unlike in a 
population-based sample as introduced at section I-1.2.4, whether causal allele frequencies 
between subpopulations are equal or not is not an essential issue any more. 
 
From our above derivations, the population stratification will have impacts on both the 
numerator and denominator of an Armitage’s trend test, i.e. formula (II-3.15). However, such 
two causes of influence have different impacts on the test statistic. For the numerator, the 
impact is defined by an extra term η , i.e. the deviation of 0β  from 0. Because η  can be either 
positive or negative, the presence of population stratification might result in an increase of 








. Since 0 1λ< < , the presence of population stratification will 
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increase the variance calculated from an original Armitage’s trend test, i.e. formula (II-1.21) 
and (II-1.22), and hence such an effect would only reduce the test statistic rather to increase. 
As the second impact is only related to the difference in marker allele frequencies irrespective 
of the case-control ratio of samples selected from each subpopulation, in order to properly 
correct for such an effect, the dummy variables introduced in Method I should always be kept. 
Also because the second effect has rarely been properly addressed before, we will address its 
influence particularly in the simulations study demonstrated in the next section.  
 
3.3.3 Simulation Study 
In order to evaluate the efficiency of above two methods in adjusting the population 
stratification, we implement simulation studies to investigate their performance under a 
variety of parameter set ups. In the following simulations, we generate 25 Case-Control 
samples, where each of them is formed by a combination of Case-Control samples randomly 
collected from two subpopulations in HWE. These 25 samples can be categorised into five 
populations with 5 each as shown in Table II-10: There is no association between the testing 
marker and the disease in Population I, II and III, i.e. 0D = , but such an association exists in 
Population IV and V, i.e. 0.0003D = ; The marker allele frequencies are identical between 
subpopulations in Population III and V, i.e. 1 2 0.55p p= = , but are different in the other 
populations, where 1 0.60p =  and 2 0.30p =  in Population I, and 1 0.60p =  and 2 0.55p =  in 
Population II and IV. Note here, because the disease causal allele is assumed to be rare, i.e. 
0.001q = , even though the value of D (0.0003) is fairly small in Population IV and V, in 
terms of the adjusted LD (i.e. D′  as introduced at section I-1.2.4), we could realise that 
D=0.0003 is adequate. For example, the corresponding D′  equals 0.4  in Population V, and 
the corresponding D′  equal 0.5 or 0.4 in Population IV depending on 1p  or 2p  respectively. 
For the sake of comparison and consistency, the sample size of control collected from each 
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subpopulation is fixed as 5000, i.e. 10000 in total, and the combined sample size of case from 
both subpopulation is fixed as 6000. However, the sample size of case for each subpopulation 
varies in order to evaluate the performances of different methods under different data 
structures, where the cases collected from each subpopulation are shown in column Case I and 
II. The level of heterogeneity (LoH) is set to 0.95 for Population III and IV, i.e. the putative 
QTL is responsible for 5% case individuals. For convenience, only the co-dominance 
situation is considered, i.e. 0.5f = , and hence the default trend set is implemented as we 
have suggested in the section II-3.2. 
 
To analyse simulated data as introduced at Table II-10, we will implement three methods, i.e. 
Method I as introduced at section II-3.3.1, Method II as introduced at section II-3.3.2 and the 
original Armitage’s trend test with default trend set without any modification as introduced as 
formula (II-1.22). In order to demonstrate the overestimate of ˆ( )Var β  if ignoring the inflation 
factor λ  as indicated in section II-3.3.2, we will list two results for Method II, i.e. one for 2
IIχ  
given as formula (II-3.15) and shown in Column ‘Method II (with λ )’ and the other for 
2
IIλ χ× , i.e. without the correction of variance as shown in Column ‘Method II (without λ ). 
For each Case-Control sample, simulations are replicated for 1000 times, and the mean and 











Table II-10. The Scheme of Simulation. 
Columns Case I and II give the sample size of case in subpopulation I and II; columns p1 and p2 list allele frequencies of testing marker in 
subpopulation I and II; q is the disease causal allele frequency, D is the coefficient of LD between marker alleles and disease causal allele, 
and LoH is the abbreviate for the level of heterogeneity which represents the proportion of case individuals caused by the putative QTL 
associated with the testing marker. 












3000 3000 0.60 0.30 0.001 0.00 / 
2 3500 2500 0.60 0.30 0.001 0.00 / 
3 4000 2000 0.60 0.30 0.001 0.00 / 
4 4500 1500 0.60 0.30 0.001 0.00 / 












3000 3000 0.60 0.55 0.001 0.00 / 
7 3500 2500 0.60 0.55 0.001 0.00 / 
8 4000 2000 0.60 0.55 0.001 0.00 / 
9 4500 1500 0.60 0.55 0.001 0.00 / 













3000 3000 0.55 0.55 0.001 0.00 / 
12 3500 2500 0.55 0.55 0.001 0.00 / 
13 4000 2000 0.55 0.55 0.001 0.00 / 
14 4500 1500 0.55 0.55 0.001 0.00 / 













3000 3000 0.60 0.55 0.001 0.0003 0.95 
17 3500 2500 0.60 0.55 0.001 0.0003 0.95 
18 4000 2000 0.60 0.55 0.001 0.0003 0.95 
19 4500 1500 0.60 0.55 0.001 0.0003 0.95 












3000 3000 0.55 0.55 0.001 0.0003 0.95 
22 3500 2500 0.55 0.55 0.001 0.0003 0.95 
23 4000 2000 0.55 0.55 0.001 0.0003 0.95 
24 4500 1500 0.55 0.55 0.001 0.0003 0.95 










Table II-11. The Results of Simulation. 
Means and variances of test statistics for Non-recessive model from populations given in Table II-10, by comparing Method I, Method II 
(with and without λ) and the non-adjusted Armitage Trend Test.  A random variable with chi-square distribution with degree freedom 1 
should have mean 1.0 and variance 2.0. Results are based on 1000 replicates for each population. 
Sample 
Method I Method II 
(without λ ) 
Original Method II  
(with λ ) 












1.051 2.151 0.876 1.493 0.876 1.493 1.050 2.139 
2 1.000 1.688 0.829 1.162 18.22 59.02 0.994 1.666 
3 1.061 2.353 0.865 1.563 69.30 243.7 1.032 2.204 
4 0.997 2.061 0.787 1.285 157.2 510.1 0.937 1.829 












0.944 1.928 0.940 1.908 0.940 1.908 0.944 1.942 
7 0.939 1.667 0.929 1.630 1.473 3.809 0.934 1.653 
8 1.011 2.077 0.979 1.950 3.179 11.78 0.984 1.980 
9 0.977 1.891 0.914 1.652 5.757 20.55 0.918 1.666 












 0.999 1.833 0.999 1.834 0.999 1.834 1.001 1.847 
12 0.982 1.823 0.975 1.800 0.985 1.833 0.975 1.795 
13 1.083 2.326 1.055 2.205 1.078 2.309 1.055 2.207 
14 0.991 1.919 0.931 1.694 0.985 1.928 0.933 1.718 












 7.903 28.87 7.864 28.58 7.863 28.58 8.010 29.66 
17 8.143 31.18 8.048 30.45 12.56 49.32 8.207 31.85 
18 7.632 28.91 7.391 27.11 17.45 68.13 7.537 28.23 
19 7.674 29.41 7.169 25.66 24.29 97.22 7.314 26.75 












7.641 29.60 7.642 29.61 7.642 29.60 7.745 30.51 
22 7.953 29.62 7.902 29.25 7.995 30.01 8.011 30.09 
23 7.755 29.01 7.551 27.50 7.963 29.37 7.651 28.19 
24 7.186 26.15 6.751 23.08 7.649 28.46 6.854 23.98 
25 6.823 24.38 6.065 19.27 7.622 26.80 6.150 19.86 
Method I: Linear Model with Dummy Variables (Section II-3.3.1) 
Method II: Non-central Chi-square Test (Section II-3.3.2) 




In Population I, we set the difference of allele frequencies between two subpopulations fairly 
large, i.e. 1 2 0.3p p− = , to demonstrate the influence of ignoring λ  as we have thoroughly 
discussed above. For Sample I, where the case control ratios between two sub-samples are 
identical, we have 0η =  and hence Method II (without λ ) is identical to Original as indicated 
by (II-3.15). We may easily notice that both Method II (without λ ) and Original suffer 
significant reduction of test statistics comparing to Method I and Method II (with λ ) (P-value 
= 0.004) as shown in Table II-11. Similar reductions can also be observed for the results of 
Method II (without λ ) in the other samples, although the introduction of η  has effectively 
eliminated the influence from the population stratification for the numerator part. We can 
hence conclude that λ  must be included in Method II to establish a reliable test without loss 
of statistical power. Of course, as we can notice from the results of the Original, the ignorance 
of η  will cause much more serious biases. Even if the allele frequencies are quite similar in 
two subpopulations as shown in Population II, i.e. 1 2 0.05p p− = , a large difference between 
case control ratios, i.e. Sample 8, 9 and 10, may still result in a significant increase of false 
positive rates under the null hypothesis, i.e. the means of test statistics from the Original 
dramatically increase in these samples where no true LD is present. A similar dramatic 
increase of test statistics for Original can also be observed in Population IV, where the 
alternative hypothesis is true, i.e. 0D ≠ . Obviously, in these situations, the implementation of 
a modified Armitage’s trend test is highly recommended, and as we can observe in 
Populations I, II and IV in Table II-11, both Method I and Method II (with) λ  can properly 
adjust the influence from population stratification, although Method I shows a higher 
statistical power if the difference of allele frequencies between sub-samples are large, i.e. 
Sample 18, 19, 20, while Method II is better if otherwise, i.e. Samples 16, 17. Note here, in 
the presence of LD, the effect of population stratification can either increase or decrease a test 





In Population III and V, where subpopulations are identical as 1 2p p= , the combined Case-
Control samples are equivalent to being collected from a single population. In such a 
circumstance, the adjustment for population stratification is not necessary, and both Methods I 
and II may suffer certain bias as unnecessary parameters are implemented. Such a bias can be 
observed from the results for Population V as shown in Table II-11, where we can notice that 
as the difference between Case I and II increase, both Methods I and II will gradually suffer a 
larger loss of statistical power if compared to the Original. Note here, for Samples 21 and 22, 
Method II (with λ ) has shown even higher test statistics than that of the Original, which is 
mainly because the inflation factor λ  will always less than 1 in the presence of LD even if 
there is no population stratification as we will discuss later. We might suspect that the 
increase in test statistic will also increase the rate of false positive. However, as shown in the 
results for Population II, both Methods I and II will not cause any increase of false positive 
rate under the null hypothesis, i.e. 0D = , and we can hence conclude that the increased 
statistical power from Method II (with λ ) is not because of a skewed distribution. Actually, 
such an increase of statistical power can be expected. In the presence of LD, i.e. the 
alternative hypothesis is true, the case individuals contributed from the putative QTL do have 
different allele frequencies in associated markers from the control individuals, and as the a 
difference will surely lead to a reduction of heterozygotes, the generalised F hence exists in 
such a case-control sample. A similar discussion can be conducted between the original 
Armitage’s trend test and the allelic analysis that in the presence of LD, as the combined case 
and control samples will tend to be biased downwards when the population deviates from the 
HWE, we might more likely to have 2
1 3 24N N N>  and hence 
2 2
A Gχ χ>  as indicated by formula 








χ λ= + + < , and hence it can be 
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concluded that 2 2 2
II A Gχ χ χ> >  given 1/ 2t = , i.e. x2 the trend coefficient for heterozygote, if 
the alternative hypothesis is true, i.e. 0D ≠ .  
 
In order to demonstrate both Method I and Method II (with λ ) can properly adjust for the 
population stratification without increase in false positive rate, we draw Q-Q Plots of Method 
I, Method II (with λ ) and Original with their theoretical distribution, i.e. chi-square 
distribution with 1 degree of freedom, for Sample 1 and 11 with 10000 replicates each. The 
Q-Q plots for Sample 1 are illustrated as Figure II-7, where the case-control ratios of sub-
samples are identical but the marker allele frequencies are different between subpopulations. 
We can notice that the Original, shown as Figure II-7 (c), are severely biased downwards 
from its theoretical distribution due to the overestimate of variance, but such an influence 
from the population stratification can be properly adjusted by both Method I, Figure II-7 (a), 
and Method II (with λ ), Figure II-7 (b), where both of which suffer slightly downward bias if 
the test statistics are large, i.e. over 10.0, which implies that both modified methods might 
suffer a certain loss of statistical power if the test statistic is large. As 10.8 is the threshold at 
significance level 0.001 in a single test, such a bias should not be a problem for a single test, 
but if a family-based significance level is applied for multiple tests, e.g. the Bonferroni’s 
correction or FDR, such a bias might result in the loss of statistical power. The Q-Q plots of 
Method I, Method II (with λ ) and Original for Sample 11 are illustrated as Figure II-8 (a), (b) 
and (c), respectively, where the case control ratios of sub-samples are identical and the marker 
allele frequencies are identical in two subpopulations. It is easy to notice that all three 
methods fit the theoretical chi-square distribution with 1 degree of freedom almost perfectly, 
and hence we can implement both Method I and Method II (with λ ) without the risk of 
causing false positive even in the absence of population stratification. From the discussion for 
Figure II-8 and the simulation results of Sample 21 in Table II-11 we can conclude that 
Method II (with λ ) would be the most powerful test among these three if the two sub-
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samples are actually sampled from the same population with equal case control ratios. Such a 
conclusion also implies that by letting 0η = , Method II (with λ ) should have a higher 
statistical power than the Original if both are applied on a case-control sample without 
population stratifications. Unfortunately, as has been indicated in the results of Population IV 
and V in Table II-11, as the difference of case control ratio between sub-samples increases, 
the estimate of η  will tend to over-correct the population stratification and the corresponding 
test statistics of Method II (with λ ) will reduce so fast that it will become less favoured than 
Method I.  
 
 
(a)                                                                           (b) 
 
(c) 









(a)                                                                           (b) 
 
(c) 
Figure II-8. Q-Q Plots of Method I (a), Method II (with λ ) (b) and Original (c) for Sample 11 in Table II-10 with 10000 replicates. 
 
 
In the above results and discussions, we have demonstrated that integrating samples with 
population stratification might cause serious false inferences, which, however, can be 
properly adjusted through both Method I and Method II (with λ ) as introduced in section II-
3.3.1 and II-3.3.2 respectively. We have also demonstrated that the implementation of Method 
I and Method II (with λ ) will not cause any increase of false positive rate, although their 
statistical powers might be reduced if the difference of case control ratios between sub-
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samples is sufficiently large. Of these two, the modified Armitage’s trend test, Method I is 
favoured if the case control ratios are largely different between sub-samples and Method II 
(with λ ) is favoured otherwise. It is also worth noting that by assigning 0η = , Method II 
(with λ ) is more powerful than the original Armitage’s trend test for an ideal population.  
 
3.3.4 Real Data Analysis 
In order to further evaluate both Method I and Method II (with λ ), we re-analyse the Stage I 
data of the Parkinson’s disease from Simon-Sanchez et al. (2009) with both our new methods. 
For Stage I data, there are 4005 individuals collected from the United States and 1686 
individuals from Germany. Of these 5691 individuals, there are 1713 cases and 3978 controls, 
where the sample from the United States consists of 971 cases and 3034 controls and the 
sample from Germany consists of 742 cases and 944 controls. After quality control, 453,585 
SNPs are left to analyse. Although both samples are European Cohort, as we have discussed 
above, this does not guarantee that both samples will have identical allele frequencies at each 
marker locus, and hence either Method I or II should be implemented rather than Original. As 
it is obvious that the case-control ratios are largely different between samples from the United 
States and Germany, i.e. approximately 2:5, we would recommend Method I rather than 
Method II (with λ ) as we have concluded in simulation studies in section II-3.3.3. Note here, 
as Method II (without λ ) will not be included in this section, we will simply use ‘Method II’ 
instead of ‘Method II (with λ )’ for convenience. As usual, the test results from Methods I 
and II are compared with Original, and their corresponding Manhattan plots, of -log(P-value), 
are illustrated in Figure II-9, Figure II-10 and Figure II-11, respectively. We have 
implemented three trend sets with all of three methods, i.e. the default {1, 0.5, 0}, the 
recessive {1, 0.25, 0} and the extremely recessive {1, 0, 0}, but only the results of default and 
the recessive are illustrated in each of below figures as (a) and (b) respectively. Although we 
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illustrate the threshold of 0.05 significant level after Bonferroni’s correction as the blue line in 
each of the figures introduced below, we have also calculated the Q-value for each method 
with a particular trend set, and the significant markers with a Q-value less than 0.05 in 







Figure II-9. The Manhattan plots of –log(P-value) for Method I with the default trend set (a), i.e. {1, 0.5, 0}, and the recessive trend set 



















Figure II-10. The Manhattan plots of –log(P-value) for Method II with the default trend set (a), i.e. {1, 0.5, 0}, and the recessive trend set 















Figure II-11. The Manhattan plots of –log(P-value) for Original, i.e. the non-adjusted Armitage’s trend test, with the default trend set (a), 



















Table II-12. List of Most Significant Markers with Test Score, of –log(P-value) from Method I 
* rs12431733 is very likely to be a false recorded marker since there is no any other marker within the ± 1Mb region with a –lg(P-value) 














rs3857059 4 90.675 SNCA 
9.57 
{1, 0.25, 0} 
0.0000 






rs12431733* 14 54.291 BMP4 
6.93 
{1, 0, 0} 
0.0060 
rs2616510 8 89.018 MMP16 
6.91 
{1, 0, 0} 
0.0065 




{1, 0, 0} 
0.0129 




{1, 0.25, 0} 
0.0166 
rs2708909 7 48.052 SUNC1 
6.04 
{1, 0.25, 0} 
0.0224 
rs6542651 2 3.760 LOC728597 
5.90 
{1, 0.5, 0} 
0.0364 




{1, 0.5, 0} 
0.0364 




{1, 0.5, 0} 
0.0364 
rs10857899 1 112.128 RAP1A 
5.87 
{1, 0.5, 0} 
0.0364 
 
Comparing Figure II-9, Figure II-10 and Figure II-11, we observed that the Manhattan plots 
of Methods I and II are quite similar to each other but they are both different from Original at 
several important marker loci, i.e. rs11591754, rs2616510 and rs199533, which are reported 
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as significant markers in Table II-12. As these differences may be largely due to the 
population stratification, i.e. different allele frequencies in sub-samples, we evaluate the 
difference of allele frequencies between two sub-samples at each significant marker loci with 
a t-test, and the corresponding test results are listed in the column ‘P-value of t-test’ in Table 
II-13. We can notice that the three significant markers rs11591754, rs2616510 and rs199533, 
do have distinguishable allele frequencies in two sub-samples, and their corresponding t-test 
results are highlighted in red as shown in Table II-13. These results hence demonstrate that 
both Methods I and II have properly adjust the population stratification in the combined data. 
In Simon-Sanchez’s paper (2009), rs11591754 and rs2616510 were missed mainly because of 
the ignorance of population stratification introduced by combining samples, and for the same 
reason the test result of rs199533 was over estimated, although the correction for population 
stratification does not affect its significance under the scheme of Q-values. Among these three 
methods, we can see from Table II-13 that Method I generally yields the highest test statistics, 
and also because of the implementation of Method I will not cause any increase of false 
positive as we have proved through comprehensive simulation studies in section II-3.3.3, we 
can conclude that Method I is preferable than Method II for this particular data as we have 
predicted before. In the following discussions, only the test results from Method I will be 
reported unless otherwise specified. 
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Table II-13. Comparison of Three Methods at Significant Loci. 
-log(P-value) of significant markers in three methods with different trend sets are shown in Table II-12. The highest –log(P-value) of significant markers under the specific trend set of each method is highlighted in Green. The 
genetic markers with significant (or almost significant) different allele frequencies in two subpopulations are highlighted in Red for P-value column in order to show the performances of our SA-Methods and Yellow indicates 
non-significant but still possible different marker allele frequencies. 
*      significant at level 0.05 
Marker Name 
Method I Method II Method III P-values of 
t-test {1,0.5,0} {1,0.25,0} {1,0,0} {1,0.5,0} {1,0.25,0} {1,0,0} {1,0.5,0} {1,0.25,0} {1,0,0} 
rs3857059 7.82 9.57 6.36 7.80 9.63 6.56 7.44 9.20 6.30 0.923067 
rs11591754 7.28 7.60 7.53 6.77 6.98 6.88 5.78 6.01 5.95 0.060454 
rs2616510 4.70 6.82 6.91 4.53 6.47 6.45 3.60 5.42 5.79 0.063007 
rs7678831 4.00 6.15 6.68 3.86 5.92 6.42 3.76 5.80 6.35 0.840235 
rs199533 6.00 6.34 6.32 5.61 5.93 5.92 7.30 7.63 7.56 0.014987* 
rs2708909 5.27 6.04 5.79 5.28 5.90 5.54 4.46 5.05 4.80 0.260811 
rs6542651 5.90 5.27 1.31 5.82 5.19 1.27 5.48 4.88 1.21 0.727532 
rs7004938 5.89 4.91 3.77 5.76 5.05 4.05 5.53 4.84 3.88 0.807172 
rs7013027 5.88 5.20 3.88 5.45 4.84 3.63 5.73 5.09 3.81 0.903645 
rs10857899 5.87 5.10 3.98 5.76 4.98 3.88 5.51 4.77 3.71 0.815306 
Method I: Linear Model with Dummy Variables (Section II-3.3.1) 
Method II: Non-central Chi-square Test (Section II-3.3.2) 
Method III: The Original Armitage’s Trend Test (Section II-1.4.3) 
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Other than the comparison between statistical methods, we can also compare the 
performances of different trend sets as introduced in section II-3.2. In Table II-13, the highest 
test statistic among three trend sets in each method is highlighted in Green. From these results, 
we noticed that of the top 6 significant SNPs, the 4 most significant results are detected under 
trend set {1, 0.25, 0} and 2 are detected under trend set {1, 0, 0}, and such a result might 
support the implementation of trend set {1, 0.25, 0}. Although because of sampling errors, a 
marker having its peak value with trend set {1, 0.25, 0} does not guarantee the corresponding 
gene is recessive. However, we are quite convinced to believe that the associated genes with 
rs2616510 and rs7678831 are recessive due to their significant increases of test statistics with 
trend set {1, 0, 0} compared to that with trend set {1, 0.5, 0}. 
 
After discussing the GWAS results statistically, we would like to look at what is behind these 
significant markers. Although some of them have already been repetitiously reported, e.g. 
rs3857059 in gene SNCA and rs199533 in gene MAPT, some of the rest have rarely been 
mentioned before, e.g. rs2616510 for gene MMP16 and rs11591754 for CUL2 or CREM. As 
Parkinson’s disease is the second largest neurodegeneration disease after Alzheimer’s disease, 
its candidate genes are very likely to be involved in the neurodegeneration process, and we 
would like to give a brief review of candidate genes which are functional in such a process as 
following: 
 
1. rs3857059 is located at 90.675Mb on the human Chromosome 4, within the range of the 
candidate gene SNCA, also known as PARK1, which is one of the most widely reported 
genes to be associated with the Parkinson’s disease (Kruger et al., 1999, Farrer et al., 2001, 
Mamah et al., 2005, Maraganore et al., 2005, Mueller et al., 2005, McCulloch et al., 2008, 
Myhre et al., 2008, Sutherland et al., 2009). There are also several other markers in support of 
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this candidate gene, such as rs11931074 (-log(P-value)=9.47), rs2736990 (-log(P-value)=9.18) 
and etc.. 
 
2. rs11591754 is located at 35.219Mb on human Chromosome 10. After correction for 
poulation stratification, both Methods I and II have indicated a strong association between 
disease and this locus. Although rs11591754 itself is not in any known gene region, around its 
locus, there are over 10 supportive markers with –log(P-value) over 5.0 in the surrounding 
0.3Mb, and there are two genes which fall within this region: CUL2 and CREM. Although 
there is no previous report about either of these two genes associated with the Parkinson’s 
disease, some researches have shown that neurodegenerative disease, such as the Parkinson’s 
disease, is related with ubiquitination (Shimura et al., 2000, Kahle and Haass, 2004) and since 
CUL2’s production Cullin has been reported to play a role in ubiquitination (Marin and Ferrus, 
2002), it may be reasonable for us to consider CUL2 as a candidate gene for the Parkinson’s 
disease. Recently, a newly published PCR Array ‘The Human Parkinson's Disease RT² 
Profiler™’ by QIAGEN has included CUL2 as one of its 84 candidate genes 
(http://www.sabiosciences.com/rt_pcr_product/HTML/PAHS-124A.html). On the other hand, 
CREM is intensively reported to be highly involved with neurodegeneration (Mantamadiotis 
et al., 2002, Klejman and Kaczmarek, 2006, Valor et al., 2010), and hence it is also an 
important candidate gene of the Parkinson’s disease. Both these two candidate genes have not 
been reported in Simon-Sanchez’s paper (1999) probably due to the ignorance of population 
stratification. 
 
3. rs2616510 is located at 89.018Mb on human Chromosome 8. As it was only observed as 
significant or close to in trend sets {1, 0.25, 0} and {1, 0, 0}, we could suggest that its 
associated putative gene may be recessive. This marker is 30Kb away from the initial of gene 
MMP16 and with its supportive markers, such as rs278891 (-log(P-value) = 5.30) and 
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rs2664363 (-log(P-value) = 5.12), in the same region. Although lack of report before, recently, 
Edwards et al. (2001) reports a detected association between the MMP16 and the Parkinson’s 
disease from a different data with a P-value at level 510− . Along with Edwards’ reports, 
several papers in Neurology have predicted the relationship between the MMP family and the 
Parkinson’s disease (Lorenzl et al., 2002, Kim et al., 2009), and we might hence be supportive 
in that gene MMP16 plays an important role in the Parkinson’s disease. In Simon-Sanchez, J. 
et. al. (2009), this candidate gene has not been reported due to both the population 
stratification as well as the improper choice of trend set, where only {1, 0.5, 0} were 
implemented. 
 
4. rs7678831 is located at 159.441 on human Chromosome 4, just located in the gene RXFP1/ 
LGR7 according to the UniGene. Although lack of direct evidence, Piccenna, L. et al. (2005) 
pointed out that ‘the strong expression of LGR7 in the claustrum is of interest’, given that the 
claustrum is implicated to be functional in the pathology of neurodegenerative disease, e.g. 
the Alzheimer’s disease and the Parkinson’s disease. 
 
5. rs199533 is located at 44.829Mb on human Chromosome 17, just within the region of the 
gene NSF. Several other supportive markers with –log(P-value) over 5.0 were in the range 
from 43.72Mb to 44.82Mb. The genes CRHR1, IMP5, MAPT, STH, KIAA1267, LRRC37A 
and NSF locate within this region, which have been repeatedly reported in association with 
Parkinson’s disease (Martin et al., 2001, Scott et al., 2001, Zappia et al., 2003, Healy et al., 
2004, Kwok et al., 2004, Skipper et al., 2004, Levecque et al., 2004, Mamah et al., 2005, 
Fidani et al., 2006, Fung et al., 2006, Goris et al., 2007, Vandrovcova et al., 2007, Winkler et 
al., 2007, Zabetian et al., 2007). Although Original has shown a higher test statistic than both 
Methods I and II, it might be explained by the chance that the presence of population 
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stratification increases the testing value instead of decreasing it. Nevertheless, after correction, 
the association between this locus and disease is still significant. 
 
Since no experimental or independent evidence is available to support the relationship 
between other candidate genes detected here and the Parkinson’s disease, no comments on the 
other candidates will be given. 
 
3.3.5 Conclusion 
In section II-3.3, we have introduced two strategies to adjust for population stratification if 
samples are combined from multiple resources. Method I is established by the implementation 
of dummy variables to denote subpopulations in a linear model, and Method II is established 
by correcting the influence from population stratification for both the numerator and 
denominator of formula (II-1.21). We have evaluated the performance of both methods in 
comprehensive simulation studies, and the results indicate that both methods can properly 
adjust for population stratification and will not cause any increase of false positive rate. Our 
simulation studies also show that Method I is preferable if the case-control ratios are largely 
different among sub-samples while Method II is preferable otherwise. An incidental result 
from the simulation studies indicates that in the absence of population stratification, where 
0η = , Method II is more powerful than the original Armitage’s trend test if the HWE in each 
subpopulation holds. We also implemented both Methods I and II into an analysis of the 
Parkinson’s disease data, and several new candidate genes have been revealed by our methods, 
e.g. MMP16, CREM, CUL2, all of which have long been proposed as candidates by neuro-
biologist but are still missing from the detected associations in the current literature of the 
GWAS with the genetic disorder.  
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3.4 Conclusion and Discussion 
In Chapter II-3, we have firstly discussed the optimal trend set for the Armitage’s trend test 
under different penetrance models as well as the presence of genetic heterogeneity. It turns 
out that a dominant QTL, i.e. 1 2 3( 1, 0)f f f= = = , or an additive QTL, i.e. 
1 1 2 3( 1, 0, 0)f f f f= > ≠ = , will result in an almost identical optimal trend set if a putative 
QTL can only explain a small proportion of case individuals, and the corresponding optimal 
trend set can be reasonably represented as {1, 0.5, 0}. For the recessive model, as the optimal 
trend set varies in term of D′ , we hence suggested using both {1, 0.25, 0} and {1, 0, 0} to 
detect recessive QTLs. These results do not favour the suggestion given by Sasieni (1997), 
where he suggested to use trend set {1, 1, 0} for dominant QTLs and {1, 0, 0} for recessive 
ones. However, the results from simulation studies for dominant, additive and recessive QTLs 
do support our suggestion. Secondly, we introduced two strategies to correct for population 
stratification when multiple samples are combined to increase the statistical power in section 
II-3.3. Both simulation studies and real data analyses have shown that both our methods could 
properly remove the influence from population stratification and will not cause any increase 
in false positive rate.  
 
In section II-3.3.2, particularly, we re-analyse the dispersion of the denominator of formula 
(II-1.22), i.e. the Armitage’s trend test with trend set {1, 0.5, 0}. A previous analysis was 
given by Devlin & Roeder (1999), who claimed that in the presence of population 
stratification, the denominator of formula (II-1.22) will tend to underestimate the variance of 
the square root of the corresponding numerator. However, we have shown in both our 
theoretical and simulation analyses that in the presence of population stratification, it is an 

















where 2( )O N  and 2( )E N  are the observed number of heterozygotes and expected number of 
heterozygotes under the HWE. We have also noticed that in both Sasieni (1997) and Devlin & 
Roeder (1999), an example that case and control sample are coincidentally collected from 
distinguishable subpopulations have been mentioned in their discussions. However, such a 
sample is inappropriate because it invalidates the null hypothesis fundamentally as we have 
discussed in section II-2.3 and hence any modifications of statistical models, which are based 
on the null hypothesis, would be meaningless. 
 
We have also re-evaluated the performances of different test statistics when no population 
stratification is present, since the previous discussion given by Sasieni (1997) is inappropriate 
as we have revealed in section II-2.3. We showed that allelic analysis, i.e. formula (II-1.19), 
would have higher statistical power than the Armitage’s trend test with trend set {1, 0.5, 0}, 
i.e. formula (II-1.22), if the alternative hypothesis is true, i.e. 0D ≠ . More importantly, we 
have also shown that if the HWE can be assumed, by assigning 0η =  in the absence of 
population stratification, our Method II with trend set {1, 0.5, 0}, i.e. formula (II-3.14), would 
be the most powerful of the three. Of course, the advantage of Method II over the original 
Armitage’s trend test is generally true irrespective of the trend set implemented as long as the 
HWE can be assumed. However, as we have indicated in section II-3.2.3, if some genotypes 
are missing from the observed data, allelic analysis should be implemented as it is the least 
influenced by a particular missing genotype. 
 
We would also like to note here that as we have not assumed the exact value of vector X in 
Method I, i.e. formula (II-3.9), Method I can also be implemented for allelic analysis by 
denoting ix  equalling 1 or 0. We will not be bothered to show the exact proof here, but such a 
test statistic yields from Method I for the allelic analysis is asymptotically identical to that of 
Mantel-Haenszel test (Zhang and Boos, 1997). 
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In above, we have summarized our methods and results in Chapter II-3, and we have shown 
that the implementation of our contributions, i.e. the optimal choice of trend set and statistical 
methods to correct for population stratification in the Armitage’s trend test, would efficiently 
decrease both false inferences. However, certain improvements are still available. For the 
optimal trend set, especially for the recessive model, our suggestion of using {1, 0.25, 0} and 
{1, 0, 0} is applicable but not an exactly optimal choice as much of other available 
information, e.g. the recombination hotspot, is not included. On the other hand, as we have 
proved that the optimal trend coefficient does not rely on the observed case proportion but 
rather the effective case proportion, i.e. the individuals contributed from the putative QTL 
under question, we may expect a significant increase of statistical power if we can move 
certain case individuals, which are contributing to the genetic heterogeneity, into the control 
sample, and a bootstrap strategy can be implemented to control the false positive rate. For the 
modified Armitage’s trend test, we haven’t considered the situation where each sub-sample 
may have their own sub-structures, which will surely cause structural LD. Such a problem can 
be easily solved in Method I by replacing the dummy variables with the principal component 
vectors (Price et al., 2006), but there might be a problem here to properly estimate the 
influence from a hidden population structure in Method II, especially for the numerator. A 
proper way to include implicit structure information, e.g. the principal component vectors, 
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CHAPTER III  
LIKELIHOOD-BASED METHODS 







CHAPTER III-1  
INFERENCE OF LINKAGE 
DISEQUILIBRIUM IN NON-RANDOM 
SAMPLE 
1.1 Related Publications 
Wang, M., Jia, T., Jiang, N., Wang, L. & Luo, Z. Inferring Linkage Disequilibrium from Non-
random Samples. BMC Genomics. 11, 328(2010) 
 
1.2 Overview 
As has been introduced in section I-1.2.3, linkage disequilibrium (LD) is the core concept in 
association studies and hence it is among the highest demands to properly infer LD coefficient 
between any two genetic loci. For random samples, Hill (1974) proposed a maximum 
likelihood based method to estimate the LD coefficient between two genetic loci given their 
diploid genotypes, which is the main driven idea of establishing the likelihood-based method 
for association studies (Luo and Suhai, 1999, Luo et al., 2000, Luo and Wu, 2001) and 
inferring the haplotypes of genetic markers (Long et al., 1995, Stephens et al., 2001). 
However, such random samples may not be available subject to many practical limitations. 
For example, certain genotypes might be missing due to the highly limited sample size or, 
more commonly, samples are collected by case and control for a certain trait in order to 
improve the statistical power. In such circumstances, simply adopting Hill’s method might 
cause severe bias due to the non-random nature of the samples, and hence a method which 
could properly adjust such non-randomness is required. 
 
 163
In this chapter, a new maximum likelihood based method will be introduced to estimate the 
LD coefficient for non-random samples and its performance will be evaluated through both 
simulation studies and real data analysis.  
 
1.3 Inferring LD in Random Samples (Hill’s Method) 
Before the introduction of our new method, we would like to have a brief review of Hill’s 
method of inferring LD in random samples in order to give a comprehensive background 
image about the inference of LD.  
 
Assume there are two biallelic loci, i.e. the marker locus with alleles M and m and disease 
locus with alleles A and a, with the allele frequencies of M and A denoted as p and q 
respectively. Following the definition of LD in section I-1.2.3 that MAD f p q= − × , where 
MAf  denotes the frequency of haplotype MA and so on, we could calculate the frequencies of 
haplotypes in terms of p, q and D as shown in Table III-1, and the corresponding joint 
distribution of marker and disease genotypes from a random mating population are presented 
in Table III-2.  
 
Table III-1. Frequencies of haplotypes between marker and disease alleles 
p and q denotes the allele frequency of maker allele M and disease allele A respectively 
 M m 
A p q D× +  (1 )p q D− × −  






Table III-2. Joint distribution of marker and disease genotypes in a randomly mated population  
The frequencies of haplotypes are given in Table III-1. 
 MM Mm mm 
AA 
2
MAf  2 MA mAf f  
2
mAf  
Aa 2 MA Maf f  2( )MA ma Ma mAf f f f+  2 mA maf f  
aa 
2





ijg  denote the i-jth row-column entry of Table III-2, e.g. 12 2 MA mAg f f= , and ijN  
denote the corresponding number of observations, we could write the log-likelihood function 
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N N=∑ , the estimator of D could be acquired through 
solving equation:                                                                    
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Instead of directly solving equation (III-1.2), Hill (1974) suggested to calculate the estimator 
of MAf  instead, and then Dˆ  could be given as 
ˆ ˆ ˆ
MAf p q− × . In his paper, Hill proposed an 
iterative process to approach ˆMAf  by updating  
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11 11
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11 11 22 11 11
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f p q f
f X N f p q f N
p f q f
+
  
− − + +  
= + − − +  
− × −    
 (III-1.3) 
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until a preset threshold δ  is reached at the tth iteration, i.e. ( ) ( )111 11ˆ ˆt tf fδ −= − , where ( )ˆ sijf  
denotes the estimator of the haplotype frequency with the ith disease genotype and the jth 
marker genotype in the sth iteration, e.g. 
( ) ( )
11
ˆ ˆs s
MAf f= , and 11 11 21 122X N N N= + + . A suitable 
starting point, as suggested by Hill, could be estimated by replacing 22n  with 
11 22 12 21
ˆ ˆ ˆ ˆ2( )f f f f N+  in formula (III-1.3), i.e. 22n  equals its expectation given 
ˆ
ijf , , 1, 2i j = , 
and we could have 
( )0
11 11 12 21 22
1 1ˆ ˆ ˆ( ) (1 )(1 )
4 2
f X X X X p q
N
= − − + + − − − , 
where 12 13 12 232X N N N= + + , 21 31 21 322X N N N= + +  and 22 33 32 232X N N N= + + . However, 
Weir & Cockerham (1979) later pointed out that the estimator of 11f , i.e. 11fˆ  could be directly 
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where  
3 2b N= , 2 11 12 21 22ˆ ˆ2 (1 2 2 ) 2(2 )b N p q N N N N= − − − + + − , 
1 11 12 21 22
ˆ ˆ ˆ ˆ ˆ ˆ2 (2 )(1 2 2 ) (1 )b Npq N N N p q N p q= − + + − − − − − , 
and 
0 11 12 21
ˆ ˆ(2 )b N N N pq= − + + . 
Nevertheless, as both strategies should give theoretically identical results, in the following 






1.4 A Likelihood-based Method for Inferring LD from 
Selected Samples 
Since Hill’s method introduced above requires the knowledge of population-based joint 
distribution of two loci as given in Table III-2, such a method will almost surely suffer certain 
biases if the information about the population is incomplete. For instance, Weir & Cockerham 
(1979) evaluated Hill’s method in a sample with part of its genotypes being missing, and they 
pointed out that it should not be used to estimate LD from non-random samples. Such a 
conclusion could be understood by realising that if the data are collected to ensure a rare allele, 
i.e. the disease causal allele, to be present in the sample, the distribution of genotypes at the 
disease locus will be significantly distinguishable from its distribution in the population, and 
hence a severe bias of the estimate of LD could be expected. However, although the joint 
distribution of two loci in a population is not available if the data are collected non-randomly, 
e.g. a Case-Control sample, the conditional distribution between these two loci might still be 
available. For instance, the conditional distribution of disease genotypes given marker 
genotypes could be given in Table III-3, where /Q q D p= + , / (1 )R q D p= − −  and ijn  
denotes the number of observations with the ith marker genotype and the jth disease 
genotypes. 
 
Table III-3. Conditional Distribution of Disease Genotypes upon Marker Genotypes 
/Q q D p= +  and /(1 )R q D p= − −  
MM Mm Mm 
AA Aa aa AA Aa aa AA Aa aa 
2Q  2 (1 )Q Q−  2(1 )Q−  QR  2Q R QR+ −  (1 )(1 )Q R− −  2R  2 (1 )R R−  2(1 )R−  
11n  12n  13n  21n  22n  23n  31n  32n  33n  
 
Let 
ijf  denote the expected frequency of the observation ijn , it would be practical to write the 
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l p q D n f
= =
∑∑∼ . (III-1.5) 
The corresponding MLE of D could hence be given through solving equation 
 ( )3 3
1 1












which could then be written into a polynomial equation of D with power 5 as 
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Although no analytical solution of D is available for equation (III-1.7), it could still be solved 
numerically. If there is more than one real root, certain criteria will be applied to distinguish 
the most appropriate estimator from the rest, i.e. D must fall within 
( ) ( )max , (1 )(1 ) ,min (1 ), (1 )pq p q p q q p− − − − − −    and the corresponding LRTs could be 
compared among these candidate MLEs, where the most possible candidate should yield the 
highest test statistic 
2
12[ ( , , ) ( , , 0)] dfl p q D l p q D χ =− = ∼ , 
which asymptotically follows 2χ  distribution with 1 degree of freedom.  
 
Note here, due to the symmetrical relationship between marker and disease loci, solving 
equation (III-1.6) with interchangeable p and q will yield the estimator of D given the 
distribution of marker genotypes conditioned on disease genotypes. It should also be noted 
that if the sample is collected non-randomly, the unbiased estimators of p and q, such as given 
in Hill’s method, are not available from a sample hence collected. In such a circumstance, we 
could either implement biased estimations from the sample or acquire unbiased estimations 
from other sources. Different strategies of dealing with this issue will be evaluated in the next 
section. In the following sections, our newly proposed method will be referred to as Method L 
for convenience and comparison 
 
1.5 Simulation Studies 
In simulation studies, three schemes of sampling are conducted, where samples in Scheme I 
are randomly collected from an ideal Mendelian population; samples in Scheme II are 
randomly collected similarly as Scheme I but with one or several genotypes completely 
missing; samples in Scheme III are collected as the case and control individuals subject to 
genotypes of the disease locus. For convenience, the same notation as in Table III-1 will be 
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adopted in this section, and as a similar simulation procedure was introduced in section II-
3.3.3, we will not be bothered to mention the details of such processes unless necessary.  
 
Table III-4. Summary of Estimates of D for Scheme I. 
All 12 simulations with 200 individuals are randomly sampled from a certain population with marker allele frequency p, disease allele 
frequency q and LD coefficient D. Dmin and Dmax represent the theoretical lower and upper bound of the LD coefficient, and the estimates of 
LD coefficients by Method H and L are represented as ˆ
H
D  and ˆ
L
D . 
Pop. P q (Dmin, Dmax) D 
ˆ . .HD s d±  ˆ . .LD s d±  
1 0.5 0.5 (-0.25, 0.25) 0.20 0.1999±0.0078 0.2004±0.0078 
2 0.5 0.5 (-0.25, 0.25) 0.10 0.1002±0.0145 0.1003±0.0145 
3 0.3 0.3 (-0.09, 0.21) 0.09 0.0898±0.0133 0.0899±0.0125 
4 0.7 0.7 (-0.09, 0.21) 0.09 0.0895±50.0133 0.0896±0.0126 
5 0.3 0.5 (-0.15 0.15) 0.10 0.0997±0.0120 0.0998±0.0111 
6 0.5 0.3 (-0.15, 0.15) 0.10 0.0995±0.0121 0.0993±0.0109 
7 0.5 0.5 (-0.25, 0.25) -0.20 -0.1995±0.0081 -0.1998±0.0081 
8 0.5 0.5 (-0.25, 0.25) -0.10 -0.0996±0.0146 -0.0997±0.0146 
9 0.3 0.3 (-0.09, 0.21) -0.09 -0.0896±0.0074 -0.0899±0.0068 
10 0.7 0.7 (-0.09, 0.21) -0.09 -0.0897±0.0073 -0.0899±0.0065 
11 0.3 0.5 (-0.15 0.15) -0.10 -0.1000±0.0124 -0.1000±0.0117 
12 0.5 0.3 (-0.15, 0.15) -0.10 -0.0995±0.0120 -0.0993±0.0111 
Method H: Hill’s Method (Section III-1.3) 
Method L: Likelihood-based Method (Section III-1.4) 
 
In Scheme I, 12 populations are considered with their parameters p, q and D listed in Table 
III-4. From each population, we simulated a random sample with 200 individuals, and as the 
unbiased estimator of p and q could be directly estimated from the simulation sample, we 
could hence easily compute the MLEs of D from both Hill’s method (Method H) and our 
newly proposed one (Method L). Such a sampling was replicated for 1000 times for each 
population and we summarize the corresponding results, i.e. means and standard deviations of 
Dˆ , in Column ˆ . .HD s d±  for Method H and Column ˆ . .LD s d±  for Method L of Table III-4 
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and henceforward. From these results, we could notice that both methods have shown 
adequate estimates of D, where, however, Method L has slightly smaller standard deviations 
than Method H in several simulations. The results of Scheme I hence show that for random 
samples, Method L is as efficient as Method H, if not better. 
 
In Scheme II, we implemented the first 6 populations as shown in Table III-4 with exactly the 
same sequences to simulate our samples. For each of these 6 populations, individuals were 
generated similar to the random sampling, but excluding certain genotypes, for example, in i= 
0, i = 1, 2, 3 corresponding to MM, Mm or mm and iin = 0, i = 1, 2, 3 corresponding to MMAA, 
MmAa or mmaa as shown in Table II-5. Similar to Scheme I, a sample with 200 individuals 
was generated and we replicated such a sample for 1000 times for each population. The 
corresponding means and standard deviations of Dˆ  of both methods are also presented in 
Table II-5, from which we could notice that, for in i= 0, i = 1, 2, 3, where a marker genotype 
is completely missing from the sample, Method L shows better performance than Method H, 
especially when the heterozygote is missing, i.e. 2n i = 0, where Method H suffers significant 
biases downwards in populations 3, 4 and 5, and for the rest part, where iin = 0, i = 1, 2, 3, i.e. 
a certain joint marker-disease genotype is missing, both methods suffer certain loss of 
accuracy, but Method L still retains better performance in all set up, especially for the cases 
n33 = 0 in population 3 and n11 = 0 in population 4. Such results show that Method L could 
substantially increase the accuracy of estimating the LD coefficient while certain genotypes 
are missing from a sample, e.g. under a strong purifying selection. Note here, both p and q 




Table III-5. Summary of Estimates of D from Scheme II. 
The simulated populations are identical with that of the same series number in Table III-4. For each population, 200 individuals are randomly collected but with certain genotype or genotypes missing and each sample such 
collected is replicated 1000 times.  The estimates of LD coefficients by Method H and L are represented as ˆ
H
D  and ˆ
L
D  repectively. 
Pop. D 
1n i . = 0 2n i . = 0 3n i  = 0 n11 = 0 n22 = 0 n33 = 0 
ˆ . .HD s d±  ˆ . .LD s d±  ˆ . .HD s d±  ˆ . .LD s d±  ˆ . .HD s d±  ˆ . .LD s d±  ˆ . .HD s d±  ˆ . .LD s d±  ˆ . .HD s d±  ˆ . .LD s d±  ˆ . .HD s d±  ˆ . .LD s d±  
1 0.20 0.18±0.01 0.20±0.03 0.20±0.01 0.20±0.01 0.18±0.01 0.20±0.03 0.17±0.01 0.18±0.04 0.17±0.01 0.17±0.01 0.17±0.01 0.18±0.04 
2 0.10 0.09±0.02 0.10±0.02 0.10±0.01 0.10±0.01 0.09±0.02 0.10±0.02 0.05±0.02 0.06±0.02 0.07±0.01 0.07±0.01 0.05±0.02 0.06±0.02 
3 0.09 0.08±0.01 0.09±0.02 0.06±0.01 0.10±0.04 0.10±0.02 0.09±0.01 0.07±0.01 0.08±0.01 0.04±0.01 0.09±0.06 0.00±0.02 0.04±0.01 
4 0.09 0.10±0.02 0.09±0.01 0.06±0.01 0.09±0.01 0.08±0.01 0.09±0.01 0.00±0.02 0.04±0.02 0.04±0.01 0.06±0.01 0.07±0.01 0.08±0.01 
5 0.10 0.08±0.01 0.10±0.01 0.06±0.01 0.10±0.01 0.12±0.01 0.10±0.01 0.07±0.01 0.08±0.01 0.07±0.01 0.08±0.01 0.05±0.02 0.06±0.02 
6 0.10 0.09±0.01 0.10±0.01 0.10±0.01 0.10±0.01 0.09±0.01 0.10±0.01 0.07±0.01 0.08±0.01 0.07±0.01 0.08±0.01 0.05±0.02 0.06±0.02 
Method H: Hill’s Method (Section III-1.3) 




In Scheme III, samples were generated as in Case-Control studies. To mimic the reality, the 
disease allele A is assumed with a low frequency, i.e. less than 0.1, and the dominance model 
was adopted such that an individual with either AA or Aa was identified as a case and the 
other individuals, i.e. with genotype aa, are grouped as controls. For each simulated sample, 
100 cases and 100 controls were collected, which yields a total of 200 individuals constantly.  
Clearly, the distribution of disease genotypes in such a Case-Control sample should severely 
deviate from the HWE, and as has been mentioned in the previous section III-1.4, such a non-
randomness would hinder our attempt to find unbiased estimators of p and q. To tackle such 
an obstacle, in Scheme III, p is directly estimated from the control individuals, which is 
reasonable if q is small as indicated in section II-3.2.3, and q will be acquired from two 
sources: Firstly, the real value of q will be implemented, which is available if extra resources 
are available, e.g. results from previous epidemiological studies; Secondly, the q could still be 
estimated from the observations directly. However, due to the severe deviation from HWE of 
such a Case-Control sample, the estimate of q hence calculated would be expected to cause 
considerable loss of accuracy in estimating LD coefficient for both methods. 
 
The corresponding parameters and results of Scheme III are all listed in Table III-6, where the 
mean and standard deviation of samples simulated from each population are calculated based 
on 1000 replicates. From Table III-6, we may notice that, even when the real value of q is 
adopted, the implementation of Method H results in severely biased estimates of D, which, as 
shown for ˆHD , will always exceed the theoretical boundaries, but Method L yields almost 
perfect estimates. If q is directly estimated from the observations, i.e. the Case-Control sample 
are treated as a random sample, both methods suffer severe loss of accuracy in estimating D 
as shown in Table III-6. Nevertheless, the estimate from ˆ LD  still deviates much less from its 
actual value than that from ˆHD  and hence Method L is still favoured in such a circumstance. 
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Note here, the reason why Method H would yield even worse estimates of D in the use of real 
q than the use of its biased estimate can be explained by the fact that the estimates of 






Table III-6. Summary of Estimates of D from Scheme III. 
Parameters are the same in Table III-4 and Table III-5. 
p q (Dmin, Dmax) D 
q was from population survey q was from sample estimation 
ˆ . .HD s d±  ˆ . .LD s d±  ˆ . .HD s d±  ˆ . .LD s d±  
0.6 0.005 (-0.003,0.002) -0.002 -0.011±0.149 -0.002±0.000 -0.113±0.015 -0.071±0.011 
0.5 0.01 (-0.005,0.005) 0.004 0.280±0.011 0.004±0.001 0.108±0.013 0.080±0.013 
0.5 0.02 (-0.010, 0.010) 0.008 0.273±0.010 0.008±0.001 0.110±0.014 0.081±0.013 
0.3 0.03 (-0.009, 0.021) 0.010 0.191±0.026 0.011±0.002 0.104±0.019 0.057±0.018 
0.7 0.04 (-0.028, 0.012) 0.010 0.309±0.016 0.011±0.002 0.071±0.012 0.061±0.017 
0.3 0.05 (-0.015, 0.035) 0.020 0.192±0.044 0.021±0.004 0.122±0.017 0.066±0.017 
0.5 0.10 (-0.050, 0.050) 0.040 0.227±0.008 0.045±0.006 0.124±0.014 0.088±0.012 
DH for Method H: Hill’s Method (Section III-1.3) 







1.6 Real Data Analysis 
1.6.1 β-Thalassemia Dataset 
 
Β-Thalassemia is an autosomal recessive blood disorder induced by mutations in the β-globin 
(HBB) gene (OMIM 141900) on the human chromosome 11, and is among the most common 
inherited hemoglobinopathies in the world. This disorder has been reported to affect 3% to 
10% population of certain tropical and subtropical areas such as South China (Weatherall and 
Clegg, 2001, Xu et al., 2004, Zhang et al., 2008). In East and Southeast Asia, the most 
common type of β-Thalassemia, β
CD41/42
-Thalassemia, is caused by a frame shift mutation in 
codons 41 and 42, a 4-bp deletion (-CTTT), of the human β-globin gene, of which the 
frequency could reach 3% in South China (Zhang et al., 2008).  
 
In Zhang et al. (2008), 16 cases with β
CD41/42
-Thalassemia and 24 controls were collected 
from China, where only the heterozygotes at the deletion locus were present due to the highly 
limited sampling size. From their study, 50 bi-allelic markers were located after sequencing 
the neighbouring area (~20kb) around the deletion locus, all of which were genotyped in all 
40 individuals. Since such a dataset is collected highly non-randomly from the population, i.e. 
not only the data is collected as Case-Control scheme, but also the homozygote deletion is 
completely missing at the disease locus, it would be a perfect example for us to evaluate the 
capability of different methods in estimating LD coefficients from non-random samples.  
 
1.6.2 Comparison of Three Methods 
As the 50 markers are of high density in a 20kb chromosome region, it would be practical to 
infer the haplotypes of each individual with the software PHASE 2.1.1 (Stephens et al., 2001), 
and we may hence directly calculate the LD coefficients with the frequencies of haplotypes. 
Along with the results acquired through predicting haplotypes by making use of PHASE 2.1.1, 
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both Methods H and L are also implemented to estimate the LD coefficient between the 
disease locus and each of 50 marker loci. By implementing the population frequency of the 
deletion allele as 3% as introduced in section III-1.6.2, the estimates of LD coefficients 
between the disease locus, located at 0 on x axis, and each marker locus are illustrated in 
Figure III-1 (a), where the theoretical upper and lower bounds for LD coefficients for any 
pairs of the disease and marker loci are also presented as the dashed lines. We may easily 
distinguish the newly proposed method, Method L, from the other two in Figure III-1 (a), 
especially for those markers closely linked to the disease locus, of which the estimates of LD 
coefficients from Method H and PHASE severely violate the theoretical upper and lower 
bounds. Figure III-1 (b) illustrates the corresponding LOD scores of Dˆ  calculated from three 
methods on base of likelihood function (III-1.5), and we could notice that as Method L will 
always yield the highest LOD score values , it is hence preferred to the other two. Clearly, the 
newly proposed method is sufficiently robust that the LD coefficients could be properly 








Figure III-1. Distribution of linkage disequilibrium between each of polymorphic sites and the β-thalassemia causing mutation in a 
20.693 kb region surrounding the human β -globin gene. (a) Estimates of the coefficients of LD from three different methods. The dot lines 
represent the lowest and highest theoretical bounds of the disequilibrium parameter.  (b) The LOD score values calculated for the LD 










1.7 Conclusion and Discussion 
We have demonstrated that a severely biased estimate of LD coefficient could arise if 
methods designed for random samples, e.g. Hill’s method (Hill, 1974), are implemented for a 
non-random sample. As shown in our simulation studies, such a biased estimate could be 
either positive or negative and even exceed the theoretical boundaries, which hence suggests 
the non-randomness might cause both false positive and negative in the estimate of LD 
coefficients. To tackle such a bias introduced by the non-randomness, we proposed a 
likelihood model based on the conditional distribution between the marker and disease loci, 
instead of the joint distribution of loci used in the traditional method (Hill, 1974, Weir and 
Cockerham, 1979). Through our comprehensive simulation studies, we have shown that our 
method could not only properly estimate LD coefficients in random samples as the traditional 
method, i.e. Hill’s (1974), being capable of (Table III-4), but also provide significant 
improvement of estimation accuracy if the data is artificially collected and thus non-random 
(Table III-5, Table III-6). However, as we have shown in Table III-6, the performance of the 
newly proposed method relies on the proper estimates of allele frequencies for both marker 
and disease locus, which are not always available from non-randomly collected data. For 
instance, in a Case-Control sample, we could estimate marker allele frequency directly from 
the control sample, which could be used as a reasonable approximate for the population 
parameter, especially if the disease causal allele frequency is reasonably small, although an 
appropriate estimate for disease allele frequency is usually not available in such a 
circumstance. However, instead of directly computing the estimates of allele frequencies from 
the collected sample, we might acquire information from other sources, e.g. previous 
epidemiological analyses. For instance, we estimated the LD coefficients between any pairs of 
marker-disease loci from the β-Thalassemia data with the disease allele frequency acquired 
from a published report (Zhang et al., 2008), and our newly proposed method has shown an 
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overall out-performance over the other two, i.e. Hill’s method and the calculation of LD 
coefficient based on the haplotype estimated from PHASE which was implemented in Zhang 
et al. (2008).  
 
Of course, a direct estimate of LD coefficient between marker and putative disease loci is 
only available if the disease is a Mendelian trait or has a major effective gene (Cardon and 
Palmer, 2003, Yu and Buckler, 2006). For instance, in our study, we have assumed that 
genotypes at both marker and disease loci are observable, which is true for a Mendelian trait, 
but not so assured in the case of a quantitative trait. However, as has been revealed by several 
previous studies (Luo, 1998, Luo et al., 2000, Luo and Wu, 2001), it is possible to further 
integrate our newly proposed method and the quantitative genetic models as introduced in 
section II-1.2 to estimate the LD coefficient between a marker and a quantitative trait showing 
either continuous or dichotomous phenotype in non-random samples. Following such an idea, 
a likelihood-based method of inferring LD between marker and putative disease loci in a 
Case-Control sample will be introduced in Chapter III-2. 
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CHAPTER III-2  
A LIKELIHOOD-BASED METHOD FOR 
ASSOCIATION STUDY IN CASE 
CONTROL SAMPLES FROM 
MULTIPLE COHORTS 
2.1 Related Publication 
This paper has been written up and is under submission. As a senior author, I have contributed 
substantially to the establishment of both the likelihood-based method and the modified allelic 
analysis, as well as their simulation studies. I have acquired the permission of all other authors 
to cite this paper (with some necessary rearrangement) as part of my thesis. 
 
2.2 Overview 
Although it has long been pointed out that the use of non-randomly collected samples might 
result in the spurious linkage disequilibrium between un-associated genetic loci, i.e. in linkage 
equilibrium (Avery and Hill, 1979), such an effect has not been paid a lot attention to until 
recently we investigated the use of non-randomly collected samples in estimating LD 
coefficients. We observed that such an estimate from a method established for random 
samples will be severely biased and the corresponding statistical power for testing for 
significance of LD coefficient may be substantially reduced (Wang et al., 2010). In practice, 
as in many association studies, sampling schemes are subject to various types of selection, a 
sample hence collected is no longer a random presentation of the corresponding population. A 
typical example of such non-random samples is the Case-Control sample as used in many 
association studies in human populations, in which frequencies of some disease genotypes are 
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artificially inflated in comparison to the population frequencies to ensure sufficient 
representation of the genotypes involving a rare disease allele.  
 
In Chapter III-1, we have introduced a likelihood-based method to properly infer LD 
coefficients between marker and disease loci with known genotypes using non-random 
samples, and such a method has been comprehensively evaluated through both simulation 
studies and real data analyses to show its overall out-performance over the existing methods, 
e.g. Hill’s method (Hill, 1974). By combining the idea of estimating LD coefficients in non-
random samples with the genetic models as introduced in section II-1.2. In this chapter, we 
will propose a new likelihood-based method for association studies in Case-Control samples. 
Besides, as such a method could allow the population structure information to be included, for 
the sake of comparison, an adjusted allelic analysis will also be introduced. We will hence 
evaluate the newly proposed method (Method I) by comparing it to both adjusted allelic 
analysis (Method II) and the Armitage’s trend test (Method III) in our simulation studies. 
Finally, we will implement all three methods to model and analyse the Parkinson’s disease 
data, which has already been introduced and analysed in Chapter II-3.  
 
2.3 Notations and Models 
Consider a case-control sample of size n is collected from a random mating population with 
regard to a disease causal allele A and the wild type a. By denoting the marker alleles as M 
and m, we may write the conditional distributions between marker genotypes and disease 
genotypes as shown in Table III-7 (a) and (b), where p and q are the frequencies of allele M 
and A respectively, and D is the coefficient of LD. Clearly, in Table III-7 (a) and (b), 
Pr( | )ijg M j G i= = =  and Pr( | )ijh G i M j= = = , where M and G represent the 
corresponding marker and disease genotypes. By assuming that, in the presence of disease 
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genotypes, the marker genotypes cannot provide any further information, we could hence 
calculate that   
 
Pr( , , )
Pr( | , )
Pr( , )
Pr( | ) Pr( , )
                                      
Pr( | ) Pr( )
                                      Pr( | ) ij
M i G j Case
M i G j Case
G j Case
Case G j G j M i
Case G j G j











where Pr( | )Case G j=  is the probability of an individual with the jth disease genotype being 
observed with disease exposure, which is normally denoted as the penetrance coefficient fj. 
Formula (III-2.1) shows a conditional distribution of marker genotypes on disease genotypes 
should be identical in a case sample and in the corresponding randomly collected sample. As 
a similar result for a control sample could be easily acquired following the same procedure, 
we may hence work out the probability distributions of marker genotypes conditioned on 
disease genotypes in both case and control samples as presented in Table III-7 (c). 
 
Similarly to function (III-1.5), it would be straightforward to write the conditional likelihood 









∏∏∏∼ , (III-2.2) 
 
where tijk denotes the number of individuals with the ith disease genotype and the jth marker 
genotype from the kth sample (k = 1 denotes case and k = 2 denotes control). However, as the 
exact values of tijk in function (III-2.2) are not observable, estimates are hence required. 
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Table III-7. Conditional Distribution between Marker and QTL Genotypes.  
(a) Conditional distribution of maker genotypes over disease genotypes; (b) Conditional distribution of disease genotypes over marker 
genotypes; (c) Conditional distribution of QTL genotypes over marker genotypes given trait statuses. 
AA Aa aa 
MM Mm mm MM Mm mm MM Mm mm 
11g  12g  13g  21g  22g  23g  31g  32g  33g  
2Q  2 (1 )Q Q−  2(1 )Q−  QR  2Q R QR+ −  (1 )(1 )Q R− −  2R  2 (1 )R R−  
2(1 )R−  
where /Q p D q= +  and /(1 )R p D q= − −  
(a) 
 
MM Mm mm 
AA Aa aa AA Aa aa AA Aa aa 
11h  21h  31h  12h  22h  32h  13h  23h  33h  
2Q  2 (1 )Q Q−  2(1 )Q−  QR  2Q R QR+ −  (1 )(1 )Q R− −  2R  2 (1 )R R−  
2(1 )R−  
where /Q q D p= +  and /(1 )R q D p= − −  
(b) 
 
 Cases Controls 
MM Mm mm MM Mm mm 
AA 
11g  12g  13g  11g  12g  13g  
Aa 
21g  22g  23g  21g  22g  23g  
aa 
31g  32g  33g  31g  32g  33g  
# observed 
11n  12n  13n  21n  22n  23n  
(c) 
 
As nki is the observed number of individuals with the ith marker genotype and the kth case-
control status, tijk could hence be directly estimated if both Pr( | , )G i M j Case= =  and 
Pr( | , )G i M j Control= =  is known. By noticing 
Pr( , | )
Pr( | )





f h Case G i M j
f h Case M j



























∑ ,                                
we may have 
2 1k k
ijk kj ij ijt n w v
− −
= . The logarithm of likelihood function (III-2.2) could hence be 
rewritten as 
 ( ) ( ) ( )3 31 2 3 1 2
1 1
, , | , , , log
j ij j ij ij
j i
l p q D N f f f n w n v g
= =
  +   
∑ ∑∼ . (III-2.3) 
 
 
With a known p, which could be estimated from the control individuals as shown in Chapter 
III-1, the remaining two parameters, i.e. q and D, could be estimated through equating the first 
partial derivatives of function (III-2.3) to zero, which lead to two normal equations: 
 
6 5 4 3 2




5 4 3 2
5 4 3 2 1 0 0b D b D b D b D b D b+ + + + + = . (III-2.5) 
 
The coefficients of above two equations could be calculated as 
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(6 10 12 20 ) (5 10 10 20 ) (4 10 8 20 )
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b p q pq x p q pq x p q pq x
p q pq x p q pq x p q pq x
p q pq x p q pq x p q pq x
= − − + + − − + + − − +
+ − − + + − − + + − − +




4b n=  
where 
1 2+ij j ij j ijx n w n v= . 
 
Although function (III-2.3) is not derived through an ECM procedure, from section II-1.3.3, 
an ECM process could be considered as an iterative process for solving equations (III-2.4) and 





ijw  and 
t










 by solving equations (III-2.4) and (III-2.5) one after the other. 
 
Iteratively updating both the E and CM steps until the increase of likelihood at the t-th 





have converged to their MLEs.  
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Clearly, there are no analytical solutions for both equations (III-2.4) and (III-2.5). However, 
they could still be solved numerically. It is also possible that multiple roots may be acquired 
while solving equations (III-2.4) and (III-2.5), and those fall into the theoretical boundary, i.e. 
0 1q< <  
and  
{ } { }, (1 )(1 ) (1 ), (1 )max pq p q D min p q p q− − − − ≤ ≤ − − , 
with the highest likelihood will be selected as the MLEs. 
 
The statistical test against the null hypothesis D = 0 could be established through the LRT as 
( ) ( )1 2 3 1 2 3ˆˆ ˆ ˆ ˆ2 , , 0 | , , , , , | , , ,LR l p q D N f f f l p q D N f f f = − = −  . 
It should be noted here that as the likelihood function (III-2.3) under the null hypothesis could 
be expressed as 
( ) 2 211 21 12 221 2 3 13 23( )log[ ( ) log[2 (1 )] ( )log, , 0 | , , , ] [(1 ) ]l p q D N n n p n n p p n n pf f f + + + − + + −= ∼ , 
which is free from both parameters q and D, we could hence claim 2LR χ∼  with 2 degrees of 
freedom as discussed in sections I-1.4.2 and II-1.3.3. Note here, if the case and control data 
are collected independently from multiple cohorts, say number equals k, one could calculate 
LR for each cohort, and the sum of all LR should follow 2χ  with 2k degrees of freedom. 
 
Clearly, the likelihood-based method proposed above retains the flexibility of adopting any a 
penetrance model, e.g. the co-dominance model, as the penetrance coefficients are explicitly 
modelled as fj. Such a flexibility is important as shown in Chapter II-3 that the penetrance 
coefficients are hard to be explicitly modelled in the existing methods, e.g. the Armitage’s 
trend test and hence approximation has to be made, where, on the contrary, the new method 
could have any penetrance models fitted in easily.   
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2.4 Allelic Analysis for Multiple Cohorts 
The relationship between the allelic analysis and the Armitage’s trend test has been discussed 
in section II-2.3 and II-3.3.3, where we have argued that the allelic analysis loses the 
information about both penetrance models but may have a higher statistical power if the 
alternative hypothesis, i.e. the testing marker locus does associate with the phenotype, is true 
under the co-dominance situation, where the HWE is also assumed. However, as the general 
validity of allelic analysis is out of question as discussed in section II-2.3, and also due to the 
simpler form of allelic analysis when compared with the Armitage’s trend test, it would be 
easier for us to manipulate the structure of allelic analysis to deal with the population 
stratification in this section. 
 
Before initiating the main derivations, an important result will be given here at the very 
beginning. Recall that Pr( | , ) Pr( | , ) Pr( | )MM AA D MM AA C MM AA= =  as given at formula 
(III-2.1), we may notice  
2 2
2
Pr( | , ) Pr( | ) / Pr( | )
                          Pr ( | ) / Pr ( | )
                          Pr ( | , )
MM AA D MMAA D AA D






by assuming random union of gametes, and similarly 2Pr( | , ) Pr ( | , )MM AA C M A C=  and 
2Pr( | ) Pr ( | )MM AA M A= . Clearly, the above indicates that 
Pr( | , ) Pr( | , ) Pr( | )M A D M A C M A= = . 
 
The idea of allelic analysis is to test the difference between the marker allele frequencies in 
case and control samples as indicated by formula (II-1.20). In the absence of population 
stratification, we could calculate theoretically  
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( )
Pr( | ) Pr( | ) Pr( | )
                Pr( | ) Pr( | ) Pr( | ) Pr( | )
                Pr( | ) Pr( | ) Pr( | ) Pr( | )
M D MA D Ma D
M A A D M a a D


















= − +  from the definition of D, where pθ  denotes 
the frequency of allele θ  and θ  equals one of A, a, M, m, we may calculate the difference 
between Pr( | )M D  and Pr( | )M C  as  
 ( )Pr( | ) Pr( | ) Pr( | ) Pr( | )
A a
D
M D M C A D A C
p p
− = − , (III-2.6) 
 
and the statistical test for the difference between marker allele frequencies in case and control 
samples is hence proportional to that between disease allele frequencies in case and control 




. Clearly, under the null hypothesis where D = 0, formula (III-2.6) 
yields Pr( | ) Pr( | )M D M C= . 
 
However, such a result does not hold in the presence of population stratifications. Let’s 
consider a Case-Control sample collected from k subpopulations, each of which with 
frequency ( )i
Mp  of marker allele M, where i = 1, 2, …, k. By letting ri and si denote the 
proportion of case and control samples collected from ith subpopulation in the whole case and 
control samples respectively, we may calculate  
 
( ) ( )
| | | |
1 1
( ) ( ) ( )
| |
1
                 ( ) ( )
k k
i i




i i M i A D i AC i i A
i A a
p p r p s p
D



















Cpθ  represent the frequency of allele θ  for the ith subpopulation in case and 
control samples respectively. It is clear that under the null hypothesis, i.e. 0
i








M D M C i i M
i
p p r s p
=
− = −∑ . An obviously sufficient condition to equate formula (III-
2.7) to 0 under the null hypothesis is either ( ) ( ) ,i jM Mp p i j= ∀  or i ir s i= ∀ , as already suggested 
in section II-3.3.2 in the modified Armitage’s trend test. We may hence expect a severe bias 
introduced by population stratification if none of such two conditions are satisfied. Given so, 
in the presence of population stratification, the numerator of allelic analysis has to be 





M i i M
i
p r s p
=




  denotes 
| |
ˆ ˆ
M D M Cp p− , i.e. the observed difference between marker 
allele frequencies in case and control, and ( )ˆ i
Mp  is calculated from each subpopulation with 
0
i
D = . 
 
On the other hand, as has been mentioned in Chapter II-3, the denominator of formula (II-1.20) 
will tend to overestimate the variance of ˆ
M
p  in the presence of population stratification. A 
corrected estimate could be calculated as 
 
( ) ( )
| |
1 1
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| |
1 1
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ˆ ˆ( ) ( )
ˆ ˆ ˆ ˆ(1 ) (1 )
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i ii i i
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M M
i i i i
Var p Var r p s p
r Var p s Var p



























( ) ( ) ( )
| |
i i i
M D M C Mp p p= =  under the null hypothesis; it  and iT  represent the sizes of the case 
and whole samples collected the ith subpopulation respectively. It could be noticed that, if 
( ) ( ) ,i jM Mp p i j= ∀ , i.e. in the absence of population stratification, formula (III-2.8) will be 
reduced to  
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which is identical to the denominator of formula (II-1.20), and we may hence conclude that 
formula (III-2.8) is appropriate even if there is no real difference at the testing marker locus 
among those subpopulations. 
 
With formulae (III-2.7) and (III-2.8), we may hence establish the allelic analysis in the 
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1
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which follows 2χ  distribution with 1 degree of freedom. 
 
2.5 Simulation Study 
To investigate statistical properties and limitations of the method developed in the present 
study, two sampling schemes will be conducted to collect case and control individuals from 
computer simulated random mating populations. Sampling Scheme A collects cases and 
controls from a single population, and Scheme B samples cases and controls from two 
genetically divergent populations with regard to a tested marker and a putative disease locus. 
The simulated populations are characterized by population genetic parameters p, q and D 
(allele frequencies at a genetic marker locus and a disease trait locus, and the coefficient of 
linkage disequilibrium between the former two loci) and quantitative genetic parameters f1, f2 
and f3 (i.e. the penetrance coefficients for genotypes at the disease locus). In the present 




 are fixed as {1, 0.5, 0}, representing a co-
dominance model of disease allele. For any given set of the simulation parameters, genotype 
data are generated for case and control samples using the modified programme as described in 
Chapter II-3. For each simulation, three statistical methods are implemented, i.e. the present 
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likelihood-based method (Method 1), the modified allelic analysis (Method 2) and the original 
Armitage’s trend test with the default trend set (Method 3).  
 
Table III-8 presents the parameters defining 10 simulated random mating populations as well 
as means and standard deviations of estimates of the model parameters from 1,000 repeated 
samples of 200 cases and 200 controls. Note that only Method 1 and 3 are implemented here, 
which is simply because Method 2 and 3 are approximately identical if no subpopulation is 
present. When the testing marker locus and disease locus are in linkage equilibrium, i.e. D = 0 
in simulated populations 1-3, the marker genotype will provide no information about the 
unobservable genotype at the disease locus and thus no estimate of disease allele frequency q 
is attempted under such a circumstance. Means of the test statistics in these populations 
approximately equal to 2.0 or 1.0 for Method 1 or 3 respectively, corresponding to the means 
of the chi-square variable with 2 or 1 degree of freedom as expected in section I-1.4 and III-
2.3. Above results demonstrate the adequacy of proposed distribution of the test statistics 
constructed in these methods under the null hypothesis and, in turn, the appropriate control of 
the type I error of the statistical tests. While the linkage disequilibrium is actually present 
(populations 4-10), Method 1 estimates the modelling parameters, q and D, adequately, 
providing a consistently higher statistical power (ρ) to test for significance of the association 









Table III-8. Results for Simulation under Scheme A with Simulation Parameters. 
Population genetic parameters for 10 simulated populations and statistical inference of model parameters from 200 cases and 200 controls 
repeatedly sampled from the simulation populations.  p and q are allelic frequencies at the marker and disease loci, D is the coefficient of 
linkage disequilibrium (LD) between the two loci. Means and standard deviations (s.d.) of the model parameters, q and D, and χ2 test statistic 
were calculated from 1000 repeated samples. ρ (%) is the proportion in 1000 repeats in which the association test surpassed the Bonferroni 
threshold of P-value at 5 × 10-5. 
Pop. p q D 
Method 1 Method 3 
ˆ . .q s d±  ˆ . .D s d±  
2
[2] . .s dχ ±  ρ (%) 2[1] . .s dχ ±  ρ (%) 
1 0.5 0.5 0 - 0.001±0.012 2.0±2.7 0 0.9±1.3 0 
2 0.3 0.7 0 - 0.002±0.011 2.0±2.7 0 1.0±1.3 0 
3 0.7 0.3 0 - 0.001±0.011 2.2±2.7 0 1.0±1.3 0 
4 0.5 0.5 0.15 0.50±0.05 0.148±0.015 184.4±42.8 100 73.3±14.0 100 
5 0.5 0.5 0.10 0.50±0.09 0.097±0.018 73.9±26.5 99.7 33.3±10.6 96.6 
6 0.5 0.5 0.05 0.50±0.20 0.043±0.020 18.1±12.0 36.8 8.8±5.6 10.8 
7 0.3 0.7 0.07 0.72±0.12 0.064±0.026 68.4±25.4 99.6 29.6±10.2 91.5 
8 0.3 0.7 0.05 0.70±0.15 0.047±0.023 33.2±17.6 77.3 15.1±7.5 38.2 
9 0.7 0.3 -0.07 0.28±0.14 -0.062±0.028 54.8±23.4 96.8 26.3±9.6 85.2 
10 0.7 0.3 -0.05 0.31±0.20 -0.042±0.024 27.8±15.6 66.1 13.7±6.9 31.0 
Method 1: Likelihood-based Method (Section III-2.3) 
Method 3: The Original Armitage’s Trend Test (Section II-1.4.3) 
 
On the other hand, all three methods are implemented for simulations under Scheme B to 
explore the influence of multiple subpopulations, or cohorts, on their performance. Table III-9 
illustrates 14 sets of simulation parameters, which define the genetic structures of two random 
mating populations and the corresponding empirical powers of these three methods. There are 
implemented to perform the association tests with case-control samples from these 
populations separately and jointly, where, in the admixed samples, 57% cases and 76% 
controls are collected from population 1 and the rest are collected from population 2. The 
table shows that while LD is null in both of the populations (Pop. 1-6), all three methods share 
a low probability of claiming false positive inference using case-control samples from these 
populations separately. The false positive rate remains at the same lower level for Methods 1 
and 2 but is increased remarkably for the Armitage’s trend test, or Method 3, when the cases 
and controls are contributed by the two populations. Moreover, the increase in the false 
positive rate for Method 3 is in proportion to the difference in marker allele frequencies 
between the two contributing populations. The larger the difference is, the higher the false 
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positive rate would be, reflecting the fact that the test statistic of this method is proportionate 
to the size of difference between the allele frequencies. When the LD does truly exist in either 
or both simulated populations (Pop. 7-14), Method 1 is able to detect it with remarkably 
higher statistical power than the other two methods. In particular, when the LD has an 
opposite sign in the two contributing populations (Pop. 14-15), i.e. the scenario where the 
disease causing gene is in association with different marker alleles in different populations, 
the highest detecting power is observed for Method 1 no matter whether the case and control 
samples are collected from the contributing populations separately or as an admixture of the 
populations. In contrast, both Method 2 and 3 fail to detect the LD under this circumstance. 
These findings strongly support the improved statistical efficiency of the likelihood-based 




Table III-9. Results for Simulations under Scheme B with Simulation Parameters. 
Population genetic parameters defining two genetically divergent populations, i.e. columns 2-7, and empirical statistical powers of Methods 1-3 (M 1-3) for detecting 
significance of linkage disequilibrium between a polymorphic marker and a putative disease locus, i.e. columns 8-16. The empirical power was calculated from 1,000 
repeated samples of 1,000 cases and 1,000 controls as the proportion of the test statistic surpassing the Bonferroni threshold 5 × 10-5. The admixed samples were made 
up of 57% cases and 76% controls from Population 1 and the rest from Population 2.  
Pop. (1)p  (1)q  (1)D  
(2)p  (2)q  (2)D  
Population 1 Population 2 Admixed Samples 
M 1  M 2 M 3 M 1  M 2 M 3 M 1  M 2 M 3 
1 0.40 0.10 0.00 0.70 0.10 0.00 0.1 0.0 0.0 1.6 0.0 0.0 1.2 0.0 25.3 
2 0.45 0.10 0.00 0.70 0.10 0.00 0.0 0.0 0.0 1.0 0.0 0.0 0.6 0.0 12.6 
3 0.50 0.10 0.00 0.70 0.10 0.00 0.3 0.0 0.0 1.4 0.0 0.0 1.2 0.0 3.7 
4 0.55 0.10 0.00 0.70 0.10 0.00 0.2 0.0 0.0 2.1 0.0 0.0 1.1 0.0 0.9 
5 0.60 0.10 0.00 0.70 0.10 0.00 0.0 0.0 0.0 1.1 0.0 0.0 1.0 0.0 0.3 
6 0.65 0.10 0.00 0.70 0.10 0.00 0.1 0.1 0.1 0.9 0.0 0.0 0.5 0.0 0.0 
7 0.40 0.10 0.00 0.50 0.10 0.02 0.1 0.0 0.0 94.3 44.8 45.6 91.1 2.9 50.8 
8 0.45 0.10 0.00 0.50 0.10 0.02 0.0 0.0 0.0 93.4 45.7 47.2 90.8 1.4 28.4 
9 0.40 0.10 0.02 0.50 0.10 0.00 99.5 93.9 94.7 1.1 0.0 0.0 99.4 70.1 90.0 
10 0.45 0.10 0.02 0.50 0.10 0.00 99.7 95.4 95.5 1.1 0.0 0.0 99.3 69.3 77.4 
11 0.40 0.10 0.02 0.50 0.10 0.02 99.6 95.0 95.1 93.2 43.7 45.7 100.0 99.7 100.0 
12 0.45 0.10 0.02 0.50 0.10 0.02 99.6 95.2 95.6 93.1 47.5 49.0 100.0 99.7 100.0 
13 0.40 0.10 0.02 0.50 0.10 -0.02 99.4 95.1 95.3 92.2 45.6 47.0 100.0 4.2 6.1 
14 0.45 0.10 0.02 0.50 0.10 -0.02 99.1 93.9 94.0 94.2 45.8 47.8 100.0 3.0 1.4 
Method 1: Likelihood-based Method (Section III-2.3) 
Method 2: Adjusted Allelic Analysis (Section III-2.4) 






2.6 Real Data Analysis 
All three methods are implemented to re-analyse the Parkinson’s disease (PD) dataset which 
was recently published by Simon-Sanchez et al.
 
 (Simon-Sanchez et al., 2009). The study 
carried out a genome-wide screening for subtle genetic variants predisposing susceptibility to 
the Parkinson’s diseases through a two-stage case-control design. In stage I, 4,005 individuals 
from the United States and 1,686 individuals recruited from the Germany were genotyped at 
463,185 quality checked SNPs by using the Infinium BeadChips. Of the 5,691 objects, 1,713 
were PD cases and remaining 3,978 controls. Because the estimate of allele frequency from a 
small sample may vary greatly, those markers, at which there were less than five individuals 
for any genotype, were hence excluded from further analysis. After this quality control, a total 
of 447,270 SNPs were used in the present study. In the stage II which was designed as a 
confirmation stage, 3,392, 3,223 and 1,319 individuals were recruited from three different 
cohorts: the United States, Germany and UK respectively. They, of which 3,341 were cases, 
were all genotyped at the 345 SNPs which showed significant associations in analysis with 
stage I dataset. After applying the same quality check on the stage II data, two SNPs were 
excluded in the present study. The genetic association with each of the SNP markers was 
evaluated by the original Armitage’s trend test (Method 3 here) and the genome-wide 
significance level was determined by the Bonferroni correction for the probability of an 
overall type I error at 5%.  
 
Figure III-2 (a)-(c) illustrate the distributions of the logarithmic significance levels (log-P) of 
genetic association tests across the 23 human chromosomes using the three sets of case and 
control SNP data from the stage I, stage II and the combination of stage I and II, respectively. 
In analysis of each of three datasets, all three methods are implemented. It could be seen from 
the analysis of stage I data (Figure III-2 (a)) that 44 SNPs, which are distributed in 25 
chromosomal regions with a size of less than 1 Mb (Table III-10), are detected by Method 1 
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developed in this chapter (black labels) to be significantly associated with the disease 
phenotype. Methods 2 and 3 are able to detect only two (4q21 and 17q21) of the 25 regions at 
the same Bonferroni threshold (P ≤ 1.1×10
-7
). In order to explore the genetic dependences 
among the 44 significant SNPs, the coefficients of LD between any pair of the SNPs are 
calculated through the approach that was introduced in Chapter III-1 for the Case-Control 
samples. The disequilibrium structure illustrated at the bottom of Figure III-2 (a) shows that 
the significant SNPs are not associated with each other across the different regions, which 
hence excludes the concern that the detected SNP- disease associations might be due to the 
random association in genotypic distribution among the SNPs between these regions. In 
particular, Method 1 uniquely detects three candidate SNPs on chromosome region 8p22 (the 
most significant P = 9.9×10
-10
, rs2736050) which are only 1.2 Mb apart from a previously 
reported PD susceptible gene FGF20 that was reported to be associated with Parkinson's 
disease synergistically with SNCA (Mizuta et al., 2008). To assess the variation of the 
predicted genetic associations, the bootstrap sampling with replacement is performed for the 
stage I dataset, where the empirical posterior probability is calculated at each of the 44 
significant SNPs from 1,000 bootstrap samples. Table III-10 summarizes the significance 
level (P value) and the bootstrap posterior probability (BPP) calculated from the three 
methods and shows that Method 1 confers a powerful test for the genetic association than the 
other two methods. The BPP values predicted for analysis with Method 1 are consistently 
higher, suggesting the method is more robust to the variation caused by sampling than the 







Figure III-2. Genome-wide association results from (a) stage I, (b) stage II and (c) two-stage combined case and control samples. The analysis with each of the three datasets was done using Method 1 (black circles), 2 (red 
circles) and 3 (blue circles) accordingly. The red and black horizontal dashed lines indicate the Bonferroni significance threshold of P value equal to 1.1×10-7 and 1.5×10-4 respectively. The triangle at the bottom of (a) is the 
estimated linkage disequilibrium structure for the 44 most significant SNPs listed in Table 1. The diamonds and squares in (a) illustrate the SNPs at which the bootstrap posterior probability for genetic association are either > 
80% or within 60~80%. 
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Table III-10. Significant Markers Detected by Method 1 from Stage I Data. 
Significance and Bootstrap posterior probabilities (BPP) for the 44 SNPs exceeding the Bonferroni genome-wide significance threshold 
(1.1×10-7) detected by Method 1 (M 1) from stage I dataset. Shadowed are the regions at which the genetic association was tested by 
Method 2 (M2) and Method 3 (M 3) at the same significance level.  
Locus SNP name Dist(kb)
*
 
P value BPP (%) 
















 57 25 27 
2p23.3 rs7564397 - 9.7×10
-8
 0.013 0.033 55 0 0 




 0.001 57 1 3 






 59 4 3 






 53 9 10 
4p15.2 rs6820719 - 1.6×10
-9
 0.23 0.30 74 0 0 
rs7676830 23 8.6×10
-10
 0.12 0.15 77 0 0 
rs12649499 11 4.8×10
-10
 0.20 0.26 77 0 0 



























 88 71 67 
6q27 rs2072638 - 1.1×10
-11
 0.014 0.012 86 0 0 






 62 21 14 
7q21 rs3779331 - 6.6×10
-8
 0.028 0.01 56 0 0 






 56 13 10 






 56 23 29 
rs4875773 63 1.6×10
-8
 0.02 0.044 63 0 0 





























 60 20 22 




















 53 21 21 






 54 29 13 


































 52 16 16 






 37 19 13 
11p15.2 rs11605276 - 3.4×10
-11
 0.079 0.19 86 0 0 
rs10500796 45 1.9×10
-8
 0.18 0.30 61 0 0 
11q13 rs1726764 - 6.6×10
-8
 0.088 0.20 53 0 0 






 68 6 12 






 56 15 38 













 60 24 55 













 56 18 18 
20p12.1 rs6041636 - 9.9×10
-9
 0.16 0.24 66 0 0 
21q22.3 rs2070535 - 5.0×10
-8
 0.060 0.096 54 0 0 
*Distance (kb) from previous significant SNP in the same chromosome region.  
Method 1: Likelihood-based Method (Section III-2.3) 
Method 2: Adjusted Allelic Analysis (Section III-2.4) 
Method 3: The Original Armitage’s Trend Test (Section II-1.4.3) 
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It is worth stressing that the 345 SNPs for the confirmation study (stage II dataset) are 
selected only from the previous analysis using Method 3 (Simon-Sanchez et al., 2009). The 
dataset contains only twenty seven of the significant forty four SNPs declaimed by Method 1 
in the stage I data analysis. In addition, the SNPs within 4q21 and 17q21 are repeatedly 
detected in significant association by all the three methods in the stage II dataset, the other six 
SNPs are detected by Method 1 to be in significant association with the disease trait at the 
Bonferroni genome-wide threshold (1.5×10
-4
) (Figure III-2 (b)). In particular, a new 
significant SNP, rs11564162, is detected within chromosome 12q12, (P = 2.2×10
-5
), which is 
only 176 Kb from the PD candidate gene PARK8 (Khan, N.L. et al. 2005). Neither Method 2 
nor 3 could detect the significance of the SNP marker rs11564162. A full list of significant 
SNPs detected by the three methods in stage II dataset analysis were shown in Table III-12.  
 
When the two datasets (stage I and stage II) are combined, ninety SNPs were detected 
significant at the Bonferroni threshold (1.5×10
-4
) by Method 1, including all the twenty nine 
significant SNPs detected by the same method in stage II analysis and eight significant SNPs 
detected by the same method in stage I data analysis (Figure III-2 (c) and Table III-13. The 
SNP marking the PD candidate gene, PARK8, detected in stage II dataset analysis, is also 
repeated in analysis with the combined dataset. As expected, the associated SNPs are detected 














Table III-11. P-values of Known Candidate Genes from Three Methods. 
The most significant SNP within ±2.5 Mb chromosome regions surrounding each of 25 Parkinson’ disease (PD) candidate genes. In parentheses 
is the physical distance (Mb) of the SNP to the corresponding PD candidate gene. P values are calculated from analysis of stage I dataset with 
Method 1 (square) and 2 (up triangle) and 3 (down triangle), and presented in the color bar depicting varying levels of significance probability. 
Note some data points are overlapped. nFD refers as to estimate of the number of false discoveries for a given P value. 
 
Method I: Likelihood-based Method (Section III-2.3) 
Method II: Adjusted Allelic Analysis (Section III-2.4) 
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5p15.2 rs26286 14219402 1.7×10
-5
 0.025 0.044 
7p21.3 rs2681051 11615690 1.5×10
-5
 0.60 0.31 
11q12-q13.1 rs1005511 57123232 6.8×10
-7
 0.14 0.25 
12q12 rs11564162 38729159 2.2×10
-5
 0.019 0.095 
14q22.2 rs2878172 54443420 1.3×10
-7
 0.06 0.12 






















































































































21q22.3 rs681210 43603771 1.1×10
-5
 0.60 0.43 
Method 1: Likelihood-based Method (Section III-2.3) 
Method 2: Adjusted Allelic Analysis (Section III-2.4) 
Method 3: The Original Armitage’s Trend Test (Section II-1.4.3) 
 
There have been a total of twenty five candidate genes discovered so far to predispose the 
Parkinson disease (the OMIM database with entry 168600). Listed in Table III-13 are the 
most significant SNP within a 2.5 Mb chromosome region surrounding each of the 25 
Parkinson’ disease (PD) candidate genes and the estimate of the number of false discoveries 
evaluated at the probability at which the SNP was claimed significant (Storey and Tibshirani, 
2003). It can be seen that all the three methods detected the SNP, rs2736990, within the PD 
candidate gene SNCA on human chromosome 4q21 and, the SNP, rs199533, only 0.72Mb 
distant from the PD candidate gene MAPT on chromosome 17q21 with negligible risk of false 
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positive. In addition, Method 1 discovered additional two SNPs which were only 1.18 Mb and 
0.18 Mb distant to the PD candidates, FGF20 and PARK8 respectively without invoking the 
risk of false positive. This positive proof analysis again supports the improved efficiency of 
the newly developed method for genetic association study. 
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Method I: Likelihood-based Method (Section III-2.3) 
Method II: Adjusted Allelic Analysis (Section III-2.4) 
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Method III: The Original Armitage’s Trend Test (Section II-1.4.3) 
 
2.7 Conclusion and Discussion 
In summary, we have shown that the existing widely used strategy in the current literature of 
genome-wide genetic association studies with a case-control setting is highly vulnerable to 
sampling schemes and genetic structure embedded in the samples. These can result in severe 
loss of statistical power or false positive inference of association. We have developed a novel 
method that is robust to these influential factors and confers a more powerful test. Although 
the method is developed for complex quantitative traits with discrete phenotype, it will not 
involve major technical problems to extend the ideas and principles behind the newly 
developed method to cope with continuous phenotype. 
 
The robustness and improved statistical power of the newly developed method have been 
demonstrated through re-analysing the large SNP genotype dataset of the Parkinson’s disease, 
of which cases and controls were collected from multiple geographical cohorts (Simon-
Sanchez et al., 2009), as well as through intensive simulation studies. The method is built 
upon the population genetic model of linkage disequilibrium between any tested polymorphic 
genetic marker and a putative QTL. The simulation study indicates that the key model 
parameters of q, allele frequency of a disease locus, of which genotypes are not observable, 
and D, the coefficient of linkage disequilibrium, can be estimated adequately under quite 
different settings. As the accurate estimate of the LD coefficient is crucial for the reliability of 
any LD analysis including LD-based mapping of complex genetic disease traits (Hill and 
Weir, 1994), this may explain the outperformance of the parametric approach over the 
existing non-parametric rival, i.e. the allelic analysis and the Armitage’s trend test. 
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The new method is built on a model-based likelihood framework. This confers several 
primary and practically useful statistical properties over the existing non-parametric 
approaches. Firstly, it is feasible to be adopted to incorporate different fixed or random effects 
in the model. For example, onset of many common diseases is sex, age, diet or life habit 
dependent. Incorporation of these as fixed effects into the model shall improve the statistical 
efficiency of genetic association analysis. Secondly, the approach enables data from different 
sources to be combined, as demonstrated in the case and control data analysis of the 
Parkinson’s disease. This provides flexibility for performing association studies using 
common control datasets. Thirdly, the parameter estimates from the method make it feasible 
to evaluate statistical and genetic properties of detected associations.  
 
However, besides all the advantages above, the background gene effect or genetic 
heterogeneity has not been implemented into the likelihood model, which will introduce 
certain degrees of bias as has been demonstrated in Chapter II-3. As our newly proposed 
method shows dominant performance over the existing ones, if the effect from genetic 
heterogeneity could be properly introduced into a likelihood-based method, we may expect a 
further increase of statistical power. On the other hand, the population stratification has 
already assumed to be known in our new method, which might not always be true in practice. 
In fact, we have been actively exploring appropriate statistical strategies that tackle this issue 




CHAPTER III-3  
A COMPOSITE LIKELIHOOD-BASED 
MODEL FOR ASSOCIATION-BASED 
MAPPING OF QUANTITATIVE TRAIT 
LOCI 
3.1 Overview 
Interval mapping was initially introduced by Lander & Botstein (1989) for linkage analysis so 
that people could screen for QTLs on the whole genome continuously instead of discretely at 
each of marker locus through the use of two flanking markers, out of which no further 
information of inferring LD within the interval could be acquired. Such a method, as well as 
its successors (Zeng, 1993, Zeng, 1994), are based on linkage analysis and hence are highly 
limited in their mapping resolution and applicable to only certain type of data as discussed in 
section I-1.2. In association studies, Terwilliger (1995) and Devlin et al. (1996) introduced 
their composite likelihood-based methods of inferring QTL within marker intervals using data 
collected from natural populations. However, both of these methods are restricted to binary 
data. In this chapter, we will introduce a composite likelihood-based method for mapping loci 
affecting a quantitative trait with continuous phenotypic distributions using a population 
genetics model. A series of simulations are conducted to demonstrate the reliability of our 
newly proposed method.  
 
3.2 Notations and Models 
Recall formula (I-1.2) as introduced in section I-1.2.3 that 
 0(1 )
T
TD r D= − , (III-3.1) 
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where r is the recombination fraction between the testing marker locus and a putative QTL; T 
is the number of generations from the introduction of the mutant allele at the QTL, i.e. the 
recombination generation; DT and D0 denotes the LD coefficients at generation T and 0 
respectively. Following the same notation in Table I-1, at generation 0, the LD coefficient 
should theoretically reach its maximum or minimum and hence one may write  
 0 min( , )D p q p q= − × , (III-3.2) 
 
where p, q denote the allele frequency of marker allele M and QTL allele A respectively. 
Without loss of generality, we have assumed alleles M and A to be positively associated in 
formula (III-3.2), and we will also keep this assumption in the following discussion for 
convenience.  
 
From formulae (III-3.1) and (III-3.2), DT is now a function of allele frequencies p and q 
instead of an independent parameter, and hence if both p and q could be properly estimated, 
the LD coefficient between a testing marker locus and a putative QTL could be directly 
calculated with known r and T. For instance, we might assume a putative QTL located at any 
a locus in the genome without restricting on a particular marker locus, and by estimating the 
most possible allele frequency at the putative QTL, we might directly calculate the LD 
coefficient between the putative QTL and its surrounding marker loci. With a LD coefficient 
hence estimated, we may expect a significant increase in mapping resolutions. However, as 
the validation of such an estimate of LD coefficient relies on known values of r and T, we 
thus need to acquire the information of both those parameters prior to the establishment of our 
new approaches. 
 
Since the development of genetic technologies (Kong et al., 2002, Frazer et al., 2007, 
Altshuler et al., 2010), either physical or genetic mapping positions of a particular marker is 
available nowadays. Since the genetic distance between any two marker loci may be properly 
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defined as the recombination fraction between them, the genetic mapping could directly 
provide the information of r. Alternatively, if only physical mapping data are available, we 
may transfer the physical mapping to genetic mapping through an appropriate mapping 
function, e.g. 20.5(1 )dr e−= −  proposed by Haldane (1919), where r and d are the genetic and 
physical distances between two genetic loci respectively. With above discussions, if the 
genetic distance between any a pair of genetic markers is either known or could be estimated, 
the genetic distances between a putative QTL, within the marker interval, and both the 
flanking markers are hence known. On the other hand, the recombination generation, i.e. T, 
could be either known, e.g. in a well established experimental population, or directly 
estimated from samples collected from a random mating population. For instance, if a sample 
is randomly collected from an ideal population, we may apply Hill’s method (Hill, 1974) as 
introduced in section III-1.3 to estimate the LD coefficient between any a pair of marker loci. 
In case non-randomness is present, our newly proposed method as introduced in section III-
1.4 could be implemented to correct the bias introduced by the non-randomness of samples. 
As D0 could be directly calculated from formula (III-3.2), with the estimate of D, we could 
compute the corresponding recombination generation as ( )0log log / log(1 )T D D r= − − , 
where r is assumed to be known as we have discussed above. Practically, we would prefer to 
use the average T throughout the whole genome instead of an estimate between a particular 
marker pair. Such a consideration is quite reasonable if we are not dealing with a newly 
introduced mutation. From above discussions, as the information of r and T could either be 
directly acquired or estimated from highly accessible resources, we could hence establish a 
likelihood function between a putative quantitative QTL and a marker locus in a randomly 
collected sample as following. 
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Consider a randomly collected sample with quantitative phenotypes 
ijy  of the jth individual 







=∑ , where in  denotes the number 
of individuals with the ith marker genotype. Assuming the normality of phenotypes that 
( , )ij ky N vµ∼  conditioned on the kth QTL genotype, we could hence write the probability of 
a single individual with phenotype 
ijy  and the kth QTL genotype. 
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[ ( ) / 2 ]1
















k a dµ µ − −= + − + , with k = 1, 2, 3, denotes the genotypic value of the kth 
QTL genotype as shown in Table II-1; G  represents the QTL genotype and 
( , , , , , , , )p q a d r Tµ νΩ =  represent the set of all modelling parameters.  
 
As from function (II-1.10), by assuming the independence among individuals, we could write 
the complete likelihood function of the observations as 
3
1 1




L y M y M i
= =
Ω = = Ω∏∏ , 
where M denotes the marker genotype. Following the ECM scheme of a randomly collected 
sample as introduced in section II-1.3.3, we could write the expectation log-likelihood 




( | , ) log Pr( | , )
in
s s s s
c ijk ik ij
i j k
l y M h y G kω
= = =
 Ω = = Ω ∑∑∑ , (III-3.4) 
 
where Pr( , | )s sikh M i G k= = = Ω  is the joint distribution of marker-QTL genotypes at sth 
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By noticing that p could be directly estimated as 
1 2
( / 2) /n n n+ , and the estimates of r and T 
are also available as introduced above, we could hence establish the ECM algorithm of 
function (III-3.4) as:  
 
E-step: Calculate the posterior probability of one individual having the thk QTL genotype 
given the ith marker genotype and its phenotype 
ijy  at the sth iteration, says 
s
ijkω . If the values 
of parameters at the sth iteration are denoted as ( , , , , , , , )s s s s s sp q a d r Tµ νΩ = , the posterior 
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ijkω  calculated from an E-step, the updated estimate of 
1sq +  could be achieved 















  ∂∂ Ω   
= × = ∂ ∂  
∑∑∑ , (III-3.6) 
 
which is equivalent to a three degree polynomial equation  
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( )0 11 12 21 22 31 322 (1 ) (2 2 2 )a p p rt rt ω ω ω ω ω ω= − − + + + + + +      , 




ω ω=∑ . Because the highest degree of formula (III-3.7) is 3, it 
could hence be analytically solved. Note here, as equation (III-3.7) is derived under the 
assumption that q p≤ , i.e. equation (III-3.2) takes the form 0 (1 )D q p= − , in each iteration 
roots acquired through solving equation (III-3.7) have to fall within the range [0, p]. If none of 
the roots could meet such a requirement, we simply carried on the iterative process by letting 
1sq p+ = . 
 
The updated estimates of the remaining parameters, i.e. ,  ,  a dµ  and ν , keep similar forms as 
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Repeating these E and CM steps iteratively until a given convergence criterion is satisfied, the 
converged values of these parameters are hence their MLEs according to the theory of ECM 
algorithm (Meng and Rubin, 1993).  
 
Note here, if the assumption q p≤  is not true, we may expect that when the convergent 
criterion is satisfied, the MLE of q would be equal to the estimate of p given the restriction we 
have set in the E-steps, and hence such an MLE is in-conclusive. However, in the case where 
positively associated marker allele M and QTL allele A have the relationship in their 
frequency as ( ) ( )f A f M> , there must be coincidentally ( ) ( )f a f m<  with alleles a and m 
positively associated, where a and m are the complementary alleles of A and M at their loci 
respectively, and hence if the MLE of q equals the estimates of p, we could simply adopt 
1p p′ = −  to repeat the ECM algorithm to avoid the problem. 
 
The corresponding LRT for the null hypothesis D = 0 could hence be given as  
2
0
ˆ ˆ2[ ( | , ) ( | , )]DLR l y M l y M χ== Ω − Ω ∼  
with 1 degree of freedom. 
 
Above, we have established the likelihood function between a putative QTL and a testing 
marker locus based on the known genetic distance between them as well as the known 
recombination generation. A more comprehensive idea would be the establishment of a 
likelihood function which could integrate the information of all genetic markers surrounding 
the putative QTL. For example, we may seek to model the joint probability of phenotypes 
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with both flanking markers, i.e. 1 2( , , | )f M Y M Ω , where M1 and M2 denote the two flanking 
markers of a putative QTL respectively. However, as the directly modelling of such a joint 
probability is hard to implement, we may turn to alternative strategies, e.g. the composite 
likelihood, which could provide efficient combination of information from multiple marker 
loci together to infer the most possible location of a putative QTL. From Devlin et al. (1996), 
it is possible to use a composite likelihood model instead of a complete likelihood model. 
Suppose there are two observations, says 1y  and 2y , the complete likelihood function should 
be 1 2 1 2( | , ) ( , | )L y y f y yΩ = Ω , the logarithm form of which could be written into 
1 2 2 1 1( | , ) log ( | , ) log ( | )l y y f y y f yΩ = Ω + Ω . Alternatively, we could choose to follow either 
of two different ‘natural choices’ of composite likelihood models instead of the complete one 
that 
1 2 1 2( | , ) log ( | ) log ( | )l y y f y f y′ Ω = Ω + Ω   
or  
1 2 1 2, 2 1,( | , ) log ( | ) log ( | )l y y f y y f y y′ Ω = Ω + Ω . 
The choice may be mainly based on the convenience of computing (Devlin et al., 1996). In 
our situation, where the putative QTL falls within the interval of two flanking markers, i.e. M1 
and M2, we may write the composite log-likelihood function as 
1 2 1 2( | , , ) ( | , ) ( | , )l y M M l y M l y M′ Ω = Ω + Ω , 
and the corresponding composite LRT could be given as 
  
1 2 1 2 1 21 2
1 2
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M Q M Q
LR l l l l
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( | , )M Ql l y M= Ω  and etc.. Note here, if a putative QTL is assumed to be located at 
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Unfortunately, due to the dependence between marker loci M1 and M2, both composite LRTs 
presented above, i.e. 
1 2M QM
LR  and 
1 2mM QM M
LR , do not follow the exact 2χ  distribution with 2 
degrees of freedom, as they were supposed to be only if M1 and M2 are independent, and 
hence alternative evaluations have to be adopted to determine the significant thresholds 
(Devlin et al., 1996). However, in the presence of a true QTL, a locally highest LR statistic 
does provide an estimate of QTL location, and as our main interest would be the accuracy of 
our presented method to infer the location of a QTL within the marker interval, only the locus 
with the highest LR statistic will be mentioned but the distribution of test statistic will not be 
focused in this context. 
 
 
3.3 Simulation Studies 
3.3.1 Simulation Models 
In this simulation study, we will mimic a species with a single pair of chromosomes, and then 
a finite population of such a species under certain generations of randomly mating will be 
simulated to evaluate our newly presented method. For simplicity, we will assume all genetic 
loci, i.e. both marker and QTL, to be bi-allelic with initial allele frequencies 0.5 at generation 
0 and the genetic distances between any two adjacent marker loci are identical. Each 
individual in such a population is assumed to have the same chance to give its offspring but 
cross-generation mating is prohibited.  
 
To generate such a population as described above, we start from an initial population, i.e. 
generation 0, with size n, and then a pool of gametes are simulated in the presence of 
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recombination events to randomly generate the zygotes for the next generation with the same 
population size n. Such a process is repeated until the population at generation T has been 
generated. Then, parameters of the phenotypic effects, i.e. population mean µ , additive effect 
a, dominant effect d, phenotype variance v, are implemented to simulate a value of phenotype 
for each individual as the observations based on a normal distribution as introduced at 
function (III-3.3). Throughout simulated schemes, µ is equal to 10.0, a is equal to 0.63, d is 
equal to 0.0 and v is 1.0, which indicates that the co-dominance model is adopted and the 
genotypic variance can explain 20% of the phenotypic variance. Irrespective of the various 
genetic distances between pairs of adjacent markers in different simulation schemes, there are 
always 41 markers equally spaced on the testing chromosome, and the true QTL is located 
between the 28th and 29th markers, except for the linked QTLs analyses, where the QTLs will 
be specified otherwise. Simulations for each set of parameters are replicated 100 times, and 
the test results of each replicate as well as the value of parameters used for the simulations are 
summarized in Table III-14 to Table III-19. 
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Table III-14. Comparison of Simulation Results with Real and Estimated T. 
Fixed means during the process of estimating parameters, the recombination generation T is not from estimation but considered as known, and it was kept constant for each of 100 replicates. Simulation 
parameters are summarized in columns ‘Simulation Model’ and ‘Simulation Parameters’ and the means and standard deviations of the corresponding estimates are summarized in column ‘Means of 
Estimates’. If the estimated QTL location for each replicate is within 0.10 Mpd to its true location, i.e. listed in column QTL of ‘Simulation Model’, it will be claimed as ‘accurate’, and the overall 
percentages of claimed ‘accurate’ throughout 100 replicates are listed in column ‘Percentage of Accuracy’. The mean of estimated T for each population is listed in column ‘Average T’.   
Simulation Model Simulation Parameters 
Means of Estimates 
(with Standard Deviations) 
Percentage of 
Accuracy 
(Biased less or 





M) T QTL  U A d v QTL U A D v  
1 300 5 35 28.40 10.000  0.630  0.000  1.000  28.42  9.976  0.295  0.002  0.957  71% 35 
           (0.19)  (0.063)  (0.046)  (0.058)  (0.039)     
                    
2 300 5 35 28.40 10.000  0.630  0.000  1.000  28.39  9.972  0.295  0.001  0.949  73%  35(fixed) 
           (0.19)  (0.070)  (0.049)  (0.049)  (0.046)     
                    
3 1000 5 40 28.40 10.000  0.630  0.000  1.000  28.41  9.996  0.233  -0.005  0.937  32%  37 
           (3.159)  (0.148)  (0.156)  (0.125)  (0.073)     
                
4 1000 5 40 28.40 10.000 0.630 0.000 1.000 28.97 9.994 0.239 0.021 0.928 28% 40(fixed) 








Table III-15. Simulation Results for QTL Locates at 28.2 with 5cM Mpd. 
Simulation parameters are summarized in columns ‘Simulation Model’ and ‘Simulation Parameters’ and the means and standard deviations of the corresponding estimates are summarized in column 
‘Means of Estimates’.  If the estimated QTL location for each replicate is within 0.10 Mpd to its true location, i.e. listed in column QTL of ‘Simulation Model’, it will be claimed as ‘accurate’, and the 
overall percentages of claimed ‘accurate’ throughout 100 replicates are listed in column ‘Percentage of Accuracy’. The mean of estimated T for each population is listed in column ‘Average T’.   
Simulation Model Simulation Parameters 
Estimates 
(with Standard Deviation) 
Percentage of 
Accuracy 
(Biased less or 





M) T QTL  u a d v QTL U A D v  
1 300 5 30 28.20 10.000  0.630  0.000  1.000  28.15  9.971  0.359  0.001  0.906  30% 29 
           (0.62)  (0.103)  (0.113)  (0.100)  (0.088)     
                    
2 300 5 35 28.20 10.000  0.630  0.000  1.000  28.07  9.991  0.349  -0.012  0.907  30%  34 
           (0.34)  (0.106)  (0.090)  (0.105)  (0.068)     
                    
3 300 5 40 28.20 10.000  0.630  0.000  1.000  28.08  9.958  0.320  0.017  0.913  48%  37 
           (0.82)  (0.150)  (0.109)  (0.104)  (0.074)     
                
4 1000 5 35 28.20 10.000 0.630 0.000 1.000 28.22 9.979 0.333 -0.003 0.928 50% 35 
         (0.23) (0.048) (0.053) (0.066) (0.041)   
                
5 1000 5 40 28.20 10.000 0.630 0.000 1.000 28.20 9.986 0.316 0.003 0.939 69% 41 
         (0.19) (0.071) (0.061) (0.059) (0.042)   
                
6 1000 5 45 28.20 10.000 0.630 0.000 1.000 28.10 9.969 0.293 0.001 0.948 68% 46 
         (0.25) (0.070) (0.058) (0.055) (0.043)   
                
7 3000 5 40 28.20 10.000 0.630 0.000 1.000 28.24 9.979 0.304 -0.003 0.945 82% 40 
         (0.15) (0.042) (0.034) (0.003) (0.028)   
                
8 3000 5 45 28.20 10.000 0.630 0.000 1.000 28.23 9.975 0.287 0.004 0.947 88% 46 




Table III-16. Simulation Results for QTL Locates at 28.4 with 5cM Mpd. 
Simulation parameters are summarized in columns ‘Simulation Model’ and ‘Simulation Parameters’ and the means and standard deviations of the corresponding estimates are summarized in column 
‘Means of Estimates’.  If the estimated QTL location for each replicate is within 0.10 Mpd to its true location, i.e. listed in column QTL of ‘Simulation Model’, it will be claimed as ‘accurate’, and the 
overall percentages of claimed ‘accurate’ throughout 100 replicates are listed in column ‘Percentage of Accuracy’. The mean of estimated T for each population is listed in column ‘Average T’.   
Simulation Model Simulation Parameters 
Estimates 
(with Standard Deviation) 
Percentage of 
Accuracy 
(Biased less or 





M) T QTL  u a d v QTL U a d v  
1 300 5 30 28.40 10.000  0.630  0.000  1.000  28.19  9.957  0.334  0.009  0.938  39% 28 
           (0.86)  (0.095)  (0.120)  (0.108)  (0.079)     
                    
2 300 5 35 28.40 10.000  0.630  0.000  1.000  28.31  9.985  0.284  -0.024  0.930  35%  34 
           (1.42)  (0.123)  (0.132)  (0.101)  (0.087)     
                    
3 300 5 40 28.40 10.000  0.630  0.000  1.000  28.41  9.996  0.233  0.004  0.937  32%  37 
           (3.16)  (0.148)  (0.156)  (0.125)  (0.073)     
                
4 1000 5 35 28.40 10.000 0.630 0.000 1.000 28.42 9.976 0.295 0.002 0.957 71% 35 
         (0.19) (0.063) (0.046) (0.058) (0.039)   
                
5 1000 5 40 28.40 10.000 0.630 0.000 1.000 28.36 9.976 0.271 -0.007 0.964 75% 41 
         (0.23) (0.077) (0.059) (0.054) (0.037)   
                
6 1000 5 45 28.40 10.000 0.630 0.000 1.000 28.36 9.967 0.228 -0.003 0.969 63% 45 
         (0.24) (0.081) (0.056) (0.051) (0.039)   
                
7 3000 5 40 28.40 10.000 0.630 0.000 1.000 28.41 9.977 0.265 0.001 0.961 94% 40 
         (0.08) (0.044) (0.028) (0.028) (0.027)   
                
8 3000 5 45 28.40 10.000 0.630 0.000 1.000 28.40 9.967 0.237 -0.006 0.970 90% 46 
         (0.10) (0.051) (0.032) (0.034) (0.025)   




Table III-17. Simulation Results for 10cM Mpd. 
Simulation parameters are summarized in columns ‘Simulation Model’ and ‘Simulation Parameters’ and the means and standard deviations of the corresponding estimates are summarized in column 
‘Means of Estimates’.  If the estimated QTL location for each replicate is within 0.10 Mpd to its true location, i.e. listed in column QTL of ‘Simulation Model’, it will be claimed as ‘accurate’, and the 
overall percentages of claimed ‘accurate’ throughout 100 replicates are listed in column ‘Percentage of Accuracy’. The mean of estimated T for each population is listed in column ‘Average T’.   
Simulation Model Simulation Parameters 
Estimates 
(with Standard Deviation) 
Percentage of 
Accuracy 
(Biased less or 





M) T QTL  u a d v QTL U A d v  
1 300 10 10 28.20 10.000  0.630  0.000  1.000  28.28 9.996  0.419  0.011  0.885  29% 9 
           (0.40)  (0.070)  (0.068)  (0.095)  (0.071)     
                    
2 300 10 15 28.20 10.000  0.630  0.000  1.000  28.23  9.990  0.367  -0.023  0.914  30%  14 
           (0.33)  (0.088)  (0.077)  (0.089)  (0.066)     
                    
3 300 10 20 28.20 10.000  0.630  0.000  1.000  27.98  9.981  0.316  -0.017  0.928  41%  20 
           (0.93)  (0.093)  (0.010)  (0.092)  (0.076)     
                
4 300 10 25 28.20 10.000 0.630 0.000 1.000 28.40 10.001 0.255 -0.018 0.948 51% 23 
         (2.04) (0.115) (0.109) (0.104) (0.078)   
                
5 300 10 10 28.40 10.000  0.630  0.000  1.000  28.43 9.991 0.410 -0.016 0.909 45% 9 
         (0.32) (0.070) (0.075) (0.091) (0.070)   
                
6 300 10 15 28.40 10.000  0.630  0.000  1.000  28.27 9.992 0.314 0.001 0.936 44% 15 
         (0.93) (0.088) (0.086) (0.089) (0.070)   
                
7 300 10 20 28.40 10.000  0.630  0.000  1.000  28.52 9.990 0.251 0.003 0.940 42% 20 
         (1.99) (0.087) (0.104) (0.089) (0.080)   
                
8 300 10 25 28.40 10.000  0.630  0.000  1.000  28.64 9.995 0.193 -0.013 0.962 22% 23 
         (2.71) (0.116) (0.117) (0.122) (0.086)   




Table III-18. Simulation Results for 50cM Mpd. 
Simulation parameters are summarized in columns ‘Simulation Model’ and ‘Simulation Parameters’ and the means and standard deviations of the corresponding estimates are summarized in column 
‘Means of Estimates’.  If the estimated QTL location for each replicate is within 0.10 Mpd to its true location, i.e. listed in column QTL of ‘Simulation Model’, it will be claimed as ‘accurate’, and the 
overall percentages of claimed ‘accurate’ throughout 100 replicates are listed in column ‘Percentage of Accuracy’. The mean of estimated T for each population is listed in column ‘Average T’.   
Simulation Model Simulation Parameters 
Estimates 
(with Standard Deviation) 
Percentage of 
Accuracy 
(Biased less or 





M) T QTL  u a d v QTL U A d v  
1 300 50 3 28.20 10.000  0.630  0.000  1.000  28.15  9.993  0.342  0.011  0.919  45% 3 
           (0.32)  (0.053)  (0.065)  (0.074)  (0.076)     
                    
2 300 50 5 28.20 10.000  0.630  0.000  1.000  28.25 9.988  0.275  0.000  0.938  58%  5 
           (1.74)  (0.061)  (0.103)  (0.092)  (0.068)     
                    
3 300 50 3 28.40 10.000  0.630  0.000  1.000  28.46  9.994  0.321  0.007  0.955  53%  3 
           (0.88)  (0.062)  (0.082)  (0.096)  (0.073)     
                
4 300 50 5 28.40 10.000 0.630 0.000 1.000 28.66 9.999 0.202 0.005 0.956 29% 5 
         (2.90) (0.068) (0.086) (0.091) (0.083)   
                
5 1000 50 5 28.40 10.000 0.630 0.000 1.000 28.32 9.994 0.203 0.005 0.974 66% 6 
         (0.16) (0.038) (0.035) (0.050) (0.043)   









Table III-19. Simulation Results for Twin QTLs. 
Simulation parameters are summarized in columns ‘Simulation Model’ and ‘Simulation Parameters’ and the means and standard deviations of the corresponding estimates are summarized in column 
‘Estimates’. The mean of estimated T for each population is listed in column ‘Average T’.   
Simulation Model 
Simulation Parameters 
(Two QTL contribute equally) 
Estimates 





M) T QTL1 QTL2 U a d v QTL1  QTL2 u1 u2 a1 a2 d1 d2 v1 v2  
1 500 1 10 17.400 22.400 10.000  0.450  0.000  1.000  18.366 21.169 9.985 9.988 0.740  0.738 0.009  0.009 0.845  0.847 7   
            (0.995) (1.002) (0.050) (0.051) (0.062)  (0.065) (0.087)  (0.081) (0.059)  (0.061)   
                         
2 500 1 30 17.400 22.400 10.000  0.450  0.000  1.000  18.000 21.932 9.982 9.981 0.526  0.531 0.004  -0.016 0.885  0.885 23  
            (0.837) (0.841) (0.077) (0.074) (0.071)  (0.069) (0.101)  (0.083) (0.056)  (0.055)   
                         
3 500 1 50 17.400 22.400 10.000  0.450  0.000  1.000  17.400 22.281 9.960 9.958 0.438  0.448 0.004  0.003 0.913  0.909 41  
            (0.621) (0.660) (0.103) (0.099) (0.085)  (0.083) (0.093)  (0.104) (0.065)  (0.060)   
                         
4 500 1 10 17.400 22.400 10.000  0.320  0.000  1.000  18.371 21.352 10.004 10.003 0.524 0.524 0.005  0.005 0.925  0.924 7  
            (1.106) (1.005) (0.046) (0.050) (0.061)  (0.062) (0.092)  (0.091) (0.060)  (0.059)   
                         
5 500 1 30 17.400 22.400 10.000 0.320 0.000 1.000 17.905 21.827 9.987 9.985 0.395 0.388 0.006 0.016 0.945 0.950 23  
            (0.898) (0.957) (0.070) (0.077) (0.077) (0.075) (0.093) (0.096) (0.060) (0.065)   
                     
6 500 1 50 17.400 22.400 10.000 0.320 0.000 1.000 17.600 22.205 9.966 9.964 0.322 0.327 0.003 0.016 0.947 0.943 41  








3.3.2 The Relationship between T, r and n 
For convenience, each putative QTL location is measured in a map distance (Mpd). For 
example, saying the location of QTL is 20.4 means the real QTL locates between the 20th and 
the 21st markers, and the distances to them are in proportion 4:6 in Mpd, or equivalently 0.4 
Mpd to the 20th marker and 0.6 Mpd to the 21st marker. The step or gap to scan for the QTL 
is set to 0.1 Mpd if not specified otherwise, and the phrase ‘accurate’ is claimed once the 
estimated QTL is no more than 0.1 Mpd away from its real location.  
 
In Table III-14, two populations with different parameters are simulated with 100 replicates. 
For each replicate of each population, we estimate the QTL and parameters with either an 
estimated T, which is estimated through the implementation of Hill’s method as introduced in 
III-3.2, or a real T, i.e. the one used to simulate the population. The averages of both T 
through 100 replicates are shown in the last column of Table III-14, and as the real T is 
constant throughout all replicates, we hence indicate its average as ‘fixed’ in the table. It can 
be noticed from Table III-14 that there is no remarkable difference between estimations of 
parameters from the using of estimated or real T. We may hence claim that the estimated T 
could efficiently represent the number of generations the population has experienced through, 
and hence we will simply adopt the estimated T in the following simulation analyses.  
 
According to our simulation models as introduced above, all the genetic markers are in 
complete linkage at generation 0 and the initial LD coefficient between any a pair of genetic 
loci is of its maximum 0.25, where we have assumed the allele frequency at each genetic 
locus is 0.5. In order to acquire a validate estimate of QTL location, certain recombination 
generations are required to break down the complete linkage between marker loci. Generally, 
the closer two adjacent markers are with each other, a larger T  is required to break down 
their linkage. However, when T is too large, the information of markers will be quickly 
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shrunk, and hence the trade off between T and r has to be balanced. Behind such an effect, 
there are two main factors: the population size and the marker distance. The two main factors 
affect the results jointly, and hence it would not be very easy to distinguish their effects 
separately. As generally believed, the population size will affect the possibility of inbreeding, 
and in a population with a small population size, the random drift of allele frequency might 
have remarkable impacts at each generation (Kimura, 1983) and results in a significant 
spurious LD after certain generations. What is more, a smaller population surely has a lower 
statistical power to detect a true LD comparing to a larger one, and the corresponding results 
might lose accuracy under such a circumstance. For instance, in Table III-15 and Table III-16, 
the accuracy increases dramatically as the increase of population size among populations with 
the same T, e.g. populations 3, 5 and 7. On the other hand, the marker distance also affects the 
reduction of LD over generations. With low marker coverage, LD between a marker and QTL 
will diminish quickly. Thus, a spurious LD randomly raised due to the genetic drift will be 
more easily detected in a population with both a small population size and low marker 
coverage than otherwise, and the estimate of QTL location in such a population is hence more 
sensitive to the increase of T. For instance, we could notice that populations 2 and 4 in Table 
III-18, i.e. n=300, Mpd=50cM and T=5, have shown worse results than populations 1 and 3, 
i.e. n=300, Mpd=50cM and T=3, where the standard deviations of the estimated QTL 
locations in the former populations are much larger than those in the later ones. Similar 
reductions of accuracy in the presence of too high a T could also be observed in populations 
with n = 300 in Table III-15, Table III-16 and Table III-17. Note here, when the true QTL 
locates at 28.2, although we could observe a significant increase of standard deviations for the 
estimated QTLs in populations with n = 300, the claimed accuracy might still increase, e.g. 
population 2 in Table III-18 and population 4 in Table III-17, which is mainly because one of 
the flanking markers in such a circumstance could still provide adequate information 
compared to those populations with true QTLs located at 28.4, e.g. population 4 in Table 
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III-18 and population 8 in Table III-17. Comparing populations with varying number of 
individuals scored in Table III-15, Table III-16 and Table III-18, the increase in standard 
deviations of estimated QTL caused by the increase in T could be efficiently compensated by 
an increased population size.  
 
With above results and discussions, we could approximately outline an adequate T, which 
could efficiently break down the linkage between adjacent markers but not increase the 
chance of detecting spurious LDs. For instance, for a population with size n=300, the 
adequate T given a known marker distance could be listed as following 
T =3 for Mpd=50cM 
T =15-20 for Mpd=10cM,   
T =35-40 for Mpd=5cM 
As indicated in previous discussions, the adequate T listed above is ideal for a small 
population size. In a larger population, the adequate T will be larger as we could easily 
observe from Table III-15 and Table III-16, for example, with n=3000 and Mpd=5cM, T =45 
is approximately the best choice comparing to T =35-40 for n=300 and Mpd=5cM as we have 
indicated above. From above results, given a constant sample size, we might approximately 
assume that a given Mpd and its correspondingly adequate T are of negative-proportionality, 
e.g. T ×Mpd = 175 approximately when n=300. Following above derivations, we might 
expect that in case a smaller Mpd, says 1cM, is presented, an adequate T might be over 150. 
Also, a sufficiently large population size is required to control the rate of inbreeding. As both 
above requirements are hardly to be achieved in experimental conditions, this method is hence 
highly limited by the resolution it could achieve in such a circumstance, although those 




3.3.3 Detecting Linked QTLs 
The purpose of this session of analysis is to demonstrate how the present method could 
distinguish two closely linked QTLs. In the simulated chromosome, we adopt Mpd=1cM 
between any two adjacent genetic markers. As these two QTLs are located at 17.4 and 22.4 in 
the chromosome, they are hence 5cM apart from each other. Except for the locations of QTLs, 
the remaining simulation processes are exactly the same as introduced in section III-3.3.1. For 
the sake of clear comparison to be made from the simulation study, we set the highest 
recombination generations T to be 50.  
 
Although 50 generations of recombination might not be large enough to yield the most 
prominently accurate estimates of QTL locations as has been indicated in section III-3.3.2, it 
is sufficient to separate these two closely linked QTLs as shown in Table III-19 and Figure 
III-3 (e),(f). Figure III-3 illustrates the lod score values of composite likelihood ratio test 
statistics for each simulated population in Table III-19, where (a) (c) (e) are illustrated for 
population 1, 2, 3, respectively and (b) (d) (f) are illustrated for population 4, 5, 6, 
respectively. We could directly observe from Figure III-3 that unless the recombination 
generation is sufficiently high, i.e. T = 50 as shown in (e) and (f), the presented method failed 
to separate these two QTLs effectively at T =10 and T =30 as shown in (a) – (d). Alternatively, 
the estimates of a for both QTLs, denoted as a1 and a2 in Table III-19, could provide a 
statistical criterion of whether these two QTLs have been detected separately through the 
presented method. It could be easily noticed that in Table III-19, the estimates of a1 and a2 
are significantly larger than their true values given T = 10 or 30, i.e. population 1, 2, 4, 5. 
Especially, in population 1 and 4, either estimates of a1 or a2 solely could represent the whole 
phenotypic contributions from both QTLs, which implies that these two QTLs are not 
sufficiently separated. 
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Above results, again, show that a sufficient recombination generation is crucial in the ability 
of the presented method to properly estimate a QTL. However, these results also show that 
even the recombination generation is far from ideal as proposed in section III-3.3.2, where the 
accuracy of estimate might be reduced when compared to an ideal T, the presented method 
could still integrate sufficient information to distinguish two closely linked QTLs.  
  
(a)                                                                                   (b) 
  
(c)                                                                                    (d) 
  
(e)                                                                                     (f) 
Figure III-3. Figure III-3 illustrates the means of lod score values of composite likelihood ratio statistics for each simulated population in 
Table III-19, where (a) (c) (e) for population 1, 2, 3, respectively and (b) (d) (f) for population 4, 5, 6, respectively. The locations of true 





3.4 Conclusion and Discussion 
In Chapter III-3, we present a likelihood-based method for association studies, which could 
properly estimate the location of a putative QTL within a marker interval. The validation of 
our presented method relies on the marker density and recombination generations, i.e. T, the 
population has experienced ever since the introduction of mutate alleles. As both information 
is either available or could be directly estimated from other resources, the presented method 
could hence be generally applied for any random samples with a quantitative trait. 
 
The validation and performance of our presented method have been intensively evaluated 
through simulation studies in III-3.3, where the method has shown a remarkable accuracy in 
estimating QTL locations within marker intervals, and the mapping resolution is hence 
improved significantly compared to traditional methods, e.g. a linear regression, which are 
based on detecting the association between a genetic marker and a putative QTL. However, 
we have also shown that the performance of this presented method heavily relies on the 
recombination generation T. That is, with a known genetic distance between any a pair of 
genetic markers, a sufficiently large T is required to allow the presence of enough 
recombination events to break down the linkage between these two markers. For instance, we 
have shown in section III-3.3.2 that T >100 is required for Mpd=1cM in order to maximize 
the performance of our presented method. Although a less sufficient T will reduce the 
accuracy of estimates of QTL parameters, it does not influence the validation of the presented 
method. The present method is fairly robust to these population parameters and should have 
taken advantages of improved mapping resolution if the population of interest has evolved 
sufficient generations after the introduction of mutated alleles at QTLs. Nowadays, with the 
development of sequencing technology and the accomplishment of HapMap Phase III 
(Altshuler et al., 2010), human data with over half a million SNPs are quite common. As 
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SNPs in these human data are so close to each other, there might not be sufficient 
recombination for us to infer a putative QTL between two SNPs. However, for less 
sophisticated species, where the available markers are of less density than in human genome, 
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FINAL CONCLUSION  
Throughout the whole thesis, I mainly focused on the strategies and statistical methods for 
association analysis of complex traits. Besides the general introduction of QTL mappings, I 
have divided this thesis into two chapters, i.e. Chapter II: The Comparison of Linear Models 
in Association Study and the Optimal Trend Coefficients in Armitage’s Trend Test, and 
Chapter III: Likelihood-based Methods for Association Studies.  
 
The thesis started to introduce the commonly used genetic and statistical models in 
association analysis in Chapter II-1, and was then followed by thorough comparison and 
evaluation of the performance of these commonly used methods in Chapter II-2. From these 
analyses, I concluded that SLR was generally better than a fixed effect model as the former 
method normally showed an increased statistical power especially if a proper set of ix , which 
represented the genetic effects of a genetic marker, was used. The two different genetic 
models, i.e. explicit and implicit, were asymptotically equivalent among various statistical 
models, e.g. SLR, ANOVA and ML, under the scheme of the Rao’s score test. These results 
hence suggest use of SLR with the explicit model for association analysis due to their 
mathematical convenience. With the results above, I further explore the optimal choice of ix  
under SLR for Case-Control studies in Chapter III-3, where in such a situation, SLR was 
demonstrated to be equivalent to the so-called Armitage’s trend test with ix  being the 
corresponding trend coefficient. I have managed to show that the presence of heterogeneity 
will largely influence the choice of optimal trend set, and hence I suggest the use of trend set 
{1, 0.5, 0} for both dominance and co-dominance models, and trend set {1, 0.25, 0} for the 
recessive model. Such suggestions differ from those given by Sasieni (1997), and the results 
from simulation analyses favour our suggestions over Sasieni’s. In Chapter III-3, I also 
compared two strategies to correct for population stratification when multiple samples are 
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combined to increase the statistical power, i.e. incorporating dummy variables as introduced 
in section II-3.3.1 and non-central χ
2
 test as introduced in section II-3.3.2 above. Through 
both simulation study and real data analysis, we have shown that both methods enable one to 
properly adjust the bias introduced by population stratification. However, the former method, 
i.e. dummy variable, is favoured if the differences of case-control ratios among multiple 
samples are large, and the other, i.e. non-central χ
2
 test, is favoured otherwise. During the 
establishment of non-central χ
2
 test, I have shown that population stratification will have 
distinguishable impacts on one or both of the numerator and denominator of the Armitage’s 
trend test given as formula (II-1.21). For the numerator, influence from population 
stratification could be either positive or negative, and it is the main cause of false positive. On 
the contrary, the influence on the denominator from population stratification could only be 
positive, and because the denominator was proportional to the variance of the numerator and 
hence was positive as well, such influence would rather reduce the statistical power than 
increase it. The influence on the denominator was initially proposed to increase the statistical 
power with certain flaws by Devlin & Roeder (1999). When the newly developed method was 
implemented to association study with Parkinson’s disease data (Simon-Sanchez et al. 2009), 
it revealed several new candidate genes which showed significant association with the disease. 
All these genes have long been proposed as candidates by neuro-biologist but never detected 
in the current literature of the GWAS. 
 
In Chapter III-1, I proposed a likelihood method using the conditional probability distribution 
to estimate the coefficient of LD between the marker and disease loci for non-random samples. 
Through the comprehensive simulation studies and real data analyses, it has been shown that 
the new method could not only properly estimate LD coefficients in random samples as the 
traditional method does, i.e. Hill’s (1974), but also provide significant improvement of 
estimation accuracy if the data is artificially collected and thus non-random. Following the 
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same idea, a further conditional likelihood of association study for Case-Control samples is 
established in Chapter III-2. This method delivers the ability to easily adapt any penetrance 
models and to count for the non-random nature of samples from a case and control design. Its 
capacity to significantly improve statistical power to detect the genetic association was 
illustrated through simulation studies and real data analyses. In the real data analysis, I 
implemented the newly proposed method to analyse the same Parkinson’s data as introduced 
in Chapter II-3 and compared the method with two other popularly cited methods in the 
literature of genetic association. Finally, in Chapter III-3, I present a likelihood-based method 
for association studies, which provided a genome-wide scan for QTL based on linkage 
disequilibrium analysis. The validation and performance of this method have been assessed 
through simulation studies, and a significant increase in mapping resolution was  shown by 
the LD based QTL analysis. 
 
Along with acquiring more comprehensive genetic knowledge through above researches, I 
have gained plenty of sophisticated trainings and practices in both statistics and computational 
programming. Not only the using of common statistical tools, e.g. SPSS, STATA, I am also 
professional in programming statistical methods and simulating statistical ideas in FORTRAN 
and R languages. These experiences hence strengthen my ability to develop new statistical 
methods and handle various kinds of data in real data analyses. 
 
